[
  {
    "id": "Medical-6e39cbe0",
    "source": "Medical",
    "question": "Which anatomical layer acts as a barrier before cancer reaches the outer membrane (serosa) of the gallbladder?",
    "answer": "The perimuscular fibrous tissue acts as a barrier before the serosa.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The perimuscular fibrous tissue acts as a barrier before the serosa."
    ],
    "evidence_relations": [
      "Perimuscular fibrous tissue surrounds the muscle layer",
      "Serosa is the outer membrane covering the gallbladder and bile ducts",
      "The gallbladder wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa"
    ]
  },
  {
    "id": "Medical-6ac9b753",
    "source": "Medical",
    "question": "What diagnostic methods are required for confirming MGZL and why?",
    "answer": "Expert hematopathologist review is required because of the overlapping features with other lymphomas.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Expert hematopathologist review is required to confirm MGZL.",
      "MGZL has overlapping features with other lymphomas."
    ],
    "evidence_relations": [
      "Diagnosis of MGZL requires expert hematopathologist review",
      "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
    ]
  },
  {
    "id": "Medical-f6a94128",
    "source": "Medical",
    "question": "Which tests are essential to perform before starting systemic therapy in a young AML patient concerned about fertility?",
    "answer": "Fertility preservation counseling and referral to a reproductive specialist should be done before therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility preservation counseling should be done before starting systemic therapy in a young AML patient.",
      "Referral to a reproductive specialist should be done before starting systemic therapy in a young AML patient."
    ],
    "evidence_relations": [
      "Fertility preservation should be discussed before starting systemic therapy",
      "Fertility Preservation includes fertility preservation counseling and referral to reproductive specialist"
    ]
  },
  {
    "id": "Medical-328006b7",
    "source": "Medical",
    "question": "What combination of exposure and symptom would most strongly suggest the need for diagnostic evaluation for lung cancer?",
    "answer": "A history of tobacco smoking combined with chest pain should prompt diagnostic evaluation for lung cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A history of tobacco smoking should prompt diagnostic evaluation for lung cancer.",
      "Chest pain should prompt diagnostic evaluation for lung cancer.",
      "The combination of tobacco smoking and chest pain suggests the need for diagnostic evaluation for lung cancer."
    ],
    "evidence_relations": [
      "Tobacco smoking is the biggest risk factor for lung cancer",
      "Symptoms of lung cancer may include chest pain",
      "Biopsy is used to confirm lung cancer diagnosis"
    ]
  },
  {
    "id": "Medical-23080670",
    "source": "Medical",
    "question": "If a patient presents with a large mediastinal mass and is assigned male at birth aged 25, what additional diagnostic step is necessary?",
    "answer": "Expert hematopathologist review is necessary to confirm MGZL diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A patient with a large mediastinal mass and assigned male at birth aged 25 requires expert hematopathologist review.",
      "Expert hematopathologist review is necessary to confirm MGZL diagnosis."
    ],
    "evidence_relations": [
      "MGZL is characterized by a large mediastinal mass",
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth",
      "Diagnosis of MGZL requires expert hematopathologist review"
    ]
  },
  {
    "id": "Medical-c7bf38df",
    "source": "Medical",
    "question": "If a tumor is located at the esophagogastric junction, which classification system and factors are used for staging and treatment planning?",
    "answer": "The Siewert classification and factors such as cancer type, location, and stage are used.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The Siewert classification is used for staging and treatment planning of tumors at the esophagogastric junction.",
      "Factors such as cancer type are used for staging and treatment planning.",
      "Factors such as cancer location are used for staging and treatment planning.",
      "Factors such as cancer stage are used for staging and treatment planning."
    ],
    "evidence_relations": [
      "Siewert types are used to stage tumors at the esophagogastric junction",
      "Treatment planning is based on cancer type, location, and stage",
      "Siewert types (for EGJ tumors) are included in treatment planning"
    ]
  },
  {
    "id": "Medical-aaefb0f2",
    "source": "Medical",
    "question": "What surveillance strategies are recommended after local excision or ESD for T1 rectal cancer?",
    "answer": "Regular flexible sigmoidoscopy every 6 months and imaging (EUS or MRI) every 3-6 months are recommended for up to 5 years.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Regular flexible sigmoidoscopy every 6 months is recommended after local excision or ESD for T1 rectal cancer.",
      "Imaging (EUS or MRI) every 3-6 months is recommended for up to 5 years after local excision or ESD for T1 rectal cancer."
    ],
    "evidence_relations": [
      "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging",
      "Flexible sigmoidoscopy every 6 months for 5 years is recommended for T1 rectal tumors",
      "Imaging (EUS or MRI) every 3-6 months for 2 years, then every 6 months through year 5 is part of surveillance for T1 tumors"
    ]
  },
  {
    "id": "Medical-f9bc1472",
    "source": "Medical",
    "question": "If a patient presents with a single enlarged lymph node in the head and neck and minimal symptoms, which FL subtype is most likely, and what is its typical genetic status?",
    "answer": "Pediatric-type FL (PTFL) is most likely, typically lacking the t(14;18) translocation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pediatric-type FL (PTFL) is most likely if a patient presents with a single enlarged lymph node in the head and neck.",
      "Pediatric-type FL (PTFL) typically lacks the t(14;18) translocation."
    ],
    "evidence_relations": [
      "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms",
      "Genetic Alteration of uncommon FL (uFL) is t(14;18)-negative",
      "PTFL is a distinct cancer subtype in the ontology"
    ]
  },
  {
    "id": "Medical-e7d1cd1c",
    "source": "Medical",
    "question": "How does the subtype of NSCLC influence the origin of the cancer cells?",
    "answer": "Adenocarcinoma forms from alveolar mucus-producing cells, while squamous cell carcinoma originates from bronchial lining cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adenocarcinoma forms from alveolar mucus-producing cells.",
      "Squamous cell carcinoma originates from bronchial lining cells."
    ],
    "evidence_relations": [
      "Adenocarcinoma often forms from cells that line the alveoli and make mucus",
      "Squamous cell carcinoma forms from cells that line the bronchi"
    ]
  },
  {
    "id": "Medical-2cc4ff58",
    "source": "Medical",
    "question": "For a patient with a tumor in the retromolar trigone, which cancer subtype and anatomic site categories are relevant for diagnosis and staging?",
    "answer": "The relevant cancer subtype is squamous cell carcinoma (SCC) and the anatomic site is the retromolar trigone.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The relevant cancer subtype for a tumor in the retromolar trigone is squamous cell carcinoma (SCC).",
      "The relevant anatomic site for a tumor in the retromolar trigone is the retromolar trigone."
    ],
    "evidence_relations": [
      "Squamous cell carcinoma (SCC) is the most common subtype of mouth cancer",
      "Mouth cancer can develop in the retromolar trigone",
      "Anatomic Site includes retromolar trigone for SCC in the ontology"
    ]
  },
  {
    "id": "Medical-333a4a3b",
    "source": "Medical",
    "question": "Which bone sarcoma subtype is most likely to arise in the diaphysis or flat bones, and what genetic alteration is characteristic of this subtype?",
    "answer": "Ewing sarcoma most commonly arises in the diaphysis or flat bones and is characterized by the t(11;22) translocation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Ewing sarcoma most commonly arises in the diaphysis or flat bones.",
      "Ewing sarcoma is characterized by the t(11;22) translocation."
    ],
    "evidence_relations": [
      "Ewing sarcoma: Anatomic Location: [\"Diaphysis\", \"Flat bones (pelvis, scapula)\"]",
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1",
      "Ewing sarcoma: Genetic Alteration: [\"t(11;22) translocation\"]"
    ]
  },
  {
    "id": "Medical-35fee661",
    "source": "Medical",
    "question": "Which diagnostic procedures would be prioritized for a patient with primary CNS lymphoma presenting with blurry vision and suspected eye involvement?",
    "answer": "Eye exam, slit lamp, and vitrectomy would be prioritized for suspected eye involvement.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Eye exam is prioritized for a patient with primary CNS lymphoma and suspected eye involvement.",
      "Slit lamp examination is prioritized for suspected eye involvement.",
      "Vitrectomy is prioritized for suspected eye involvement."
    ],
    "evidence_relations": [
      "Primary CNS lymphoma most commonly affects the brain, but can also involve the spinal cord, cerebrospinal fluid, and eyes",
      "Primary CNS lymphoma can cause neurological symptoms such as vision changes",
      "Diagnostic Method for Primary CNS lymphoma includes Eye exam, Slit lamp, and Vitrectomy"
    ]
  },
  {
    "id": "Medical-ed26b623",
    "source": "Medical",
    "question": "Which laboratory tests are essential for initial workup of primary CNS lymphoma, particularly in patients with suspected immunodeficiency?",
    "answer": "Blood tests including CBC, CMP, LDH, and HIV blood test are essential for initial workup.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood tests including CBC are essential for initial workup of primary CNS lymphoma.",
      "Blood tests including CMP are essential for initial workup of primary CNS lymphoma.",
      "Blood tests including LDH are essential for initial workup of primary CNS lymphoma.",
      "HIV blood test is essential for initial workup of primary CNS lymphoma."
    ],
    "evidence_relations": [
      "Primary CNS lymphoma is diagnosed using blood tests",
      "Laboratory Tests for Primary CNS lymphoma include Complete blood count (CBC), Comprehensive metabolic panel (CMP), Lactate dehydrogenase (LDH), HIV blood test"
    ]
  },
  {
    "id": "Medical-2782702e",
    "source": "Medical",
    "question": "What symptoms would prompt a clinician to perform a skin biopsy for suspected CSCC?",
    "answer": "Scaly patches, solid or misshapen lesions, or lesions in areas of chronic damage would prompt a skin biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Scaly patches would prompt a skin biopsy for suspected CSCC.",
      "Solid or misshapen lesions would prompt a skin biopsy for suspected CSCC.",
      "Lesions in areas of chronic damage would prompt a skin biopsy for suspected CSCC."
    ],
    "evidence_relations": [
      "Symptoms of CSCC include scaly patches, solid or misshapen skin lesions, and lesions in areas of chronic damage",
      "Diagnosis of CSCC involves clinical examination, skin biopsy, and imaging (CT, MRI, PET/CT) if deeper invasion or spread is suspected"
    ]
  },
  {
    "id": "Medical-c09d2bcb",
    "source": "Medical",
    "question": "Which populations are at increased risk for nasopharyngeal carcinoma and what risk factors contribute to this increased incidence?",
    "answer": "People from Asia, Native America, and North Africa are at increased risk due to geographic origin and EBV infection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "People from Asia are at increased risk for nasopharyngeal carcinoma.",
      "Native Americans are at increased risk for nasopharyngeal carcinoma.",
      "People from North Africa are at increased risk for nasopharyngeal carcinoma.",
      "Geographic origin contributes to the increased incidence of nasopharyngeal carcinoma.",
      "EBV infection contributes to the increased incidence of nasopharyngeal carcinoma."
    ],
    "evidence_relations": [
      "NPC most often occurs in people from parts of Asia, Native America, and North Africa",
      "Most NPCs are related to Epstein-Barr virus (EBV) infection",
      "Geographic origin and EBV are risk factors for NPC"
    ]
  },
  {
    "id": "Medical-68e55e0e",
    "source": "Medical",
    "question": "If a patient has papules under the skin and is diagnosed with a lymphoma subtype originating from B lymphocytes, which subtypes should be considered?",
    "answer": "Primary cutaneous marginal zone lymphoma, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type should be considered.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary cutaneous marginal zone lymphoma should be considered.",
      "Primary cutaneous follicle center lymphoma should be considered.",
      "Primary cutaneous diffuse large B-cell lymphoma, leg type should be considered."
    ],
    "evidence_relations": [
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "CBCL appears as nodules or papules under the skin",
      "CBCL starts in B cells"
    ]
  },
  {
    "id": "Medical-1e7500e4",
    "source": "Medical",
    "question": "What combination of tests would be used to assess both disease burden and prognosis in CLL?",
    "answer": "CBC, beta-2 microglobulin, biomarker testing (FISH, DNA sequencing, karyotype), and diagnostic CT scan assess disease burden and prognosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CBC is used to assess disease burden in CLL.",
      "Beta-2 microglobulin is used to assess prognosis in CLL.",
      "Biomarker testing, including FISH, DNA sequencing, and karyotype, is used to assess disease burden in CLL.",
      "A diagnostic CT scan is used to assess prognosis in CLL."
    ],
    "evidence_relations": [
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis",
      "Diagnostic CT scans may be used to assess lymph node involvement and disease extent"
    ]
  },
  {
    "id": "Medical-37f18801",
    "source": "Medical",
    "question": "What features distinguish grade 3A from grade 3B follicular lymphoma in terms of treatment?",
    "answer": "Grade 3A FL may be treated as classic FL or as DLBCL, while grade 3B FL is always treated as DLBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Grade 3A FL may be treated as classic FL.",
      "Grade 3A FL may be treated as DLBCL.",
      "Grade 3B FL is always treated as DLBCL."
    ],
    "evidence_relations": [
      "Grade 3A FL may be treated as classic FL or as diffuse large B-cell lymphoma (DLBCL)",
      "Grade 3B FL is treated as DLBCL",
      "Grade 3A and 3B differ in classification and management"
    ]
  },
  {
    "id": "Medical-f57e3ab2",
    "source": "Medical",
    "question": "What combination of clinical and pathological features would support a diagnosis of mediastinal gray zone lymphoma (MGZL) in a young male patient?",
    "answer": "A large mediastinal mass, Reed-Sternberg cells, and an age of 20-40 years assigned male at birth support MGZL diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A large mediastinal mass supports a diagnosis of mediastinal gray zone lymphoma (MGZL).",
      "Reed-Sternberg cells support a diagnosis of mediastinal gray zone lymphoma (MGZL).",
      "An age of 20-40 years assigned male at birth supports a diagnosis of mediastinal gray zone lymphoma (MGZL)."
    ],
    "evidence_relations": [
      "MGZL is characterized by a large mediastinal mass",
      "Reed-Sternberg cells are characteristic histopathological features in MGZL",
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth"
    ]
  },
  {
    "id": "Medical-6d56985a",
    "source": "Medical",
    "question": "How does the diagnosis of gray zone lymphoma change if there is extra-mediastinal disease?",
    "answer": "If extra-mediastinal disease is present, the diagnosis changes to DLBCL, not otherwise specified (DLBCL-NOS).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "If extra-mediastinal disease is present, the diagnosis changes.",
      "The diagnosis changes to DLBCL, not otherwise specified (DLBCL-NOS) if extra-mediastinal disease is present."
    ],
    "evidence_relations": [
      "If extra-mediastinal disease: Diagnose as DLBCL-NOS",
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement"
    ]
  },
  {
    "id": "Medical-831bb1e6",
    "source": "Medical",
    "question": "Which combination of risk factors should prompt earlier and more frequent skin exams for BCC?",
    "answer": "A combination of older age, fair skin, and family history of skin cancer should prompt more frequent skin exams.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Older age is a risk factor for basal cell carcinoma.",
      "Fair skin is a risk factor for basal cell carcinoma.",
      "Family history of skin cancer is a risk factor for basal cell carcinoma.",
      "A combination of these risk factors should prompt more frequent skin exams."
    ],
    "evidence_relations": [
      "Older age is associated with higher risk of BCC",
      "Fair skin and family history of skin cancer increase risk of BCC",
      "Follow-up includes full skin exams with a doctor at least once a year"
    ]
  },
  {
    "id": "Medical-781a9787",
    "source": "Medical",
    "question": "What diagnostic tests are used for both initial evaluation and staging of colon cancer, and what unique information does each provide?",
    "answer": "Blood tests (CBC, chemistry profile, CEA) are used for initial evaluation, while CT with contrast is the main imaging test for staging and surveillance; CEA is also a biomarker for monitoring.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood tests like CBC, chemistry profile, and CEA are used for initial evaluation of colon cancer.",
      "CT with contrast is the main imaging test for staging and surveillance of colon cancer.",
      "CEA is a biomarker for monitoring colon cancer."
    ],
    "evidence_relations": [
      "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing",
      "CT with contrast is the main imaging test for staging and surveillance",
      "CEA is a biomarker for monitoring colon cancer"
    ]
  },
  {
    "id": "Medical-27edd702",
    "source": "Medical",
    "question": "What systemic therapies are available for bladder cancer patients with advanced or metastatic disease?",
    "answer": "Systemic therapies include chemotherapy (cisplatin-based regimens), immunotherapy (checkpoint inhibitors), and targeted therapies.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Systemic therapies for advanced or metastatic bladder cancer include chemotherapy.",
      "Cisplatin-based regimens are a type of chemotherapy for bladder cancer.",
      "Systemic therapies for advanced or metastatic bladder cancer include immunotherapy.",
      "Checkpoint inhibitors are a type of immunotherapy for bladder cancer.",
      "Systemic therapies for advanced or metastatic bladder cancer include targeted therapies."
    ],
    "evidence_relations": [
      "Systemic therapy includes chemotherapy, immunotherapy (checkpoint inhibitors), and targeted therapy",
      "Chemotherapy regimens include cisplatin-based combinations such as ddMVAC",
      "Immunotherapy agents include pembrolizumab, nivolumab, avelumab, and atezolizumab",
      "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy)",
      "Stage 4 bladder cancer is metastatic and may involve distant organs"
    ]
  },
  {
    "id": "Medical-884a8392",
    "source": "Medical",
    "question": "Which cancers are managed similarly to ovarian cancer and why might their management overlap?",
    "answer": "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer due to shared origin and treatment protocols.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary peritoneal cancer is managed similarly to ovarian cancer.",
      "Fallopian tube cancer is managed similarly to ovarian cancer.",
      "Primary peritoneal cancer and fallopian tube cancer share an origin.",
      "Primary peritoneal cancer and fallopian tube cancer have similar treatment protocols."
    ],
    "evidence_relations": [
      "Primary peritoneal cancer and fallopian tube cancer are managed similarly to ovarian cancer",
      "The ontology lists primary peritoneal cancer and fallopian tube cancer as related cancers under ovarian cancer"
    ]
  },
  {
    "id": "Medical-e0c754c6",
    "source": "Medical",
    "question": "How does the histopathology of MGZL relate to its clinical presentation?",
    "answer": "MGZL presents with a large mediastinal mass and Reed-Sternberg cells as histopathological features.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MGZL presents with a large mediastinal mass.",
      "MGZL has Reed-Sternberg cells as histopathological features."
    ],
    "evidence_relations": [
      "MGZL is characterized by a large mediastinal mass",
      "Reed-Sternberg cells are characteristic histopathological features in MGZL"
    ]
  },
  {
    "id": "Medical-98bb0bbc",
    "source": "Medical",
    "question": "How does the classification of uncommon FL (uFL) differ from classic FL (cFL), and how does this affect treatment?",
    "answer": "Uncommon FL is t(14;18)-negative or has unusual features, but is treated as classic FL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Uncommon FL is t(14;18)-negative.",
      "Uncommon FL has unusual features.",
      "Uncommon FL is treated as classic FL."
    ],
    "evidence_relations": [
      "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features and is treated as classic FL",
      "classic FL (cFL) is the standard classification for most FL"
    ]
  },
  {
    "id": "Medical-95bdfdba",
    "source": "Medical",
    "question": "Which symptoms should prompt consideration of throat cancer and subsequent diagnostic evaluation?",
    "answer": "Difficulty swallowing, sore throat, and voice changes should prompt evaluation for throat cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Difficulty swallowing should prompt evaluation for throat cancer.",
      "A sore throat should prompt evaluation for throat cancer.",
      "Voice changes should prompt evaluation for throat cancer."
    ],
    "evidence_relations": [
      "Symptoms of throat cancer may include difficulty swallowing, sore throat, and changes in voice",
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging"
    ]
  },
  {
    "id": "Medical-8ac49b5b",
    "source": "Medical",
    "question": "Which biomarker must be tested in all patients diagnosed with oropharyngeal cancer, and what is its clinical significance?",
    "answer": "p16 (HPV) testing must be performed in all oropharyngeal cancer patients as it serves as a surrogate biomarker for HPV-mediated disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "p16 (HPV) testing must be performed in all oropharyngeal cancer patients.",
      "p16 (HPV) serves as a surrogate biomarker for HPV-mediated disease."
    ],
    "evidence_relations": [
      "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer",
      "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer"
    ]
  },
  {
    "id": "Medical-5f54bb84",
    "source": "Medical",
    "question": "What symptoms and diagnostic findings would prompt a clinician to test for biomarkers and genetic changes in a suspected case of CBCL?",
    "answer": "The presence of skin nodules or papules and findings from biopsy or immunophenotyping would prompt biomarker and genetic testing in suspected CBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The presence of skin nodules or papules would prompt testing for biomarkers in suspected cutaneous B-cell lymphoma.",
      "Findings from biopsy would prompt testing for biomarkers in suspected cutaneous B-cell lymphoma.",
      "Findings from immunophenotyping would prompt testing for biomarkers in suspected cutaneous B-cell lymphoma."
    ],
    "evidence_relations": [
      "CBCL appears as nodules or papules under the skin",
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes"
    ]
  },
  {
    "id": "Medical-890965f6",
    "source": "Medical",
    "question": "What laboratory findings and symptoms together would strongly suggest a diagnosis of AML?",
    "answer": "The presence of ≥20% myeloblasts in bone marrow or blood along with symptoms such as fatigue, infections, bleeding, and bruising suggest AML.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The presence of ≥20% myeloblasts in bone marrow or blood suggests AML.",
      "Symptoms such as fatigue suggest AML.",
      "Symptoms such as infections suggest AML.",
      "Symptoms such as bleeding suggest AML.",
      "Symptoms such as bruising suggest AML."
    ],
    "evidence_relations": [
      "AML is diagnosed by the presence of ≥20% myeloblasts in bone marrow or blood",
      "Symptoms of AML include fatigue, infections, bleeding, and bruising"
    ]
  },
  {
    "id": "Medical-836e7db0",
    "source": "Medical",
    "question": "Which symptoms, when present together, would most strongly suggest CLL as a diagnosis requiring further blood and immunophenotyping tests?",
    "answer": "Swollen glands, fatigue, and recurrent infections together should prompt CLL workup with blood test and flow cytometry.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Swollen glands, fatigue, and recurrent infections together suggest CLL as a diagnosis.",
      "These symptoms should prompt a CLL workup.",
      "A blood test is required for the CLL workup.",
      "Flow cytometry is required for the CLL workup."
    ],
    "evidence_relations": [
      "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss",
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy"
    ]
  },
  {
    "id": "Medical-c58fae3b",
    "source": "Medical",
    "question": "Which targeted therapies are approved for progressive, unresectable, or metastatic thyroid cancer, and what is their main indication?",
    "answer": "Lenvatinib, sorafenib, and cabozantinib are approved for progressive, unresectable, or metastatic thyroid cancer not responsive to surgery or RAI.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lenvatinib is approved for progressive thyroid cancer.",
      "Sorafenib is approved for progressive thyroid cancer.",
      "Cabozantinib is approved for progressive thyroid cancer.",
      "These therapies are approved for unresectable thyroid cancer.",
      "These therapies are approved for metastatic thyroid cancer.",
      "These therapies are not responsive to surgery or RAI."
    ],
    "evidence_relations": [
      "Lenvatinib, sorafenib, and cabozantinib are targeted therapies for progressive, unresectable, or metastatic thyroid cancer",
      "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis"
    ]
  },
  {
    "id": "Medical-2045d4e4",
    "source": "Medical",
    "question": "Which diagnostic approach is shared among all adrenal tumor types and why is it important?",
    "answer": "CT scan and MRI scan are shared diagnostic methods among all adrenal tumor types because they are essential for detecting and characterizing adrenal masses.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CT scan is a shared diagnostic method among all adrenal tumor types.",
      "MRI scan is a shared diagnostic method among all adrenal tumor types.",
      "CT scan and MRI scan are essential for detecting adrenal masses.",
      "CT scan and MRI scan are essential for characterizing adrenal masses."
    ],
    "evidence_relations": [
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT",
      "Adrenocortical carcinoma (ACC) diagnostic methods include CT scan and MRI scan",
      "Pheochromocytoma diagnostic methods include CT scan and MRI scan"
    ]
  },
  {
    "id": "Medical-fdd40f83",
    "source": "Medical",
    "question": "What symptoms would most likely prompt a physician to perform a digital rectal exam and anoscopy for suspected anal cancer?",
    "answer": "Rectal bleeding, anal itching, anal pain, and an anal lump would prompt these exams.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Rectal bleeding would prompt a physician to perform a digital rectal exam and anoscopy for suspected anal cancer.",
      "Anal itching would prompt a physician to perform a digital rectal exam and anoscopy for suspected anal cancer.",
      "Anal pain would prompt a physician to perform a digital rectal exam and anoscopy for suspected anal cancer.",
      "An anal lump would prompt a physician to perform a digital rectal exam and anoscopy for suspected anal cancer."
    ],
    "evidence_relations": [
      "Common symptoms of anal cancer include rectal bleeding, anal itching, pain, and a lump near the anus",
      "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy"
    ]
  },
  {
    "id": "Medical-6fb8996b",
    "source": "Medical",
    "question": "What factors would lead to recommending a clinical trial for a lung cancer patient?",
    "answer": "Patients with lung cancer may be eligible for clinical trials as part of their treatment or prevention options.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Patients with lung cancer may be eligible for clinical trials.",
      "Clinical trials can be part of treatment options for lung cancer patients.",
      "Clinical trials can be part of prevention options for lung cancer patients."
    ],
    "evidence_relations": [
      "Clinical trials are available for lung cancer treatment and prevention",
      "NSCLC treatment options include clinical trial"
    ]
  },
  {
    "id": "Medical-a7e62dce",
    "source": "Medical",
    "question": "What combination of diagnostic methods is necessary to both confirm nasopharyngeal carcinoma and determine its subtype?",
    "answer": "Biopsy is required to confirm NPC and to determine its cancer subtype.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A biopsy is required to confirm nasopharyngeal carcinoma.",
      "A biopsy is required to determine the subtype of nasopharyngeal carcinoma."
    ],
    "evidence_relations": [
      "Biopsy confirms diagnosis and determines cancer subtype",
      "Diagnosis of NPC involves medical history, physical exam, imaging (CT, MRI, PET/CT, ultrasound), and biopsy"
    ]
  },
  {
    "id": "Medical-7b682af7",
    "source": "Medical",
    "question": "Which additional therapy may be used alongside chemotherapy for localized MGZL, and under what circumstance?",
    "answer": "Involved-site radiation therapy (ISRT) may be added to chemotherapy in localized MGZL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Involved-site radiation therapy (ISRT) may be used alongside chemotherapy for localized MGZL.",
      "ISRT is added to chemotherapy under the circumstance of localized MGZL."
    ],
    "evidence_relations": [
      "Involved-site radiation therapy (ISRT) may be added in localized MGZL",
      "MGZL is usually treated with chemotherapy"
    ]
  },
  {
    "id": "Medical-8407a0ab",
    "source": "Medical",
    "question": "Which patient characteristics would prompt the use of imaging during the diagnostic workup of CSCC?",
    "answer": "Imaging is used if deeper invasion or spread is suspected, especially in high-risk, regional, or metastatic CSCC cases.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging is used if deeper invasion is suspected.",
      "Imaging is used if spread is suspected.",
      "Imaging is especially used in high-risk CSCC cases.",
      "Imaging is especially used in regional CSCC cases.",
      "Imaging is especially used in metastatic CSCC cases."
    ],
    "evidence_relations": [
      "Diagnosis of CSCC involves clinical examination, skin biopsy, and imaging (CT, MRI, PET/CT) if deeper invasion or spread is suspected",
      "Imaging is used for staging and surveillance in regional and high-risk cases"
    ]
  },
  {
    "id": "Medical-1f7241a3",
    "source": "Medical",
    "question": "How does the presence of BCR::ABL1-positive status in B-ALL affect treatment choice in children?",
    "answer": "BCR::ABL1-positive B-ALL requires intensive systemic therapies compared to other B-ALL cases.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BCR::ABL1-positive B-ALL requires intensive systemic therapies.",
      "BCR::ABL1-positive B-ALL is different from other B-ALL cases in treatment choice."
    ],
    "evidence_relations": [
      "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies",
      "B-cell ALL (B-ALL) has a biomarker called BCR::ABL1-positive",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors"
    ]
  },
  {
    "id": "Medical-f27c64c0",
    "source": "Medical",
    "question": "What steps are involved in the diagnostic workup for a patient suspected of colon cancer based on symptoms?",
    "answer": "Diagnostic workup includes colonoscopy (with possible polypectomy), blood tests (CBC, chemistry profile, CEA), and CT with contrast for staging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The diagnostic workup for suspected colon cancer includes colonoscopy.",
      "Colonoscopy may include a polypectomy.",
      "The diagnostic workup includes blood tests.",
      "The blood tests include CBC, chemistry profile, and CEA.",
      "The diagnostic workup includes CT with contrast for staging."
    ],
    "evidence_relations": [
      "Colonoscopy and polypectomy are diagnostic methods",
      "Blood tests (CBC, chemistry profile, CEA) are recommended for initial testing",
      "CT with contrast is the main imaging test for staging and surveillance"
    ]
  },
  {
    "id": "Medical-9d34bcac",
    "source": "Medical",
    "question": "Which subtype of Hodgkin lymphoma is less common, and what unique risk does it carry compared to the common subtype?",
    "answer": "Nodular lymphocyte-predominant Hodgkin lymphoma is less common and can transform into diffuse large B-cell lymphoma, unlike the classic subtype.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma is less common than classic Hodgkin lymphoma.",
      "Nodular lymphocyte-predominant Hodgkin lymphoma can transform into diffuse large B-cell lymphoma.",
      "Classic Hodgkin lymphoma does not carry the same risk of transformation."
    ],
    "evidence_relations": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a rare subtype of Hodgkin lymphoma",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
    ]
  },
  {
    "id": "Medical-395b9708",
    "source": "Medical",
    "question": "Which symptoms and hormone findings would suggest a cortisol-producing adenoma causing Cushing syndrome?",
    "answer": "Symptoms such as weight gain, muscle weakness, and pink or purple stretch marks with excess cortisol on testing suggest a cortisol-producing adenoma causing Cushing syndrome.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of weight gain suggest a cortisol-producing adenoma causing Cushing syndrome.",
      "Symptoms of muscle weakness suggest a cortisol-producing adenoma causing Cushing syndrome.",
      "Pink or purple stretch marks suggest a cortisol-producing adenoma causing Cushing syndrome.",
      "Excess cortisol on testing suggests a cortisol-producing adenoma causing Cushing syndrome."
    ],
    "evidence_relations": [
      "Adenoma producing excess cortisol causes Cushing syndrome",
      "Cortisol-producing adenoma is associated with Cushing syndrome",
      "Adrenocortical carcinoma (ACC) symptoms include weight gain, muscle weakness, and pink or purple stretch marks"
    ]
  },
  {
    "id": "Medical-5504201a",
    "source": "Medical",
    "question": "If a kidney tumor is found in the renal pelvis, which cancer subtype is most likely and why?",
    "answer": "Urothelial carcinoma is most likely since it starts in the cells lining the renal pelvis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Urothelial carcinoma is most likely if a kidney tumor is found in the renal pelvis.",
      "Urothelial carcinoma starts in the cells lining the renal pelvis."
    ],
    "evidence_relations": [
      "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter",
      "Renal pelvis is listed under Anatomical Structure for Kidney cancer in the ontology"
    ]
  },
  {
    "id": "Medical-a5f2e7a9",
    "source": "Medical",
    "question": "What are the key factors that determine the treatment approach for RCC according to the classification system?",
    "answer": "Histology, tumor size, tumor location, and presence of metastasis are key treatment factors for RCC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Histology is a key treatment factor for RCC.",
      "Tumor size is a key treatment factor for RCC.",
      "Tumor location is a key treatment factor for RCC.",
      "Presence of metastasis is a key treatment factor for RCC."
    ],
    "evidence_relations": [
      "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis",
      "Treatment Factor in the ontology lists histology, tumor size, tumor location, and presence of metastasis"
    ]
  },
  {
    "id": "Medical-9bc8aaa1",
    "source": "Medical",
    "question": "What findings from both the patient's age and the location of lymph node involvement would increase suspicion for Hodgkin lymphoma?",
    "answer": "A patient aged 15-30 or over 55 with lymph node involvement in the upper body increases suspicion for Hodgkin lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A patient aged 15-30 with lymph node involvement in the upper body increases suspicion for Hodgkin lymphoma.",
      "A patient over 55 with lymph node involvement in the upper body increases suspicion for Hodgkin lymphoma."
    ],
    "evidence_relations": [
      "Most people are diagnosed between ages 15 to 30 or after age 55",
      "Hodgkin lymphoma usually starts in lymph nodes in the upper body"
    ]
  },
  {
    "id": "Medical-59890a0c",
    "source": "Medical",
    "question": "What is the preferred radiation technique for treating non-metastatic anal cancer and which stages does this include?",
    "answer": "IMRT is the preferred technique for stages I-III anal cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "IMRT is the preferred radiation technique for treating non-metastatic anal cancer.",
      "Stages I-III anal cancer are included in the preferred radiation technique."
    ],
    "evidence_relations": [
      "IMRT is the preferred radiation technique for anal cancer",
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)"
    ]
  },
  {
    "id": "Medical-baed6d13",
    "source": "Medical",
    "question": "For a patient with CSCC arising in a chronic wound, what two risk factors are present and how does this affect staging and management?",
    "answer": "Both chronic wounds and scars are risk factors, increasing the likelihood of high-risk CSCC, which may require advanced staging and aggressive treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chronic wounds are a risk factor for high-risk CSCC.",
      "Scars are a risk factor for high-risk CSCC.",
      "Chronic wounds and scars increase the likelihood of high-risk CSCC.",
      "High-risk CSCC may require advanced staging.",
      "High-risk CSCC may require aggressive treatment."
    ],
    "evidence_relations": [
      "Major risk factors for CSCC include chronic wounds or scars",
      "CSCC is staged as local (confined to skin), regional (spread to lymph nodes), or metastatic (distant spread)",
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible"
    ]
  },
  {
    "id": "Medical-3964e4de",
    "source": "Medical",
    "question": "What factors would indicate that a patient with anal cancer should undergo HIV testing as part of their diagnostic workup?",
    "answer": "Because HIV infection increases anal cancer risk and HIV testing is recommended in patients with anal cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HIV infection increases anal cancer risk.",
      "HIV testing is recommended in patients with anal cancer."
    ],
    "evidence_relations": [
      "HIV infection increases the risk of anal cancer",
      "HIV testing is recommended in patients with anal cancer"
    ]
  },
  {
    "id": "Medical-33e5776d",
    "source": "Medical",
    "question": "Which patients with prostate cancer should receive molecular biomarker testing as part of their follow-up?",
    "answer": "Patients with high-risk, very-high-risk, regional, or metastatic prostate cancer should receive molecular biomarker testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Patients with high-risk prostate cancer should receive molecular biomarker testing.",
      "Patients with very-high-risk prostate cancer should receive molecular biomarker testing.",
      "Patients with regional prostate cancer should receive molecular biomarker testing.",
      "Patients with metastatic prostate cancer should receive molecular biomarker testing."
    ],
    "evidence_relations": [
      "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer",
      "Molecular biomarker testing helps assess risk and guide treatment decisions",
      "Follow-up strategy includes molecular biomarker testing"
    ]
  },
  {
    "id": "Medical-eab49131",
    "source": "Medical",
    "question": "Which diagnostic tests are necessary to confirm CLL and detect prognostic biomarkers, and why are multiple methods needed?",
    "answer": "Blood test, flow cytometry, FISH, DNA sequencing, and karyotype are all needed to confirm CLL and identify prognostic biomarkers.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A blood test is necessary to confirm CLL.",
      "Flow cytometry is necessary to confirm CLL.",
      "FISH is necessary to confirm CLL.",
      "DNA sequencing is necessary to confirm CLL.",
      "Karyotype is necessary to confirm CLL.",
      "Multiple methods are needed to identify prognostic biomarkers."
    ],
    "evidence_relations": [
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1",
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "In the ontology, diagnostic methods for CLL include blood test, flow cytometry, FISH, DNA sequencing, and karyotype"
    ]
  },
  {
    "id": "Medical-9db4f113",
    "source": "Medical",
    "question": "What evidence would indicate that an adrenal tumor is benign and unlikely to metastasize?",
    "answer": "If the tumor is a benign adrenal tumor, such as an adenoma, it does not metastasize.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A benign adrenal tumor is an adenoma.",
      "A benign adrenal tumor does not metastasize."
    ],
    "evidence_relations": [
      "Adrenal tumors can be benign or malignant",
      "Benign adrenal tumors do not metastasize",
      "Adenoma is the most common type of adrenal gland tumor"
    ]
  },
  {
    "id": "Medical-9386f24f",
    "source": "Medical",
    "question": "How do grade and biomarker status together affect the classification of astrocytoma and oligodendroglioma?",
    "answer": "Grade and IDH mutation status are both required to classify astrocytoma and oligodendroglioma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Grade is required to classify astrocytoma.",
      "IDH mutation status is required to classify astrocytoma.",
      "Grade is required to classify oligodendroglioma.",
      "IDH mutation status is required to classify oligodendroglioma."
    ],
    "evidence_relations": [
      "Astrocytoma and oligodendroglioma have IDH mutation as a biomarker",
      "Gliomas are classified by histology, grade, and biomarkers",
      "Astrocytoma: Grade 1, 2, 3, 4; Oligodendroglioma: Grade 2, 3"
    ]
  },
  {
    "id": "Medical-5456c556",
    "source": "Medical",
    "question": "Which hereditary syndromes should be considered risk factors if a patient is diagnosed with adrenocortical carcinoma (ACC)?",
    "answer": "Beckwith-Wiedemann syndrome, Carney complex, FAP, PGL/PCC syndrome, Li-Fraumeni syndrome, Lynch syndrome, MEN 1, MEN 2, NF1, and VHL should be considered as risk factors for ACC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Beckwith-Wiedemann syndrome is a risk factor for adrenocortical carcinoma (ACC).",
      "Carney complex is a risk factor for adrenocortical carcinoma (ACC).",
      "FAP is a risk factor for adrenocortical carcinoma (ACC).",
      "PGL/PCC syndrome is a risk factor for adrenocortical carcinoma (ACC).",
      "Li-Fraumeni syndrome is a risk factor for adrenocortical carcinoma (ACC).",
      "Lynch syndrome is a risk factor for adrenocortical carcinoma (ACC).",
      "MEN 1 is a risk factor for adrenocortical carcinoma (ACC).",
      "MEN 2 is a risk factor for adrenocortical carcinoma (ACC).",
      "NF1 is a risk factor for adrenocortical carcinoma (ACC).",
      "VHL is a risk factor for adrenocortical carcinoma (ACC)."
    ],
    "evidence_relations": [
      "Certain hereditary syndromes increase the risk of adrenal tumors",
      "Adrenocortical carcinoma (ACC) risk factors include Beckwith-Wiedemann syndrome, Carney complex, Familial adenomatous polyposis (FAP), Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndrome, Li-Fraumeni syndrome, Lynch syndrome, Multiple endocrine neoplasia type 1 (MEN 1), Multiple endocrine neoplasia type 2 (MEN 2), Neurofibromatosis type 1 (NF1), and Von Hippel-Lindau syndrome (VHL)"
    ]
  },
  {
    "id": "Medical-eb042e58",
    "source": "Medical",
    "question": "Which biomarkers are tested to determine eligibility for targeted therapies in ovarian cancer?",
    "answer": "BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FRα, RET mutations, and NTRK gene fusion are tested.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BRCA mutation is tested to determine eligibility for targeted therapies in ovarian cancer.",
      "HRD status is tested to determine eligibility for targeted therapies in ovarian cancer.",
      "MSI is tested to determine eligibility for targeted therapies in ovarian cancer.",
      "MMR is tested to determine eligibility for targeted therapies in ovarian cancer.",
      "HER2 expression is tested to determine eligibility for targeted therapies in ovarian cancer.",
      "TMB is tested to determine eligibility for targeted therapies in ovarian cancer.",
      "BRAF V600E is tested to determine eligibility for targeted therapies in ovarian cancer.",
      "FRα is tested to determine eligibility for targeted therapies in ovarian cancer.",
      "RET mutations are tested to determine eligibility for targeted therapies in ovarian cancer.",
      "NTRK gene fusion is tested to determine eligibility for targeted therapies in ovarian cancer."
    ],
    "evidence_relations": [
      "Tumor biomarker testing includes BRCA mutation, HRD status, MSI, MMR, HER2 expression, TMB, BRAF V600E, FRα, RET mutations, and NTRK gene fusion",
      "The ontology lists these as genetic alterations or biomarkers for ovarian cancer"
    ]
  },
  {
    "id": "Medical-b914d234",
    "source": "Medical",
    "question": "Which diagnostic procedures and biomarkers are required to confirm and assess the aggressiveness of localized prostate cancer?",
    "answer": "PSA test, digital rectal exam, and biopsy are used for diagnosis, while Gleason score and Grade Group estimate aggressiveness.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PSA test is used for the diagnosis of localized prostate cancer.",
      "Digital rectal exam is used for the diagnosis of localized prostate cancer.",
      "Biopsy is used for the diagnosis of localized prostate cancer.",
      "Gleason score is used to estimate the aggressiveness of localized prostate cancer.",
      "Grade Group is used to estimate the aggressiveness of localized prostate cancer."
    ],
    "evidence_relations": [
      "PSA test and digital rectal exam are used for screening and diagnosis",
      "Biopsy is required to confirm prostate cancer diagnosis",
      "Gleason score and Grade Group are used to estimate cancer aggressiveness",
      "Localized prostate cancer uses PSA test, digital rectal exam, biopsy, MRI, and ultrasound as diagnostic methods and PSA, Gleason score, and Grade Group as biomarkers"
    ]
  },
  {
    "id": "Medical-833eac1d",
    "source": "Medical",
    "question": "Which risk factors and genetic syndromes should prompt genetic testing in a patient with pancreatic cancer?",
    "answer": "Risk factors like family history of pancreatic, breast, ovarian, colorectal cancer, or melanoma, and genetic syndromes such as HBOC, Peutz-Jeghers, Lynch, Li-Fraumeni, FAMMM, and hereditary pancreatitis should prompt genetic testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Family history of pancreatic cancer is a risk factor for genetic testing.",
      "Family history of breast cancer is a risk factor for genetic testing.",
      "Family history of ovarian cancer is a risk factor for genetic testing.",
      "Family history of colorectal cancer is a risk factor for genetic testing.",
      "Family history of melanoma is a risk factor for genetic testing.",
      "Genetic syndromes that should prompt genetic testing include HBOC.",
      "Genetic syndromes that should prompt genetic testing include Peutz-Jeghers.",
      "Genetic syndromes that should prompt genetic testing include Lynch syndrome.",
      "Genetic syndromes that should prompt genetic testing include Li-Fraumeni syndrome.",
      "Genetic syndromes that should prompt genetic testing include FAMMM.",
      "Genetic syndromes that should prompt genetic testing include hereditary pancreatitis."
    ],
    "evidence_relations": [
      "Risk factors for pancreatic cancer include family history of certain cancers",
      "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer",
      "Genetic test is a diagnostic method for pancreatic ductal adenocarcinoma (ontology, rewritten: Genetic testing is used to diagnose hereditary pancreatic cancer risk)"
    ]
  },
  {
    "id": "Medical-e3da3cd7",
    "source": "Medical",
    "question": "Which diagnostic methods are common to both adrenocortical carcinoma (ACC) and pheochromocytoma, and which are unique to ACC?",
    "answer": "CT scan, MRI scan, and biochemical test are common to both; PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, genetic test, and biopsy are unique to ACC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CT scan is a common diagnostic method for both adrenocortical carcinoma (ACC) and pheochromocytoma.",
      "MRI scan is a common diagnostic method for both adrenocortical carcinoma (ACC) and pheochromocytoma.",
      "Biochemical test is a common diagnostic method for both adrenocortical carcinoma (ACC) and pheochromocytoma.",
      "PET scan is a diagnostic method unique to adrenocortical carcinoma (ACC).",
      "FDG-PET/CT is a diagnostic method unique to adrenocortical carcinoma (ACC).",
      "SSTR-PET/CT is a diagnostic method unique to adrenocortical carcinoma (ACC).",
      "Blood test is a diagnostic method unique to adrenocortical carcinoma (ACC).",
      "Genetic test is a diagnostic method unique to adrenocortical carcinoma (ACC).",
      "Biopsy is a diagnostic method unique to adrenocortical carcinoma (ACC)."
    ],
    "evidence_relations": [
      "Adrenocortical carcinoma (ACC) diagnostic methods include CT scan, MRI scan, PET scan, FDG-PET/CT, SSTR-PET/CT, blood test, biochemical test, genetic test, and biopsy",
      "Pheochromocytoma diagnostic methods include CT scan, MRI scan, and biochemical test"
    ]
  },
  {
    "id": "Medical-1ab31cd8",
    "source": "Medical",
    "question": "What combination of findings would support a diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN)?",
    "answer": "BPDCN diagnosis is supported by its aggressive nature, involvement of blood, bone marrow, lymph nodes, and skin, and its classification as an AML subtype.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The aggressive nature of BPDCN supports its diagnosis.",
      "Involvement of blood supports the diagnosis of BPDCN.",
      "Involvement of bone marrow supports the diagnosis of BPDCN.",
      "Involvement of lymph nodes supports the diagnosis of BPDCN.",
      "Involvement of skin supports the diagnosis of BPDCN.",
      "BPDCN is classified as an AML subtype."
    ],
    "evidence_relations": [
      "Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive subtype of AML",
      "Sites of Involvement for BPDCN include blood, bone marrow, lymph nodes, skin",
      "AML subtypes are defined by gene mutations or abnormal chromosomes"
    ]
  },
  {
    "id": "Medical-99713759",
    "source": "Medical",
    "question": "Which diagnostic methods are recommended for confirming a diagnosis of kidney cancer, and what is their basis in the classification system?",
    "answer": "Imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing are all recommended diagnostic methods for kidney cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging tests are recommended for confirming a diagnosis of kidney cancer.",
      "Blood tests are recommended for confirming a diagnosis of kidney cancer.",
      "Urine tests are recommended for confirming a diagnosis of kidney cancer.",
      "Biopsy is recommended for confirming a diagnosis of kidney cancer.",
      "Biomarker testing is recommended for confirming a diagnosis of kidney cancer.",
      "Genetic risk testing is recommended for confirming a diagnosis of kidney cancer."
    ],
    "evidence_relations": [
      "Diagnosis of kidney cancer involves imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing",
      "Diagnostic Method includes imaging tests, blood tests, urine tests, biopsy, biomarker testing, and genetic risk testing for Kidney cancer in the ontology"
    ]
  },
  {
    "id": "Medical-64f219fe",
    "source": "Medical",
    "question": "Why is fertility preservation considered before ALL treatment, and which treatment modalities make this necessary?",
    "answer": "Fertility preservation is considered before ALL treatment because steroids and multiagent chemotherapy may affect fertility.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility preservation is considered before ALL treatment.",
      "Steroids may affect fertility.",
      "Multiagent chemotherapy may affect fertility."
    ],
    "evidence_relations": [
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Fertility preservation should be considered before treatment",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors"
    ]
  },
  {
    "id": "Medical-fad3190e",
    "source": "Medical",
    "question": "For a patient with a history of FAP, what combination of surveillance and diagnostic methods is most critical?",
    "answer": "Regular colonoscopy and polypectomy are critical due to the high risk of multiple polyps and rectal cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Regular colonoscopy is critical for patients with a history of FAP.",
      "Polypectomy is critical for patients with a history of FAP.",
      "Patients with a history of FAP have a high risk of multiple polyps.",
      "Patients with a history of FAP have a high risk of rectal cancer."
    ],
    "evidence_relations": [
      "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk",
      "Colonoscopy is recommended after surgery for surveillance",
      "Polypectomy during colonoscopy can remove most polyps and prevent cancer"
    ]
  },
  {
    "id": "Medical-8233f77f",
    "source": "Medical",
    "question": "What laboratory and tissue-based tests are required to assess both biomarkers and genetic alterations in cutaneous B-cell lymphoma?",
    "answer": "Biopsy and immunophenotyping are required to assess biomarkers and genetic changes in CBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biopsy is required to assess biomarkers in cutaneous B-cell lymphoma.",
      "Immunophenotyping is required to assess biomarkers in cutaneous B-cell lymphoma.",
      "Biopsy is required to assess genetic changes in cutaneous B-cell lymphoma.",
      "Immunophenotyping is required to assess genetic changes in cutaneous B-cell lymphoma."
    ],
    "evidence_relations": [
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes"
    ]
  },
  {
    "id": "Medical-bb794987",
    "source": "Medical",
    "question": "What are the primary symptoms and diagnostic methods associated with pancreatic ductal adenocarcinoma?",
    "answer": "Jaundice is a primary symptom, and diagnostic methods include imaging, endoscopic test, biopsy, blood test, genetic test, and biomarker test.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Jaundice is a primary symptom of pancreatic ductal adenocarcinoma.",
      "Imaging is a diagnostic method for pancreatic ductal adenocarcinoma.",
      "Endoscopic tests are a diagnostic method for pancreatic ductal adenocarcinoma.",
      "Biopsy is a diagnostic method for pancreatic ductal adenocarcinoma.",
      "Blood tests are a diagnostic method for pancreatic ductal adenocarcinoma.",
      "Genetic tests are a diagnostic method for pancreatic ductal adenocarcinoma.",
      "Biomarker tests are a diagnostic method for pancreatic ductal adenocarcinoma."
    ],
    "evidence_relations": [
      "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)",
      "Diagnostic methods for pancreatic cancer include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests",
      "Symptom: Jaundice; Diagnostic Method: Imaging, Endoscopic test, Biopsy, Blood test, Genetic test, Biomarker test (ontology, rewritten: Jaundice is a symptom and these are the diagnostic methods for pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-e0a5fcc5",
    "source": "Medical",
    "question": "How is high-grade squamous intraepithelial lesion (HSIL) related to cervical cancer progression and diagnosis?",
    "answer": "HSIL corresponds to CIN 2 and 3, is considered pre-cancer, and may be identified by biopsy as part of cervical cancer diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-grade squamous intraepithelial lesion (HSIL) corresponds to CIN 2 and 3.",
      "HSIL is considered pre-cancer.",
      "HSIL may be identified by biopsy as part of cervical cancer diagnosis."
    ],
    "evidence_relations": [
      "High-grade squamous intraepithelial lesion (HSIL) corresponds to CIN 2 and 3 and is considered pre-cancer",
      "Cervical biopsy is the primary diagnostic method for cervical cancer",
      "Biopsy is listed as a diagnostic method for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-3776fc3d",
    "source": "Medical",
    "question": "How does achieving minimal residual disease status affect the prognosis and management of CLL?",
    "answer": "Minimal residual disease indicates mostly healthy blood cells and is a treatment goal associated with better prognosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Achieving minimal residual disease status indicates mostly healthy blood cells.",
      "Minimal residual disease status is a treatment goal in CLL.",
      "Achieving minimal residual disease status is associated with better prognosis."
    ],
    "evidence_relations": [
      "Minimal residual disease is a treatment goal indicating mostly healthy blood cells",
      "In the ontology, minimal residual disease is listed as a disease stage for CLL"
    ]
  },
  {
    "id": "Medical-f5688b0c",
    "source": "Medical",
    "question": "What are the necessary follow-up procedures after completing primary treatment for breast cancer to monitor for recurrence?",
    "answer": "Follow-up includes imaging, physical exams, and monitoring for recurrence after primary breast cancer treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up after primary breast cancer treatment includes imaging.",
      "Follow-up after primary breast cancer treatment includes physical exams.",
      "Follow-up after primary breast cancer treatment includes monitoring for recurrence."
    ],
    "evidence_relations": [
      "Follow-up includes imaging, physical exams, and monitoring for recurrence",
      "Follow-up/Surveillance for breast cancer includes these components"
    ]
  },
  {
    "id": "Medical-bc622c63",
    "source": "Medical",
    "question": "How does the unregulated growth of lymphocytes relate to the development of cutaneous B-cell lymphoma?",
    "answer": "Unregulated growth of B lymphocytes can develop into CBCL, a subtype of primary cutaneous lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Unregulated growth of B lymphocytes can develop into cutaneous B-cell lymphoma.",
      "Cutaneous B-cell lymphoma is a subtype of primary cutaneous lymphoma."
    ],
    "evidence_relations": [
      "Unregulated growth of lymphocytes can develop into lymphoma",
      "CBCL starts in B cells",
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin"
    ]
  },
  {
    "id": "Medical-ed5085d7",
    "source": "Medical",
    "question": "Which anatomical structures are at risk for local spread of kidney cancer, and how are they categorized?",
    "answer": "Surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerota’s fascia are at risk for local spread.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surrounding fat is at risk for local spread of kidney cancer.",
      "Blood vessels are at risk for local spread of kidney cancer.",
      "Lymph nodes are at risk for local spread of kidney cancer.",
      "Adrenal glands are at risk for local spread of kidney cancer.",
      "Gerota’s fascia is at risk for local spread of kidney cancer."
    ],
    "evidence_relations": [
      "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerota’s fascia",
      "Stage in the ontology lists local spread to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerota’s fascia"
    ]
  },
  {
    "id": "Medical-ef429fbb",
    "source": "Medical",
    "question": "Which risk factors should be investigated in a patient with a suspected stomach mass and a positive genetic risk test?",
    "answer": "H. pylori infection and family history should be investigated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "H. pylori infection should be investigated in a patient with a suspected stomach mass.",
      "Family history should be investigated in a patient with a suspected stomach mass."
    ],
    "evidence_relations": [
      "H. pylori infection is a risk factor for stomach cancer",
      "Family history is a risk factor for stomach cancer",
      "Genetic risk testing is a diagnostic method for stomach cancer (ontology rewritten)",
      "Symptoms can include ulcer or mass formation in the stomach"
    ]
  },
  {
    "id": "Medical-4744dfa7",
    "source": "Medical",
    "question": "Which performance evaluation is necessary before determining eligibility for clinical trials in primary CNS lymphoma patients and why?",
    "answer": "Performance status evaluation is necessary to guide treatment decisions and clinical trial eligibility.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status evaluation is necessary before determining eligibility for clinical trials in primary CNS lymphoma patients.",
      "Performance status evaluation guides treatment decisions.",
      "Performance status evaluation guides clinical trial eligibility."
    ],
    "evidence_relations": [
      "Performance status is evaluated to guide treatment decisions and eligibility for clinical trials",
      "Diagnostic Method for Primary CNS lymphoma includes Performance status evaluation"
    ]
  },
  {
    "id": "Medical-efd1af00",
    "source": "Medical",
    "question": "What evidence supports the use of chemoimmunotherapy instead of chemotherapy alone in MGZL?",
    "answer": "Chemoimmunotherapy is supported because rituximab may be added to chemotherapy for MGZL treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chemoimmunotherapy is supported for MGZL treatment.",
      "Rituximab may be added to chemotherapy for MGZL treatment."
    ],
    "evidence_relations": [
      "Rituximab may be added to chemotherapy for chemoimmunotherapy",
      "MGZL is usually treated with chemotherapy"
    ]
  },
  {
    "id": "Medical-e7ebb96c",
    "source": "Medical",
    "question": "Which diagnostic methods are necessary for confirming both the subtype and stage of esophageal cancer?",
    "answer": "Imaging tests, endoscopy, and biopsy are required to determine both subtype and stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging tests are necessary for confirming the subtype and stage of esophageal cancer.",
      "Endoscopy is necessary for confirming the subtype and stage of esophageal cancer.",
      "Biopsy is necessary for confirming the subtype and stage of esophageal cancer."
    ],
    "evidence_relations": [
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Treatment planning is based on cancer type, location, and stage"
    ]
  },
  {
    "id": "Medical-4aed3e10",
    "source": "Medical",
    "question": "Which blood tests are included in the evaluation of bone cancer, and what is their collective purpose?",
    "answer": "Alkaline phosphatase, CBC, CMP, and LDH are used to evaluate bone cancer as part of blood tests.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Alkaline phosphatase is included in the evaluation of bone cancer.",
      "CBC is included in the evaluation of bone cancer.",
      "CMP is included in the evaluation of bone cancer.",
      "LDH is included in the evaluation of bone cancer.",
      "These blood tests are used to evaluate bone cancer."
    ],
    "evidence_relations": [
      "Blood tests such as alkaline phosphatase, CBC, CMP, and LDH are used in evaluation",
      "Blood tests: [\"Alkaline phosphatase\", \"CBC\", \"Comprehensive metabolic panel (CMP)\", \"Lactate dehydrogenase (LDH)\"]"
    ]
  },
  {
    "id": "Medical-c2ead218",
    "source": "Medical",
    "question": "Which abnormal blood counts and genetic findings together support a diagnosis of CML?",
    "answer": "Increased white blood cells and abnormal platelet counts, along with the Philadelphia chromosome or BCR::ABL1 gene, support CML diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Increased white blood cells support a diagnosis of CML.",
      "Abnormal platelet counts support a diagnosis of CML.",
      "The Philadelphia chromosome supports a diagnosis of CML.",
      "The BCR::ABL1 gene supports a diagnosis of CML."
    ],
    "evidence_relations": [
      "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis"
    ]
  },
  {
    "id": "Medical-0093e2ec",
    "source": "Medical",
    "question": "What combination of symptoms and imaging findings would indicate metastatic prostate cancer?",
    "answer": "Bone pain and unexplained weight loss with positive findings on bone scan or PET scan indicate metastatic prostate cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Bone pain can indicate metastatic prostate cancer.",
      "Unexplained weight loss can indicate metastatic prostate cancer.",
      "Positive findings on a bone scan can indicate metastatic prostate cancer.",
      "Positive findings on a PET scan can indicate metastatic prostate cancer."
    ],
    "evidence_relations": [
      "Symptoms of advanced prostate cancer include bone pain, weight loss",
      "Metastatic prostate cancer has spread to distant organs such as bones",
      "Bone scan and PET scan are imaging methods used to assess extent of disease"
    ]
  },
  {
    "id": "Medical-a6968a78",
    "source": "Medical",
    "question": "Which diagnostic methods are recommended for a patient presenting with hematuria and frequent urination suspected of having bladder cancer?",
    "answer": "Cystoscopy, urine cytology, biopsy, and imaging such as CT scan or MRI are recommended diagnostic methods.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cystoscopy is a recommended diagnostic method for suspected bladder cancer.",
      "Urine cytology is a recommended diagnostic method for suspected bladder cancer.",
      "Biopsy is a recommended diagnostic method for suspected bladder cancer.",
      "Imaging such as CT scan is a recommended diagnostic method for suspected bladder cancer.",
      "Imaging such as MRI is a recommended diagnostic method for suspected bladder cancer."
    ],
    "evidence_relations": [
      "Blood in urine (hematuria) is the most common symptom of bladder cancer",
      "Other symptoms include frequent urination",
      "Diagnosis of bladder cancer involves cystoscopy, urine cytology, biopsy, and imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram)"
    ]
  },
  {
    "id": "Medical-7f3beb74",
    "source": "Medical",
    "question": "If a tumor spreads through all histological layers of the bile duct, which anatomical structures could it potentially invade next?",
    "answer": "It could invade nearby blood vessels, the liver, or structures outside the liver.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A tumor that spreads through all histological layers of the bile duct could invade nearby blood vessels.",
      "A tumor that spreads could invade the liver.",
      "A tumor that spreads could invade structures outside the liver."
    ],
    "evidence_relations": [
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
    ]
  },
  {
    "id": "Medical-42d7ac7c",
    "source": "Medical",
    "question": "If a patient presents with jaundice and has a family history of breast cancer, which diagnostic tests and risk factors should be considered?",
    "answer": "Imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests should be considered, and family history of breast cancer is a risk factor for pancreatic ductal adenocarcinoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging tests should be considered for a patient with jaundice and a family history of breast cancer.",
      "Endoscopic tests should be considered for a patient with jaundice and a family history of breast cancer.",
      "Biopsy should be considered for a patient with jaundice and a family history of breast cancer.",
      "Blood tests should be considered for a patient with jaundice and a family history of breast cancer.",
      "Genetic tests should be considered for a patient with jaundice and a family history of breast cancer.",
      "Biomarker tests should be considered for a patient with jaundice and a family history of breast cancer.",
      "Family history of breast cancer is a risk factor for pancreatic ductal adenocarcinoma."
    ],
    "evidence_relations": [
      "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)",
      "Family history of breast cancer is a risk factor for pancreatic cancer",
      "Diagnostic methods for pancreatic cancer include imaging, endoscopic tests, biopsy, blood tests, genetic tests, and biomarker tests",
      "Risk Factor: Family history of breast cancer (ontology, rewritten: Family history of breast cancer is a risk factor for pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-83eb6b6b",
    "source": "Medical",
    "question": "What follow-up methods are recommended after cervical cancer treatment, and how do they help in surveillance?",
    "answer": "Regular physical exams, imaging as indicated, Pap testing, and blood tests are recommended for surveillance after treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Regular physical exams are recommended for surveillance after cervical cancer treatment.",
      "Imaging as indicated is recommended for surveillance after cervical cancer treatment.",
      "Pap testing is recommended for surveillance after cervical cancer treatment.",
      "Blood tests are recommended for surveillance after cervical cancer treatment."
    ],
    "evidence_relations": [
      "Surveillance after treatment includes regular physical exams and imaging as indicated",
      "Follow-up in the ontology includes physical exam, imaging, Pap testing, and blood tests"
    ]
  },
  {
    "id": "Medical-6e8f1b95",
    "source": "Medical",
    "question": "Which tumor markers should be monitored during surveillance after ovarian cancer treatment?",
    "answer": "CA-125 or other tumor markers such as HE4, CEA, and CA 19-9 should be monitored during surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CA-125 should be monitored during surveillance after ovarian cancer treatment.",
      "HE4 should be monitored during surveillance after ovarian cancer treatment.",
      "CEA should be monitored during surveillance after ovarian cancer treatment.",
      "CA 19-9 should be monitored during surveillance after ovarian cancer treatment."
    ],
    "evidence_relations": [
      "Surveillance after treatment includes regular physical and pelvic exams, and monitoring of CA-125 or other tumor markers",
      "The ontology lists CA-125, HE4, CEA, and CA 19-9 as tumor markers for ovarian cancer"
    ]
  },
  {
    "id": "Medical-dc695a12",
    "source": "Medical",
    "question": "What histopathological finding is essential for diagnosing MGZL, and how is it confirmed?",
    "answer": "Reed-Sternberg cells are essential and diagnosis is confirmed by expert hematopathologist review.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Reed-Sternberg cells are essential for diagnosing MGZL.",
      "Diagnosis of MGZL is confirmed by expert hematopathologist review."
    ],
    "evidence_relations": [
      "Reed-Sternberg cells are characteristic histopathological features in MGZL",
      "Diagnosis of MGZL requires expert hematopathologist review"
    ]
  },
  {
    "id": "Medical-cd4d3dd1",
    "source": "Medical",
    "question": "What factors are considered prognostic in treatment planning for throat cancer?",
    "answer": "ECOG performance status and HPV/p16 status are prognostic factors in treatment planning.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ECOG performance status is a prognostic factor in treatment planning for throat cancer.",
      "HPV/p16 status is a prognostic factor in treatment planning for throat cancer."
    ],
    "evidence_relations": [
      "Performance status (ECOG) is a prognostic factor considered in treatment planning",
      "HPV/p16 status is a prognostic factor for throat cancer"
    ]
  },
  {
    "id": "Medical-e8163237",
    "source": "Medical",
    "question": "Which surgical procedures are specifically used for tumors in different parts of the rectum?",
    "answer": "Low anterior resection (LAR) is used for mid to upper rectum tumors, while abdominoperineal resection (APR) is used for lower rectum tumors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Low anterior resection (LAR) is used for mid to upper rectum tumors.",
      "Abdominoperineal resection (APR) is used for lower rectum tumors."
    ],
    "evidence_relations": [
      "Low anterior resection (LAR) is used for tumors in the mid to upper rectum",
      "Abdominoperineal resection (APR) is used for tumors in the lower rectum"
    ]
  },
  {
    "id": "Medical-cfdb85ba",
    "source": "Medical",
    "question": "Which risk factors and genetic alterations should be evaluated in a patient with a family history of prostate cancer?",
    "answer": "Age, family history, and genetic mutations such as BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, and PMS2 should be evaluated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Age should be evaluated in a patient with a family history of prostate cancer.",
      "Family history should be evaluated in a patient with a family history of prostate cancer.",
      "Genetic mutations should be evaluated in a patient with a family history of prostate cancer.",
      "BRCA1 is a genetic mutation that should be evaluated.",
      "BRCA2 is a genetic mutation that should be evaluated.",
      "ATM is a genetic mutation that should be evaluated.",
      "CHEK2 is a genetic mutation that should be evaluated.",
      "MLH1 is a genetic mutation that should be evaluated.",
      "MSH2 is a genetic mutation that should be evaluated.",
      "MSH6 is a genetic mutation that should be evaluated.",
      "PALB2 is a genetic mutation that should be evaluated.",
      "PMS2 is a genetic mutation that should be evaluated."
    ],
    "evidence_relations": [
      "Age, family history, and genetic mutations are risk factors for prostate cancer",
      "BRCA2 mutation increases risk of prostate cancer",
      "Genetic Alteration category includes BRCA1, BRCA2, ATM, CHEK2, MLH1, MSH2, MSH6, PALB2, PMS2"
    ]
  },
  {
    "id": "Medical-659d7c0a",
    "source": "Medical",
    "question": "How do the purposes of lung cancer screening and follow-up care differ?",
    "answer": "Screening aims for early detection in high-risk individuals, while follow-up care monitors for recurrence after treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Screening aims for early detection in high-risk individuals.",
      "Follow-up care monitors for recurrence after treatment.",
      "The purposes of lung cancer screening and follow-up care differ."
    ],
    "evidence_relations": [
      "Lung cancer screening aims to detect cancer at an early, more treatable stage",
      "Follow-up care is planned after treatment and includes surveillance for recurrence"
    ]
  },
  {
    "id": "Medical-c6b862bd",
    "source": "Medical",
    "question": "What are the key risk factors for developing glioma, and how are these determined from the ontology?",
    "answer": "Key risk factors are age (more common in adults) and non-hereditary mutation, as indicated by the ontology.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Key risk factors for developing glioma include age.",
      "Glioma is more common in adults.",
      "Non-hereditary mutation is a key risk factor for glioma.",
      "The ontology indicates the key risk factors for glioma."
    ],
    "evidence_relations": [
      "Gliomas are more common in adults than children",
      "Most gliomas are not hereditary",
      "Risk Factor includes age (more common in adults) and non-hereditary mutation"
    ]
  },
  {
    "id": "Medical-92ed141f",
    "source": "Medical",
    "question": "How does the approach to fertility preservation differ between early-stage cervical cancer patients and those with advanced disease?",
    "answer": "Early-stage patients may undergo fertility-sparing surgery or ovarian transposition, while these options are not available for advanced disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Early-stage cervical cancer patients may undergo fertility-sparing surgery.",
      "Early-stage cervical cancer patients may undergo ovarian transposition.",
      "Fertility-sparing surgery and ovarian transposition are not available for advanced disease."
    ],
    "evidence_relations": [
      "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases",
      "Ovarian transposition is listed under fertility preservation in the ontology",
      "Surgery is the main treatment for early-stage cervical cancer",
      "Fertility preservation is not mentioned as an option for advanced stages in the ontology"
    ]
  },
  {
    "id": "Medical-da2b7d6f",
    "source": "Medical",
    "question": "Which treatments are used for non–muscle-invasive bladder cancer and what surgical procedure is typically involved?",
    "answer": "TURBT and intravesical therapy (BCG or chemotherapy) are used for non–muscle-invasive bladder cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "TURBT is used for non–muscle-invasive bladder cancer.",
      "Intravesical therapy is used for non–muscle-invasive bladder cancer.",
      "BCG is a type of intravesical therapy for non–muscle-invasive bladder cancer.",
      "Chemotherapy is a type of intravesical therapy for non–muscle-invasive bladder cancer."
    ],
    "evidence_relations": [
      "Stage 0 and Stage 1 bladder cancers are non–muscle-invasive",
      "TURBT is used for tumor removal in non–muscle-invasive bladder cancer",
      "Intravesical therapy (BCG or chemotherapy) is used for non–muscle-invasive bladder cancer"
    ]
  },
  {
    "id": "Medical-a9db9ed9",
    "source": "Medical",
    "question": "If a child under 5 presents with an adrenal mass and bone metastases, what is the most likely diagnosis and which diagnostic methods should be prioritized?",
    "answer": "Neuroblastoma is most likely, and imaging tests plus biochemical tests should be prioritized.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Neuroblastoma is the most likely diagnosis for a child under 5 with an adrenal mass and bone metastases.",
      "Imaging tests should be prioritized for diagnosis.",
      "Biochemical tests should be prioritized for diagnosis."
    ],
    "evidence_relations": [
      "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5",
      "Neuroblastoma may metastasize to bones",
      "Neuroblastoma diagnostic methods include imaging tests and biochemical test"
    ]
  },
  {
    "id": "Medical-9499de40",
    "source": "Medical",
    "question": "Which biomarkers are most closely associated with the development of anal squamous cell carcinoma, and what is the most common risk factor?",
    "answer": "HPV and HPV16 are closely associated biomarkers, with HPV infection being the strongest risk factor.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HPV is closely associated with the development of anal squamous cell carcinoma.",
      "HPV16 is closely associated with the development of anal squamous cell carcinoma.",
      "HPV infection is the strongest risk factor for anal squamous cell carcinoma."
    ],
    "evidence_relations": [
      "HPV infection is the strongest risk factor for anal cancer",
      "HPV16 is a high-risk strain associated with anal cancer",
      "Anal squamous cell carcinoma is the most common subtype of anal cancer",
      "HPV and HPV16 are listed as biomarkers for anal cancer"
    ]
  },
  {
    "id": "Medical-34a9155d",
    "source": "Medical",
    "question": "Why is a lung nodule detected by imaging not sufficient for a lung cancer diagnosis?",
    "answer": "Because biopsy is required to confirm the malignancy of a lung nodule detected by imaging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A lung nodule detected by imaging is not sufficient for a lung cancer diagnosis.",
      "A biopsy is required to confirm the malignancy of a lung nodule detected by imaging."
    ],
    "evidence_relations": [
      "Lung nodules may be detected by imaging and require further assessment to determine malignancy",
      "Biopsy is used to confirm lung cancer diagnosis"
    ]
  },
  {
    "id": "Medical-e2bcebf4",
    "source": "Medical",
    "question": "When is enrollment in a clinical trial particularly recommended for ovarian cancer patients?",
    "answer": "Clinical trial enrollment is recommended for recurrent or persistent ovarian cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trial enrollment is recommended for recurrent ovarian cancer.",
      "Clinical trial enrollment is recommended for persistent ovarian cancer."
    ],
    "evidence_relations": [
      "Clinical trials are recommended for recurrent or persistent ovarian cancer",
      "The ontology lists clinical trial enrollment for recurrent or persistent disease"
    ]
  },
  {
    "id": "Medical-950b879f",
    "source": "Medical",
    "question": "How does the typical site of involvement differ between mediastinal and non-mediastinal gray zone lymphomas?",
    "answer": "Mediastinal gray zone lymphomas involve the mediastinum and supraclavicular lymph nodes, while non-mediastinal types involve bone marrow and extranodal sites.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mediastinal gray zone lymphomas involve the mediastinum.",
      "Mediastinal gray zone lymphomas involve supraclavicular lymph nodes.",
      "Non-mediastinal gray zone lymphomas involve bone marrow.",
      "Non-mediastinal gray zone lymphomas involve extranodal sites."
    ],
    "evidence_relations": [
      "Sites of involvement for MGZL include mediastinum and lymph nodes above the collar bone (supraclavicular)",
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement"
    ]
  },
  {
    "id": "Medical-14d39f0c",
    "source": "Medical",
    "question": "What are the common symptoms and metabolic complications associated with bone cancer, and what causes the metabolic complication?",
    "answer": "Bone pain and hypercalcemia are common symptoms, with hypercalcemia caused by bone destruction.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Common symptoms of bone cancer include bone pain.",
      "Common symptoms of bone cancer include hypercalcemia.",
      "Hypercalcemia is caused by bone destruction."
    ],
    "evidence_relations": [
      "Bone cancer can cause hypercalcemia due to bone destruction",
      "Symptom: [\"Bone pain\", \"Hypercalcemia\"]"
    ]
  },
  {
    "id": "Medical-3e87c7a1",
    "source": "Medical",
    "question": "What anatomical locations are at risk for distant metastasis from stomach cancer and what is the typical spread pattern?",
    "answer": "The liver, peritoneum, distant lymph nodes, pancreas, and spleen are at risk due to distant spread.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The liver is at risk for distant metastasis from stomach cancer.",
      "The peritoneum is at risk for distant metastasis from stomach cancer.",
      "Distant lymph nodes are at risk for distant metastasis from stomach cancer.",
      "The pancreas is at risk for distant metastasis from stomach cancer.",
      "The spleen is at risk for distant metastasis from stomach cancer.",
      "Stomach cancer typically spreads to distant organs."
    ],
    "evidence_relations": [
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes",
      "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen",
      "Distant spread pattern includes liver, peritoneum, distant lymph nodes, pancreas, and spleen (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-6b3f89bd",
    "source": "Medical",
    "question": "Which RCC subtypes are considered non-clear cell RCC, and how are they grouped in the classification?",
    "answer": "Papillary RCC, chromophobe RCC, collecting duct RCC, renal medullary carcinoma, clear cell papillary renal cell tumor, fumarate hydratase-deficient RCC, and ELOC-mutated RCC are all non-clear cell RCC subtypes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Papillary RCC is a non-clear cell RCC subtype.",
      "Chromophobe RCC is a non-clear cell RCC subtype.",
      "Collecting duct RCC is a non-clear cell RCC subtype.",
      "Renal medullary carcinoma is a non-clear cell RCC subtype.",
      "Clear cell papillary renal cell tumor is a non-clear cell RCC subtype.",
      "Fumarate hydratase-deficient RCC is a non-clear cell RCC subtype.",
      "ELOC-mutated RCC is a non-clear cell RCC subtype."
    ],
    "evidence_relations": [
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
      "Non-clear cell RCC (nccRCC) in the ontology includes Papillary RCC, Chromophobe RCC, Collecting duct RCC, Renal medullary carcinoma, Clear cell papillary renal cell tumor, Fumarate hydratase-deficient RCC, and ELOC-mutated RCC"
    ]
  },
  {
    "id": "Medical-f63520dd",
    "source": "Medical",
    "question": "What is the role of supportive and palliative care in advanced or metastatic cervical cancer management?",
    "answer": "Supportive and palliative care are integral for advanced or metastatic cervical cancer to manage symptoms and improve quality of life.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Supportive care is integral for advanced cervical cancer management.",
      "Palliative care is integral for advanced cervical cancer management.",
      "Supportive and palliative care help manage symptoms.",
      "Supportive and palliative care improve quality of life."
    ],
    "evidence_relations": [
      "Supportive care and palliative care are integral for advanced or metastatic disease",
      "Supportive care and palliative care are listed as treatments for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-f2800f11",
    "source": "Medical",
    "question": "Which care team roles are necessary for comprehensive diagnosis and treatment planning in pancreatic cancer?",
    "answer": "A multidisciplinary care team including diagnostic radiologist, interventional radiologist, pathologist, gastroenterologist, medical oncologist, surgical oncologist, radiation oncologist, geriatrician, registered dietitian, genetic counselor, palliative care provider, and mental health provider is necessary.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A multidisciplinary care team is necessary for comprehensive diagnosis and treatment planning in pancreatic cancer.",
      "The care team includes a diagnostic radiologist.",
      "The care team includes an interventional radiologist.",
      "The care team includes a pathologist.",
      "The care team includes a gastroenterologist.",
      "The care team includes a medical oncologist.",
      "The care team includes a surgical oncologist.",
      "The care team includes a radiation oncologist.",
      "The care team includes a geriatrician.",
      "The care team includes a registered dietitian.",
      "The care team includes a genetic counselor.",
      "The care team includes a palliative care provider.",
      "The care team includes a mental health provider."
    ],
    "evidence_relations": [
      "A multidisciplinary care team is essential for diagnosis and treatment planning in pancreatic cancer",
      "Care Team Role: Diagnostic radiologist, Interventional radiologist, Pathologist, Gastroenterologist, Medical oncologist, Surgical oncologist, Radiation oncologist, Geriatrician, Registered dietitian, Genetic counselor, Palliative care provider, Mental health provider (ontology, rewritten: These roles are part of the multidisciplinary care team for pancreatic cancer)"
    ]
  },
  {
    "id": "Medical-78897235",
    "source": "Medical",
    "question": "Which two diagnostic methods are used to confirm CML by detecting its key biomarkers?",
    "answer": "Blood tests and bone marrow tests are used to detect the BCR::ABL1 fusion gene or Philadelphia chromosome.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood tests are used to confirm CML by detecting key biomarkers.",
      "Bone marrow tests are used to confirm CML by detecting key biomarkers.",
      "Blood tests can detect the BCR::ABL1 fusion gene.",
      "Blood tests can detect the Philadelphia chromosome."
    ],
    "evidence_relations": [
      "Blood tests and bone marrow tests are used to diagnose CML",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "Biomarker includes BCR::ABL1 fusion gene and Philadelphia chromosome (Ph)"
    ]
  },
  {
    "id": "Medical-df366063",
    "source": "Medical",
    "question": "If a patient presents with a shiny bump on the face and has a history of tanning bed use, what diagnostic steps should be taken to evaluate for basal cell carcinoma?",
    "answer": "A medical and family history, physical and skin exam, and biopsy should be performed.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A medical and family history should be performed to evaluate for basal cell carcinoma.",
      "A physical and skin exam should be performed to evaluate for basal cell carcinoma.",
      "A biopsy should be performed to evaluate for basal cell carcinoma."
    ],
    "evidence_relations": [
      "BCC presents as shiny bumps",
      "BCC most commonly develops in sun-exposed areas such as the face",
      "Tanning beds are a risk factor for BCC",
      "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy"
    ]
  },
  {
    "id": "Medical-441c763b",
    "source": "Medical",
    "question": "Which treatment is indicated for a patient with persistent or recurrent anal cancer after initial chemoradiation, and what is a major consequence of this intervention?",
    "answer": "Abdominoperineal resection (APR) is indicated, resulting in a permanent colostomy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Abdominoperineal resection (APR) is indicated for persistent or recurrent anal cancer after initial chemoradiation.",
      "Abdominoperineal resection (APR) results in a permanent colostomy."
    ],
    "evidence_relations": [
      "Abdominoperineal resection (APR) is recommended for persistent, recurrent, or locally progressive anal cancer",
      "APR results in a permanent colostomy"
    ]
  },
  {
    "id": "Medical-de3d6946",
    "source": "Medical",
    "question": "Which diagnostic methods would be most informative for differentiating between cutaneous B-cell and T-cell lymphomas?",
    "answer": "Immunophenotyping and biopsy are most informative for differentiating CBCL from CTCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Immunophenotyping is informative for differentiating cutaneous B-cell lymphoma from cutaneous T-cell lymphoma.",
      "Biopsy is informative for differentiating cutaneous B-cell lymphoma from cutaneous T-cell lymphoma."
    ],
    "evidence_relations": [
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Testing for CBCL includes assessment of biomarkers and genetic changes",
      "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
      "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
    ]
  },
  {
    "id": "Medical-6e99ce81",
    "source": "Medical",
    "question": "For a patient with anaplastic thyroid cancer and distant metastasis, which combination of therapies is most likely to be recommended?",
    "answer": "External beam radiation therapy, chemotherapy, and possibly targeted therapy are most likely recommended.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "External beam radiation therapy is likely recommended for a patient with anaplastic thyroid cancer and distant metastasis.",
      "Chemotherapy is likely recommended for a patient with anaplastic thyroid cancer and distant metastasis.",
      "Possibly targeted therapy is likely recommended for a patient with anaplastic thyroid cancer and distant metastasis."
    ],
    "evidence_relations": [
      "Anaplastic thyroid cancer is the most aggressive and rarest subtype",
      "Anaplastic thyroid cancer Treatment: External beam radiation therapy, Chemotherapy (with radiation), Surgery (if possible), Targeted therapy (if indicated)",
      "Stage Distant metastasis Treatment: External beam radiation therapy, Chemotherapy (for anaplastic), Targeted therapy"
    ]
  },
  {
    "id": "Medical-b6fbf092",
    "source": "Medical",
    "question": "Why is clinical trial participation recommended for all primary CNS lymphoma patients regardless of treatment phase?",
    "answer": "Because clinical trial participation is recommended for all patients and can be part of both induction and consolidation phases.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trial participation is recommended for all primary CNS lymphoma patients.",
      "Clinical trial participation can be part of the induction phase for primary CNS lymphoma patients.",
      "Clinical trial participation can be part of the consolidation phase for primary CNS lymphoma patients."
    ],
    "evidence_relations": [
      "Clinical trial participation is recommended for all patients with primary CNS lymphoma",
      "Treatment is typically given in phases: induction and consolidation",
      "Clinical trial is listed as an option in both induction and consolidation phases"
    ]
  },
  {
    "id": "Medical-ff2105ab",
    "source": "Medical",
    "question": "Why is dental health assessment important in the management of nasopharyngeal carcinoma?",
    "answer": "Dental health can be affected by head and neck cancer and its treatment, so dental exams are part of NPC management.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Dental health can be affected by head and neck cancer.",
      "Dental health can be affected by the treatment of head and neck cancer.",
      "Dental exams are part of the management of nasopharyngeal carcinoma (NPC)."
    ],
    "evidence_relations": [
      "Dental health can be affected by head and neck cancer and its treatment",
      "Dental exam is a diagnostic method for NPC"
    ]
  },
  {
    "id": "Medical-2157ec85",
    "source": "Medical",
    "question": "What features distinguish diffuse type adenocarcinoma from intestinal type in stomach cancer pathology?",
    "answer": "Diffuse type consists of scattered cells and is less common, while intestinal type forms tube- and gland-shaped structures.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diffuse type adenocarcinoma consists of scattered cells.",
      "Diffuse type adenocarcinoma is less common than intestinal type.",
      "Intestinal type adenocarcinoma forms tube-shaped structures.",
      "Intestinal type adenocarcinoma forms gland-shaped structures."
    ],
    "evidence_relations": [
      "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy",
      "Diffuse type adenocarcinoma consists of scattered cells and is less common",
      "There are two major subtypes of stomach adenocarcinoma: intestinal and diffuse"
    ]
  },
  {
    "id": "Medical-025c325c",
    "source": "Medical",
    "question": "Which symptoms and risk factors would prompt early diagnostic evaluation for bladder cancer?",
    "answer": "Blood in urine, frequent urination, and risk factors like smoking and chemical exposure should prompt early diagnostic evaluation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood in urine should prompt early diagnostic evaluation for bladder cancer.",
      "Frequent urination should prompt early diagnostic evaluation for bladder cancer.",
      "Smoking is a risk factor that should prompt early diagnostic evaluation for bladder cancer.",
      "Chemical exposure is a risk factor that should prompt early diagnostic evaluation for bladder cancer."
    ],
    "evidence_relations": [
      "Blood in urine (hematuria) is the most common symptom of bladder cancer",
      "Other symptoms include frequent urination",
      "Smoking is the greatest risk factor for bladder cancer",
      "Other risk factors include chemical exposure"
    ]
  },
  {
    "id": "Medical-535c413f",
    "source": "Medical",
    "question": "Which diagnostic steps should be taken if a screening ultrasound and AFP test suggest liver cancer in a patient with hepatitis B?",
    "answer": "Imaging tests should be performed to confirm diagnosis, and a biopsy may be needed.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging tests should be performed to confirm diagnosis.",
      "A biopsy may be needed."
    ],
    "evidence_relations": [
      "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months",
      "Diagnosis of liver cancer is usually confirmed with imaging tests",
      "Biopsy may be needed to confirm liver cancer"
    ]
  },
  {
    "id": "Medical-aa9a54c8",
    "source": "Medical",
    "question": "Which diagnostic methods would be used to assess both lymph node involvement and distant metastasis in mouth cancer?",
    "answer": "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used to assess lymph node involvement and distant metastasis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging tests such as CT are used to assess lymph node involvement.",
      "Imaging tests such as MRI are used to assess lymph node involvement.",
      "Imaging tests such as PET/CT are used to assess lymph node involvement.",
      "Imaging tests such as ultrasound are used to assess lymph node involvement.",
      "Imaging tests are used to assess distant metastasis."
    ],
    "evidence_relations": [
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Cancer staging is based on the TNM system, which includes lymph node involvement and distant metastasis"
    ]
  },
  {
    "id": "Medical-f8e45373",
    "source": "Medical",
    "question": "Which subtype of Hodgkin lymphoma is most likely to transform into diffuse large B-cell lymphoma, and how is this subtype identified?",
    "answer": "Nodular lymphocyte-predominant Hodgkin lymphoma can transform into diffuse large B-cell lymphoma and is identified by popcorn-shaped cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Nodular lymphocyte-predominant Hodgkin lymphoma can transform into diffuse large B-cell lymphoma.",
      "Nodular lymphocyte-predominant Hodgkin lymphoma is identified by popcorn-shaped cells."
    ],
    "evidence_relations": [
      "NLPHL is characterized by popcorn-shaped cells",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
    ]
  },
  {
    "id": "Medical-f9e22272",
    "source": "Medical",
    "question": "Which two related lymphomas share overlapping features with gray zone lymphomas, complicating diagnosis?",
    "answer": "Primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL) share overlapping features with gray zone lymphomas.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary mediastinal B-cell lymphoma (PMBL) shares overlapping features with gray zone lymphomas.",
      "Hodgkin lymphoma (HL) shares overlapping features with gray zone lymphomas."
    ],
    "evidence_relations": [
      "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)",
      "Related Entities for gray zone lymphoma include Primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
    ]
  },
  {
    "id": "Medical-2148e062",
    "source": "Medical",
    "question": "What is the purpose of surveillance for relapse in ALL patients and which follow-up methods are used?",
    "answer": "Surveillance for relapse aims to detect disease return using regular blood tests and clinical monitoring.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surveillance for relapse aims to detect disease return.",
      "Regular blood tests are used for surveillance in ALL patients.",
      "Clinical monitoring is used for surveillance in ALL patients."
    ],
    "evidence_relations": [
      "Follow-up includes regular blood tests and surveillance for relapse",
      "ALL is a fast-growing blood cancer that starts in lymphocytes"
    ]
  },
  {
    "id": "Medical-b7e4be0e",
    "source": "Medical",
    "question": "What combination of risk factors and diagnostic methods would justify recommending lung cancer screening?",
    "answer": "Individuals with high-risk factors such as tobacco smoking should undergo lung cancer screening using imaging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Individuals with high-risk factors such as tobacco smoking should undergo lung cancer screening.",
      "Lung cancer screening should use imaging."
    ],
    "evidence_relations": [
      "Tobacco smoking is the biggest risk factor for lung cancer",
      "Lung cancer screening is recommended for people at high risk",
      "Screening: lung cancer screening is indicated for high risk individuals"
    ]
  },
  {
    "id": "Medical-e8957bed",
    "source": "Medical",
    "question": "Why is ctDNA testing not routinely used in colon cancer management outside clinical trials?",
    "answer": "ctDNA testing is considered investigational and recommended only in clinical trials, not in standard management.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ctDNA testing is considered investigational.",
      "ctDNA testing is recommended only in clinical trials.",
      "ctDNA testing is not used in standard management of colon cancer."
    ],
    "evidence_relations": [
      "ctDNA testing is investigational and recommended only in clinical trials",
      "ctDNA is listed as a biomarker but not part of routine diagnostic or surveillance methods"
    ]
  },
  {
    "id": "Medical-81c95a46",
    "source": "Medical",
    "question": "Which anatomic locations are most commonly associated with osteosarcoma and giant cell tumor of bone, and what do these locations have in common?",
    "answer": "Osteosarcoma commonly arises in the metaphysis near growth plates, and giant cell tumor of bone often occurs in the metaphysis and epiphysis; both involve the metaphysis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Osteosarcoma commonly arises in the metaphysis near growth plates.",
      "Giant cell tumor of bone often occurs in the metaphysis.",
      "Giant cell tumor of bone often occurs in the epiphysis.",
      "Both osteosarcoma and giant cell tumor of bone involve the metaphysis."
    ],
    "evidence_relations": [
      "Osteosarcoma commonly arises in the metaphysis near growth plates",
      "Giant cell tumor of bone often occurs in the metaphysis and epiphysis",
      "Osteosarcoma: Anatomic Location: [\"Metaphysis\", \"Near growth plates\"]",
      "Giant cell tumor of bone (GCTB): Anatomic Location: [\"Metaphysis\", \"Epiphysis\"]"
    ]
  },
  {
    "id": "Medical-3a5671fc",
    "source": "Medical",
    "question": "What diagnostic methods are used to detect hereditary pancreatic cancer risk, and which genetic syndromes are relevant?",
    "answer": "Genetic tests are used to detect hereditary pancreatic cancer risk, especially in patients with syndromes like HBOC, Peutz-Jeghers, Lynch, Li-Fraumeni, FAMMM, and hereditary pancreatitis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic tests are used to detect hereditary pancreatic cancer risk.",
      "Patients with HBOC syndrome are relevant for hereditary pancreatic cancer risk.",
      "Patients with Peutz-Jeghers syndrome are relevant for hereditary pancreatic cancer risk.",
      "Patients with Lynch syndrome are relevant for hereditary pancreatic cancer risk.",
      "Patients with Li-Fraumeni syndrome are relevant for hereditary pancreatic cancer risk.",
      "Patients with FAMMM syndrome are relevant for hereditary pancreatic cancer risk.",
      "Patients with hereditary pancreatitis are relevant for hereditary pancreatic cancer risk."
    ],
    "evidence_relations": [
      "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer",
      "Hereditary syndromes such as HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, FAMMM syndrome, and hereditary pancreatitis increase risk of pancreatic cancer",
      "Genetic test is a diagnostic method for pancreatic ductal adenocarcinoma (ontology, rewritten: Genetic tests are among the diagnostic methods for pancreatic ductal adenocarcinoma)",
      "Genetic Syndrome: Hereditary breast-ovarian cancer syndrome, HBOC, Peutz-Jeghers syndrome, Lynch syndrome, Li-Fraumeni syndrome, Familial malignant melanoma syndrome, FAMMM syndrome, Hereditary pancreatitis (ontology, rewritten: These genetic syndromes are risk factors for pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-54cc91bf",
    "source": "Medical",
    "question": "Which diagnostic methods are needed to both confirm squamous cell carcinoma (SCC) in the mouth and assess its anatomical extent?",
    "answer": "Biopsy is required to confirm SCC diagnosis and imaging tests like CT, MRI, PET/CT, and ultrasound are used to assess anatomical extent.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A biopsy is required to confirm the diagnosis of squamous cell carcinoma (SCC) in the mouth.",
      "Imaging tests like CT are used to assess the anatomical extent of SCC.",
      "Imaging tests like MRI are used to assess the anatomical extent of SCC.",
      "Imaging tests like PET/CT are used to assess the anatomical extent of SCC.",
      "Imaging tests like ultrasound are used to assess the anatomical extent of SCC."
    ],
    "evidence_relations": [
      "Biopsy is required to confirm diagnosis and determine histology",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging"
    ]
  },
  {
    "id": "Medical-def9b488",
    "source": "Medical",
    "question": "Why is expert hematopathologist review crucial in diagnosing MGZL?",
    "answer": "Because diagnosis of MGZL requires expert hematopathologist review due to its overlapping features with PMBL and HL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Expert hematopathologist review is crucial in diagnosing MGZL.",
      "The diagnosis of MGZL requires expert hematopathologist review.",
      "MGZL has overlapping features with PMBL.",
      "MGZL has overlapping features with HL."
    ],
    "evidence_relations": [
      "Diagnosis of MGZL requires expert hematopathologist review",
      "Gray zone lymphomas have overlapping features of primary mediastinal B-cell lymphoma (PMBL) and Hodgkin lymphoma (HL)"
    ]
  },
  {
    "id": "Medical-8ff4d088",
    "source": "Medical",
    "question": "What treatment options are specifically recommended for hormone receptor-positive, HER2-negative, PIK3CA-mutated metastatic breast cancer?",
    "answer": "Endocrine therapy, CDK4/6 inhibitors, and PIK3CA inhibitors are recommended for hormone receptor-positive, HER2-negative, PIK3CA-mutated metastatic breast cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Endocrine therapy is recommended for hormone receptor-positive, HER2-negative, PIK3CA-mutated metastatic breast cancer.",
      "CDK4/6 inhibitors are recommended for hormone receptor-positive, HER2-negative, PIK3CA-mutated metastatic breast cancer.",
      "PIK3CA inhibitors are recommended for hormone receptor-positive, HER2-negative, PIK3CA-mutated metastatic breast cancer."
    ],
    "evidence_relations": [
      "CDK4/6 inhibitors are used for hormone receptor-positive, HER2-negative breast cancer",
      "PIK3CA inhibitors are used for PIK3CA-mutated, hormone receptor-positive, HER2-negative breast cancer",
      "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs"
    ]
  },
  {
    "id": "Medical-3bea99a2",
    "source": "Medical",
    "question": "Which imaging modalities are necessary to fully stage a patient with suspected regional prostate cancer spread?",
    "answer": "MRI, CT scan, and PSMA-PET are necessary to assess regional spread in prostate cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MRI is necessary to assess regional spread in prostate cancer.",
      "CT scan is necessary to assess regional spread in prostate cancer.",
      "PSMA-PET is necessary to assess regional spread in prostate cancer."
    ],
    "evidence_relations": [
      "Regional prostate cancer has spread to nearby lymph nodes",
      "MRI, CT, PET, ultrasound, and bone scan are imaging methods used to assess extent of disease",
      "Regional prostate cancer diagnostic methods include MRI, CT scan, and PSMA-PET"
    ]
  },
  {
    "id": "Medical-9231a873",
    "source": "Medical",
    "question": "Which cancer subtype is most commonly found in the nasopharynx and how is it classified within the cancer ontology?",
    "answer": "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer, classified under nasopharyngeal carcinoma (NPC) in the ontology.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer.",
      "SCC is classified under nasopharyngeal carcinoma (NPC) in the cancer ontology."
    ],
    "evidence_relations": [
      "Squamous cell carcinoma (SCC) is the most common subtype of nasopharyngeal cancer",
      "Squamous cell carcinoma (SCC) is a subtype of NPC in the ontology"
    ]
  },
  {
    "id": "Medical-efd5b238",
    "source": "Medical",
    "question": "What is the significance of identifying the disease stage in esophageal cancer for determining metastatic sites?",
    "answer": "Disease stage determines if metastasis to organs like liver, lung, bone, and brain has occurred.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Identifying the disease stage in esophageal cancer is significant for determining metastatic sites.",
      "Disease stage determines if metastasis to the liver has occurred.",
      "Disease stage determines if metastasis to the lung has occurred.",
      "Disease stage determines if metastasis to the bone has occurred.",
      "Disease stage determines if metastasis to the brain has occurred."
    ],
    "evidence_relations": [
      "Disease Stage: Metastatic: Spread to distant organs, including liver, lung, bone, brain, and distant lymph nodes",
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain"
    ]
  },
  {
    "id": "Medical-5e530443",
    "source": "Medical",
    "question": "Which symptoms and risk factors together would most strongly indicate the need for biopsy to rule out BCC?",
    "answer": "A flat pale area on sun-exposed skin in a fair-skinned patient with a history of sun exposure strongly indicates the need for biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A flat pale area on sun-exposed skin is a symptom that may indicate basal cell carcinoma.",
      "Fair-skinned patients with a history of sun exposure are at higher risk for basal cell carcinoma.",
      "This combination of symptoms and risk factors strongly indicates the need for biopsy."
    ],
    "evidence_relations": [
      "BCC presents as flat, pale or yellow areas",
      "BCC most commonly develops in sun-exposed areas",
      "Fair skin and sun exposure are risk factors for BCC",
      "Diagnosis of BCC involves biopsy"
    ]
  },
  {
    "id": "Medical-52ca0ffb",
    "source": "Medical",
    "question": "Why are both biomarker testing and genetic risk testing included in the diagnostic process for esophageal cancer?",
    "answer": "Both are needed to identify molecular and inherited factors influencing cancer risk and treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biomarker testing is included in the diagnostic process for esophageal cancer.",
      "Genetic risk testing is included in the diagnostic process for esophageal cancer.",
      "Biomarker testing is needed to identify molecular factors influencing cancer risk.",
      "Genetic risk testing is needed to identify inherited factors influencing cancer risk.",
      "Both tests influence treatment decisions."
    ],
    "evidence_relations": [
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Biomarker testing and genetic risk testing are diagnostic methods for esophageal cancer"
    ]
  },
  {
    "id": "Medical-a7a91e43",
    "source": "Medical",
    "question": "For a patient with high-grade, muscle-invasive urothelial carcinoma, what are the standard treatment options?",
    "answer": "Radical cystectomy, systemic chemotherapy, and possibly chemoradiation or trimodal therapy are standard options.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Standard treatment options for high-grade, muscle-invasive urothelial carcinoma include radical cystectomy.",
      "Standard treatment options for high-grade, muscle-invasive urothelial carcinoma include systemic chemotherapy.",
      "Standard treatment options for high-grade, muscle-invasive urothelial carcinoma may include chemoradiation.",
      "Standard treatment options for high-grade, muscle-invasive urothelial carcinoma may include trimodal therapy."
    ],
    "evidence_relations": [
      "Cancer grade is classified as low grade (LG) or high grade (HG)",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Systemic therapy includes chemotherapy",
      "Radiation therapy (EBRT) is used alone or in combination with chemotherapy (chemoradiation)",
      "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach"
    ]
  },
  {
    "id": "Medical-47504b64",
    "source": "Medical",
    "question": "Why is supportive care considered a treatment option for all stages of lung cancer?",
    "answer": "Supportive care improves quality of life for people with lung cancer regardless of stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Supportive care improves quality of life for people with lung cancer.",
      "Supportive care is considered a treatment option for all stages of lung cancer."
    ],
    "evidence_relations": [
      "Supportive care extends and enhances life for people with lung cancer",
      "NSCLC treatment options include supportive care"
    ]
  },
  {
    "id": "Medical-462ecc23",
    "source": "Medical",
    "question": "How are PD-1 inhibitors used in the treatment of CSCC and at which stage are they preferred?",
    "answer": "PD-1 inhibitors are systemic therapy options preferred for metastatic CSCC, but may also be used for high-risk or regional disease if other treatments are not possible.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PD-1 inhibitors are systemic therapy options for CSCC.",
      "PD-1 inhibitors are preferred for metastatic CSCC.",
      "PD-1 inhibitors may also be used for high-risk disease.",
      "PD-1 inhibitors may also be used for regional disease if other treatments are not possible."
    ],
    "evidence_relations": [
      "Systemic therapy options include platinum-based chemotherapy, EGFR inhibitors (cetuximab), and PD-1 inhibitors (cemiplimab, pembrolizumab)",
      "Metastatic CSCC is treated with systemic therapy (immunotherapy preferred), and surgery or radiation if feasible",
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible"
    ]
  },
  {
    "id": "Medical-6cb18929",
    "source": "Medical",
    "question": "Which glioma subtype is always considered high-grade and what diagnostic and treatment steps are typically involved?",
    "answer": "Glioblastoma is always high-grade (Grade 4) and requires MRI, biopsy, and additional therapy after surgery.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Glioblastoma is always considered high-grade.",
      "Glioblastoma is classified as Grade 4.",
      "MRI is required for glioblastoma diagnosis.",
      "A biopsy is required for glioblastoma diagnosis.",
      "Additional therapy is required after surgery for glioblastoma."
    ],
    "evidence_relations": [
      "Glioblastoma is the most aggressive subtype of glioma",
      "Grade 4 gliomas are most commonly glioblastomas",
      "MRI is the most useful imaging test for identifying glioma",
      "Biopsy is required for definitive diagnosis and molecular testing",
      "High-grade gliomas require additional therapy after surgery"
    ]
  },
  {
    "id": "Medical-b9f39886",
    "source": "Medical",
    "question": "What factors distinguish non-mediastinal gray zone lymphomas from mediastinal gray zone lymphomas?",
    "answer": "Non-mediastinal gray zone lymphomas occur in older persons and have more bone marrow and extranodal involvement, unlike mediastinal types seen in younger males.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Non-mediastinal gray zone lymphomas occur in older persons.",
      "Non-mediastinal gray zone lymphomas have more bone marrow involvement.",
      "Non-mediastinal gray zone lymphomas have more extranodal involvement.",
      "Mediastinal gray zone lymphomas are seen in younger males."
    ],
    "evidence_relations": [
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement",
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth"
    ]
  },
  {
    "id": "Medical-69bd1f37",
    "source": "Medical",
    "question": "Which biomarkers should be tested in a patient with SCC of the tongue to inform treatment options?",
    "answer": "PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB) should be tested.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PD-L1 should be tested in a patient with SCC of the tongue.",
      "MSI-H/dMMR should be tested in a patient with SCC of the tongue.",
      "Tumor mutational burden (TMB) should be tested in a patient with SCC of the tongue."
    ],
    "evidence_relations": [
      "Biomarker testing may include PD-L1, MSI-H/dMMR, and tumor mutational burden (TMB)",
      "Biomarker includes PD-L1, MSI-H/dMMR, and TMB for SCC in the ontology"
    ]
  },
  {
    "id": "Medical-2a24f6a2",
    "source": "Medical",
    "question": "Which methods are used to confirm both the presence and subtype of cutaneous B-cell lymphoma in a patient with skin lesions?",
    "answer": "Biopsy and immunophenotyping are used to confirm both the presence and subtype of CBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biopsy is used to confirm the presence and subtype of cutaneous B-cell lymphoma.",
      "Immunophenotyping is used to confirm the presence and subtype of cutaneous B-cell lymphoma."
    ],
    "evidence_relations": [
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)"
    ]
  },
  {
    "id": "Medical-0a6379ff",
    "source": "Medical",
    "question": "Which genetic syndromes are associated with increased CSCC risk and what is their implication for surveillance?",
    "answer": "Xeroderma pigmentosum and RDEB increase CSCC risk, necessitating regular skin and lymph node exams for surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Xeroderma pigmentosum is associated with increased CSCC risk.",
      "RDEB is associated with increased CSCC risk.",
      "Xeroderma pigmentosum necessitates regular skin exams for surveillance.",
      "RDEB necessitates regular skin exams for surveillance.",
      "Xeroderma pigmentosum necessitates regular lymph node exams for surveillance.",
      "RDEB necessitates regular lymph node exams for surveillance."
    ],
    "evidence_relations": [
      "Genetic syndromes such as xeroderma pigmentosum and RDEB increase risk for CSCC",
      "Clinical Management: Surveillance: Regular skin and lymph node exams"
    ]
  },
  {
    "id": "Medical-ef073c61",
    "source": "Medical",
    "question": "What age group is most commonly affected by ALL and how does this influence diagnostic and treatment strategies?",
    "answer": "Children, adolescents, and young adults are most often affected, requiring age-specific diagnostic and treatment approaches.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Children are most commonly affected by ALL.",
      "Adolescents are most commonly affected by ALL.",
      "Young adults are most commonly affected by ALL.",
      "The age group affected by ALL influences diagnostic strategies.",
      "The age group affected by ALL influences treatment strategies."
    ],
    "evidence_relations": [
      "ALL is the most common cancer diagnosed in children",
      "ALL most often affects children, adolescents, and young adults (AYAs)",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors"
    ]
  },
  {
    "id": "Medical-6a5c89f3",
    "source": "Medical",
    "question": "Why do not all patients with follicular lymphoma require immediate treatment upon diagnosis?",
    "answer": "Because clinical management guidelines state not all patients require immediate treatment and treatment decisions are guided by grade and cell type.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Not all patients with follicular lymphoma require immediate treatment upon diagnosis.",
      "Clinical management guidelines state that treatment decisions are guided by grade.",
      "Clinical management guidelines state that treatment decisions are guided by cell type."
    ],
    "evidence_relations": [
      "Not all patients with FL require immediate treatment",
      "Treatment decisions are guided by grade and cell type",
      "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma"
    ]
  },
  {
    "id": "Medical-9675683c",
    "source": "Medical",
    "question": "What methods are used to monitor rectal cancer after initial treatment and what biomarker is involved?",
    "answer": "Blood tests such as CEA and imaging are used for monitoring after treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood tests such as CEA are used for monitoring rectal cancer after treatment.",
      "Imaging is used for monitoring rectal cancer after treatment."
    ],
    "evidence_relations": [
      "Blood tests such as CEA are used for monitoring rectal cancer",
      "Surveillance after local excision or ESD includes regular sigmoidoscopy and imaging"
    ]
  },
  {
    "id": "Medical-f473bcb0",
    "source": "Medical",
    "question": "What is the main chemotherapy agent used during the induction phase of primary CNS lymphoma treatment and which diagnostic procedure confirms the diagnosis?",
    "answer": "High-dose methotrexate is the main chemotherapy agent, and stereotactic biopsy is the standard diagnostic procedure.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-dose methotrexate is the main chemotherapy agent used during the induction phase of primary CNS lymphoma treatment.",
      "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma."
    ],
    "evidence_relations": [
      "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma",
      "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma",
      "Treatment is typically given in phases: induction and consolidation"
    ]
  },
  {
    "id": "Medical-b2da7aee",
    "source": "Medical",
    "question": "What are the recommended surveillance strategies after treatment for colon cancer and which biomarkers are involved?",
    "answer": "Surveillance includes colonoscopy, CEA testing, and CT scans, with CEA serving as a biomarker for monitoring.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surveillance after treatment for colon cancer includes colonoscopy.",
      "Surveillance after treatment for colon cancer includes CEA testing.",
      "Surveillance after treatment for colon cancer includes CT scans.",
      "CEA serves as a biomarker for monitoring after treatment for colon cancer."
    ],
    "evidence_relations": [
      "Surveillance after treatment includes colonoscopy, CEA testing, and CT scans",
      "CEA is a biomarker for monitoring colon cancer"
    ]
  },
  {
    "id": "Medical-5adcec8a",
    "source": "Medical",
    "question": "How do symptoms guide the use of imaging and biopsy in the diagnostic process for mouth cancer?",
    "answer": "Symptoms such as changes in the mouth, tongue, or neck area prompt the use of imaging and biopsy for diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms such as changes in the mouth prompt the use of imaging for diagnosis.",
      "Symptoms such as changes in the tongue prompt the use of imaging for diagnosis.",
      "Symptoms such as changes in the neck area prompt the use of imaging for diagnosis.",
      "Symptoms prompt the use of biopsy for diagnosis."
    ],
    "evidence_relations": [
      "Symptoms may include changes in the mouth, tongue, or neck area",
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Biopsy is required to confirm diagnosis and determine histology"
    ]
  },
  {
    "id": "Medical-72cfd9c6",
    "source": "Medical",
    "question": "What symptoms and risk factors would prompt early screening for prostate cancer?",
    "answer": "Urinary symptoms and risk factors such as age, family history, and Black race would prompt early screening.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Urinary symptoms would prompt early screening for prostate cancer.",
      "Risk factors such as age would prompt early screening for prostate cancer.",
      "Family history would prompt early screening for prostate cancer.",
      "Black race would prompt early screening for prostate cancer."
    ],
    "evidence_relations": [
      "Symptoms of prostate cancer include urinary symptoms",
      "Age, family history, and Black race are risk factors for prostate cancer",
      "PSA test and digital rectal exam are used for screening"
    ]
  },
  {
    "id": "Medical-d7e8bc97",
    "source": "Medical",
    "question": "Which symptoms would raise suspicion for advanced follicular lymphoma involving multiple disease sites?",
    "answer": "Swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss suggest advanced FL involving lymph nodes, spleen, and possibly bone marrow.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Swollen lymph nodes suggest advanced follicular lymphoma.",
      "Enlarged spleen suggests advanced follicular lymphoma.",
      "Fever suggests advanced follicular lymphoma.",
      "Night sweats suggest advanced follicular lymphoma.",
      "Fatigue suggests advanced follicular lymphoma.",
      "Weight loss suggests advanced follicular lymphoma.",
      "Advanced follicular lymphoma may involve lymph nodes, spleen, and possibly bone marrow."
    ],
    "evidence_relations": [
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)",
      "FL can present as nodal or extranodal disease",
      "Disease Site of FL includes lymph node, bone marrow, spleen, extranodal sites"
    ]
  },
  {
    "id": "Medical-c650bba8",
    "source": "Medical",
    "question": "How does the treatment of infant ALL differ from that of older children or adolescents?",
    "answer": "Infant ALL (under 12 months) is treated differently than other age groups, with specialized protocols.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Infant ALL is treated differently than older children or adolescents.",
      "Infant ALL refers to patients under 12 months of age.",
      "Specialized protocols are used for treating infant ALL."
    ],
    "evidence_relations": [
      "Infant ALL (under 12 months) is treated differently than other age groups",
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "Age Group for ALL includes infant, child, adolescent, and young adult (AYA)"
    ]
  },
  {
    "id": "Medical-38fc968c",
    "source": "Medical",
    "question": "Which surgical procedures may be required for colon cancer patients and under what circumstances is a colostomy necessary?",
    "answer": "Colectomy removes the cancerous colon segment, and colostomy is needed if bowel reconnection is not possible, diverting stool through a stoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Colectomy removes the cancerous segment of the colon.",
      "A colostomy is needed if bowel reconnection is not possible.",
      "A colostomy diverts stool through a stoma."
    ],
    "evidence_relations": [
      "Colectomy is surgery to remove the cancerous part of the colon",
      "Colostomy diverts stool through an abdominal stoma if reconnection is not possible"
    ]
  },
  {
    "id": "Medical-99964376",
    "source": "Medical",
    "question": "Why would a lumbar puncture be performed in the diagnostic workup of a child with ALL?",
    "answer": "A lumbar puncture is performed to assess central nervous system (CNS) involvement, a potential disease site in ALL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A lumbar puncture is performed in the diagnostic workup of a child with ALL.",
      "A lumbar puncture assesses central nervous system involvement.",
      "Central nervous system involvement is a potential disease site in ALL."
    ],
    "evidence_relations": [
      "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture",
      "ALL can be found in bone marrow, blood, testicles, or central nervous system (CNS)",
      "Lumbar puncture is listed as a diagnostic method for ALL"
    ]
  },
  {
    "id": "Medical-a88065af",
    "source": "Medical",
    "question": "If a patient with esophageal cancer presents with liver and bone metastases, what is their disease stage and which diagnostic methods are necessary?",
    "answer": "The patient has metastatic disease and requires imaging tests and biopsy for confirmation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The patient has metastatic disease.",
      "The patient requires imaging tests for confirmation.",
      "The patient requires biopsy for confirmation."
    ],
    "evidence_relations": [
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Metastatic: Spread to distant organs, including liver and bone"
    ]
  },
  {
    "id": "Medical-7b422282",
    "source": "Medical",
    "question": "How does the presence of Lynch syndrome affect colon cancer risk and management?",
    "answer": "Lynch syndrome increases colon cancer risk and requires testing for mismatch repair deficiency (dMMR) or MSI-H, which guides immunotherapy decisions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lynch syndrome increases colon cancer risk.",
      "Lynch syndrome requires testing for mismatch repair deficiency (dMMR) or MSI-H.",
      "Testing for dMMR or MSI-H guides immunotherapy decisions."
    ],
    "evidence_relations": [
      "Lynch syndrome and familial adenomatous polyposis (FAP) are inherited syndromes increasing colon cancer risk",
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)",
      "dMMR/MSI-H is a biomarker guiding immunotherapy"
    ]
  },
  {
    "id": "Medical-35afeb4b",
    "source": "Medical",
    "question": "What treatment modification is made for MGZL patients to enhance chemoimmunotherapy?",
    "answer": "Rituximab may be added to chemotherapy for chemoimmunotherapy in MGZL patients.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Rituximab may be added to chemotherapy for MGZL patients.",
      "The addition of rituximab enhances chemoimmunotherapy in MGZL patients."
    ],
    "evidence_relations": [
      "Rituximab may be added to chemotherapy for chemoimmunotherapy",
      "MGZL is usually treated with chemotherapy"
    ]
  },
  {
    "id": "Medical-88e1fb4a",
    "source": "Medical",
    "question": "How does the treatment approach differ for mature B-cell ALL (Burkitt leukemia) compared to other B-cell ALL subtypes in children?",
    "answer": "Mature B-cell ALL (Burkitt leukemia) is treated differently from B-ALL, requiring a distinct therapeutic protocol.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mature B-cell ALL (Burkitt leukemia) is treated differently from other B-cell ALL subtypes.",
      "Mature B-cell ALL (Burkitt leukemia) requires a distinct therapeutic protocol."
    ],
    "evidence_relations": [
      "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL",
      "B-cell ALL (B-ALL) starts in B-cell lymphocytes and is more common than T-ALL",
      "B-cell ALL (B-ALL) has a variant called Mature B-cell ALL (Burkitt leukemia)"
    ]
  },
  {
    "id": "Medical-fb234ffb",
    "source": "Medical",
    "question": "What is the significance of BCL2 protein in the diagnosis or classification of follicular lymphoma?",
    "answer": "BCL2 protein is a biomarker found in almost all FL cases, often due to chromosome translocation, and helps confirm the diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BCL2 protein is a biomarker found in almost all follicular lymphoma cases.",
      "BCL2 protein is often due to chromosome translocation.",
      "BCL2 protein helps confirm the diagnosis of follicular lymphoma."
    ],
    "evidence_relations": [
      "Almost all FL cases have a chromosome translocation or excess BCL2 protein",
      "Biomarker of FL is BCL2 protein",
      "Genetic Alteration of FL includes chromosome translocation, t(14;18)"
    ]
  },
  {
    "id": "Medical-c58dca0f",
    "source": "Medical",
    "question": "Which chemotherapy agents may be included in rectal cancer treatment regimens and for what stage are they typically used?",
    "answer": "Oxaliplatin and irinotecan may be included in chemotherapy regimens, typically used for locally advanced rectal cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Oxaliplatin may be included in chemotherapy regimens for rectal cancer.",
      "Irinotecan may be included in chemotherapy regimens for rectal cancer.",
      "Oxaliplatin and irinotecan are typically used for locally advanced rectal cancer."
    ],
    "evidence_relations": [
      "Chemotherapy regimens may include oxaliplatin or irinotecan",
      "Chemoradiation is used for locally advanced rectal cancer"
    ]
  },
  {
    "id": "Medical-1930c305",
    "source": "Medical",
    "question": "What features distinguish Hodgkin lymphoma from other lymphomas based on the ontology and relations provided?",
    "answer": "Hodgkin lymphoma is defined by its subtypes (CHL and NLPHL), characteristic cell types (Reed-Sternberg or popcorn-shaped cells), and typical onset in upper body lymph nodes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hodgkin lymphoma is defined by its subtypes, which are classic Hodgkin lymphoma and NLPHL.",
      "Hodgkin lymphoma is characterized by Reed-Sternberg cells or popcorn-shaped cells.",
      "Hodgkin lymphoma typically has an onset in upper body lymph nodes."
    ],
    "evidence_relations": [
      "Hodgkin lymphoma is a type of lymphoma",
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma",
      "NLPHL is a rare subtype of Hodgkin lymphoma",
      "CHL is characterized by Reed-Sternberg cells",
      "NLPHL is characterized by popcorn-shaped cells",
      "Hodgkin lymphoma usually starts in lymph nodes in the upper body"
    ]
  },
  {
    "id": "Medical-5e3016f9",
    "source": "Medical",
    "question": "What combination of features would indicate a diagnosis of non-mediastinal gray zone lymphoma rather than MGZL?",
    "answer": "Older age, bone marrow or extranodal involvement, and absence of mediastinal mass indicate non-mediastinal gray zone lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Older age indicates non-mediastinal gray zone lymphoma.",
      "Bone marrow involvement indicates non-mediastinal gray zone lymphoma.",
      "Extranodal involvement indicates non-mediastinal gray zone lymphoma.",
      "Absence of mediastinal mass indicates non-mediastinal gray zone lymphoma."
    ],
    "evidence_relations": [
      "Non-mediastinal gray zone lymphomas occur in older persons and have higher rates of bone marrow and extranodal involvement",
      "MGZL is characterized by a large mediastinal mass"
    ]
  },
  {
    "id": "Medical-68694b91",
    "source": "Medical",
    "question": "Why might a core needle biopsy be chosen over an excisional lymph node biopsy in Hodgkin lymphoma diagnosis?",
    "answer": "Core needle biopsy may be used in some cases as an alternative to excisional lymph node biopsy for diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Core needle biopsy may be used as an alternative to excisional lymph node biopsy.",
      "Core needle biopsy can be chosen in some cases for Hodgkin lymphoma diagnosis."
    ],
    "evidence_relations": [
      "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy",
      "Core needle biopsy may be used for diagnosis in some cases"
    ]
  },
  {
    "id": "Medical-3f8a738d",
    "source": "Medical",
    "question": "If a patient with a history of head and neck radiation presents with a neck lump and trouble swallowing, what diagnostic steps should be taken to evaluate for thyroid cancer?",
    "answer": "TSH test, neck ultrasound, and fine-needle aspiration biopsy should be performed to evaluate for thyroid cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "TSH test should be performed to evaluate for thyroid cancer.",
      "Neck ultrasound should be performed to evaluate for thyroid cancer.",
      "Fine-needle aspiration biopsy should be performed to evaluate for thyroid cancer."
    ],
    "evidence_relations": [
      "Radiation exposure to the head or neck increases risk of thyroid cancer",
      "Symptoms of large thyroid nodules include visible neck lump, problems swallowing",
      "TSH blood test and neck ultrasound are recommended for evaluation of thyroid nodules",
      "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules"
    ]
  },
  {
    "id": "Medical-f00f6356",
    "source": "Medical",
    "question": "What combination of factors must be considered in treatment planning for a locoregional esophageal adenocarcinoma at the lower esophagus?",
    "answer": "Treatment planning requires cancer type (adenocarcinoma), location (lower esophagus), and stage (locoregional).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment planning for locoregional esophageal adenocarcinoma requires cancer type.",
      "Treatment planning for locoregional esophageal adenocarcinoma requires location.",
      "Treatment planning for locoregional esophageal adenocarcinoma requires stage."
    ],
    "evidence_relations": [
      "Treatment planning is based on cancer type, location, and stage",
      "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus",
      "Locoregional esophageal cancer has invaded the esophagus wall and/or spread to nearby lymph nodes or organs"
    ]
  },
  {
    "id": "Medical-4b359d87",
    "source": "Medical",
    "question": "If a patient's lymph node biopsy reveals popcorn-shaped cells, what is the diagnosis and what is a potential complication?",
    "answer": "The diagnosis is nodular lymphocyte-predominant Hodgkin lymphoma, which can transform into diffuse large B-cell lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The diagnosis is nodular lymphocyte-predominant Hodgkin lymphoma.",
      "Nodular lymphocyte-predominant Hodgkin lymphoma can transform into diffuse large B-cell lymphoma."
    ],
    "evidence_relations": [
      "NLPHL is characterized by popcorn-shaped cells",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
    ]
  },
  {
    "id": "Medical-c7c59020",
    "source": "Medical",
    "question": "What is the rationale for using both imaging and biopsy in the assessment of a lung nodule?",
    "answer": "Imaging detects the lung nodule, but biopsy is necessary to determine if it is cancerous.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging detects the lung nodule.",
      "A biopsy is necessary to determine if the lung nodule is cancerous."
    ],
    "evidence_relations": [
      "Lung nodules may be detected by imaging and require further assessment to determine malignancy",
      "Biopsy is used to confirm lung cancer diagnosis"
    ]
  },
  {
    "id": "Medical-311d66d6",
    "source": "Medical",
    "question": "Which risk factors should be evaluated in a patient with a new breast lump to assess their likelihood of breast cancer?",
    "answer": "Family history, BRCA1/2 mutations, and assigned female at birth should be evaluated as risk factors for breast cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Family history should be evaluated as a risk factor for breast cancer.",
      "BRCA1/2 mutations should be evaluated as a risk factor for breast cancer.",
      "Assigned female at birth should be evaluated as a risk factor for breast cancer."
    ],
    "evidence_relations": [
      "Risk factors include family history, BRCA mutations, and being assigned female at birth",
      "Breast lump is a common symptom of breast cancer"
    ]
  },
  {
    "id": "Medical-b6f1658b",
    "source": "Medical",
    "question": "What is the relationship between HPV status and the recommended biomarker testing in oropharyngeal cancer?",
    "answer": "HPV status is assessed by p16 (HPV) testing, which is recommended for all oropharyngeal cancer patients.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HPV status is assessed by p16 (HPV) testing.",
      "p16 (HPV) testing is recommended for all oropharyngeal cancer patients."
    ],
    "evidence_relations": [
      "p16 (HPV) testing is recommended for all patients with oropharyngeal cancer",
      "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer"
    ]
  },
  {
    "id": "Medical-417cbcfd",
    "source": "Medical",
    "question": "What is the connection between the assessment of biomarkers/genetic changes and the selection of diagnostic methods in CBCL?",
    "answer": "Assessment of biomarkers and genetic changes in CBCL requires diagnostic methods like biopsy and immunophenotyping.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Assessment of biomarkers in CBCL requires diagnostic methods.",
      "Assessment of genetic changes in CBCL requires diagnostic methods.",
      "Biopsy is a diagnostic method used in CBCL.",
      "Immunophenotyping is a diagnostic method used in CBCL."
    ],
    "evidence_relations": [
      "Testing for CBCL includes assessment of biomarkers and genetic changes",
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping"
    ]
  },
  {
    "id": "Medical-ac781c3a",
    "source": "Medical",
    "question": "If a patient with stage 4 primary biliary cholangitis develops liver cancer, what is the likely sequence of risk events?",
    "answer": "Stage 4 primary biliary cholangitis increases risk of cirrhosis, which then raises the risk for liver cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 4 primary biliary cholangitis increases the risk of cirrhosis.",
      "Cirrhosis raises the risk for liver cancer."
    ],
    "evidence_relations": [
      "Stage 4 primary biliary cholangitis is a risk factor for cirrhosis and liver cancer",
      "Cirrhosis is a major risk factor for developing liver cancer"
    ]
  },
  {
    "id": "Medical-6d12f4ff",
    "source": "Medical",
    "question": "How does immunosuppression influence both the risk and clinical management of CSCC?",
    "answer": "Immunosuppression increases CSCC risk and is a factor in risk assessment, requiring intensified surveillance and potentially altered treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Immunosuppression increases CSCC risk.",
      "Immunosuppression is a factor in risk assessment for CSCC.",
      "Immunosuppression requires intensified surveillance for CSCC.",
      "Immunosuppression may require altered treatment for CSCC."
    ],
    "evidence_relations": [
      "Major risk factors for CSCC include weakened immune system",
      "Risk assessment for CSCC is based on patient immune status",
      "Clinical Management: Risk Assessment: Immunosuppression"
    ]
  },
  {
    "id": "Medical-f7300f3c",
    "source": "Medical",
    "question": "Which diagnostic methods are shared between classic Hodgkin lymphoma and NLPHL, and what does this suggest about their diagnostic process?",
    "answer": "Both use excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, and imaging tests, indicating a similar diagnostic process.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Both classic Hodgkin lymphoma and NLPHL use excisional lymph node biopsy.",
      "Both classic Hodgkin lymphoma and NLPHL use core needle biopsy.",
      "Both classic Hodgkin lymphoma and NLPHL use health history in diagnosis.",
      "Both classic Hodgkin lymphoma and NLPHL use physical exams in diagnosis.",
      "Both classic Hodgkin lymphoma and NLPHL use blood tests in diagnosis.",
      "Both classic Hodgkin lymphoma and NLPHL use imaging tests in diagnosis.",
      "This suggests a similar diagnostic process for both types."
    ],
    "evidence_relations": [
      "Classic Hodgkin lymphoma (CHL): Diagnostic Method: excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, imaging tests",
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): Diagnostic Method: excisional lymph node biopsy, core needle biopsy, health history, physical exam, blood tests, imaging tests"
    ]
  },
  {
    "id": "Medical-2a5688d0",
    "source": "Medical",
    "question": "What are the main imaging modalities used in the diagnosis and surveillance of bladder cancer?",
    "answer": "CT scan, MRI, PET/CT, ultrasound, pyelogram, and urogram are main imaging modalities used.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CT scan is a main imaging modality used in the diagnosis of bladder cancer.",
      "MRI is a main imaging modality used in the diagnosis of bladder cancer.",
      "PET/CT is a main imaging modality used in the diagnosis of bladder cancer.",
      "Ultrasound is a main imaging modality used in the diagnosis of bladder cancer.",
      "Pyelogram is a main imaging modality used in the diagnosis of bladder cancer.",
      "Urogram is a main imaging modality used in the diagnosis of bladder cancer."
    ],
    "evidence_relations": [
      "Diagnosis of bladder cancer involves imaging (CT, MRI, PET/CT, ultrasound, pyelogram, urogram)",
      "Follow-up/Surveillance includes imaging"
    ]
  },
  {
    "id": "Medical-18be1c24",
    "source": "Medical",
    "question": "Which diagnostic and biomarker tests are indicated for a patient with a visible neck lump suspected to be papillary thyroid carcinoma?",
    "answer": "TSH test, neck ultrasound, fine-needle aspiration, pathology review, molecular tests, and biomarker analysis for BRAF, NTRK, and ALK gene mutations are indicated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "TSH test is indicated for a patient with a visible neck lump suspected to be papillary thyroid carcinoma.",
      "Neck ultrasound is indicated for a patient with a visible neck lump suspected to be papillary thyroid carcinoma.",
      "Fine-needle aspiration is indicated for a patient with a visible neck lump suspected to be papillary thyroid carcinoma.",
      "Pathology review is indicated for a patient with a visible neck lump suspected to be papillary thyroid carcinoma.",
      "Molecular tests are indicated for a patient with a visible neck lump suspected to be papillary thyroid carcinoma.",
      "Biomarker analysis for BRAF, NTRK, and ALK gene mutations is indicated for a patient with a visible neck lump suspected to be papillary thyroid carcinoma."
    ],
    "evidence_relations": [
      "Symptoms of large thyroid nodules include visible neck lump",
      "Papillary thyroid carcinoma Diagnostic Method: TSH test, Ultrasound, Fine-needle aspiration, Pathology review, Molecular tests",
      "Papillary thyroid carcinoma Biomarker: BRAF gene mutation, NTRK gene fusion, ALK gene fusion"
    ]
  },
  {
    "id": "Medical-2f70ddcb",
    "source": "Medical",
    "question": "What follow-up tests are recommended after total thyroidectomy for thyroid cancer, and how can recurrence be detected?",
    "answer": "Physical exam, TSH, thyroglobulin, anti-thyroglobulin antibodies blood tests, and neck ultrasound are recommended; recurrence may be detected by rising thyroglobulin or imaging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Physical exam is a recommended follow-up test after total thyroidectomy for thyroid cancer.",
      "TSH blood test is a recommended follow-up test after total thyroidectomy for thyroid cancer.",
      "Thyroglobulin blood test is a recommended follow-up test after total thyroidectomy for thyroid cancer.",
      "Anti-thyroglobulin antibodies blood test is a recommended follow-up test after total thyroidectomy for thyroid cancer.",
      "Neck ultrasound is a recommended follow-up test after total thyroidectomy for thyroid cancer.",
      "Recurrence of thyroid cancer may be detected by rising thyroglobulin levels.",
      "Recurrence of thyroid cancer may be detected by imaging."
    ],
    "evidence_relations": [
      "Follow-up after treatment includes physical exam, blood tests (TSH, Tg, Tg ab), and neck ultrasound",
      "Rising thyroglobulin after thyroidectomy may indicate recurrence",
      "Recurrence Detection: Rising thyroglobulin, Neck ultrasound, Imaging (CT, MRI)"
    ]
  },
  {
    "id": "Medical-6e464eb2",
    "source": "Medical",
    "question": "In a patient with symptoms of hormone excess and an adrenal mass found incidentally on CT, what further tests are indicated to determine tumor type?",
    "answer": "Biochemical tests to assess hormone secretion and further imaging such as MRI or PET scan are indicated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Biochemical tests are indicated to assess hormone secretion in a patient with an adrenal mass.",
      "Further imaging such as MRI is indicated to determine tumor type in a patient with an adrenal mass.",
      "Further imaging such as PET scan is indicated to determine tumor type in a patient with an adrenal mass."
    ],
    "evidence_relations": [
      "Half of adrenal cancer patients have symptoms due to hormone excess",
      "Adrenal tumors are often found incidentally on imaging tests such as CT or MRI",
      "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors",
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT"
    ]
  },
  {
    "id": "Medical-3a5fb7b0",
    "source": "Medical",
    "question": "Why are high-grade gliomas treated differently than low-grade gliomas following surgery?",
    "answer": "High-grade gliomas require additional therapy after surgery due to their aggressive nature, unlike low-grade gliomas.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-grade gliomas require additional therapy after surgery.",
      "Low-grade gliomas do not require additional therapy after surgery.",
      "High-grade gliomas are more aggressive than low-grade gliomas."
    ],
    "evidence_relations": [
      "High-grade gliomas require additional therapy after surgery",
      "Grades 1 and 2 are low-grade gliomas; grades 3 and 4 are high-grade gliomas",
      "Glioblastoma is the most aggressive subtype of glioma"
    ]
  },
  {
    "id": "Medical-e851fe04",
    "source": "Medical",
    "question": "What factors determine the use of fertility-sparing surgery in ovarian cancer patients?",
    "answer": "Fertility-sparing surgery is considered for select early-stage cases, depending on stage and patient fertility desires.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility-sparing surgery is considered for select early-stage cases.",
      "The use of fertility-sparing surgery depends on the stage of cancer.",
      "The use of fertility-sparing surgery depends on patient fertility desires."
    ],
    "evidence_relations": [
      "Fertility-sparing surgery may be considered for select early-stage cases",
      "Staging is based on the FIGO system (Stages I-IV) and requires surgical staging",
      "The ontology lists surgical procedures and stages relevant to ovarian cancer"
    ]
  },
  {
    "id": "Medical-4a4eaab8",
    "source": "Medical",
    "question": "How does the presence or absence of the t(14;18) translocation affect the classification of follicular lymphoma?",
    "answer": "FL cases lacking t(14;18) or with uncommon pathologic features are classified as uncommon FL (uFL) but are treated as classic FL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "FL cases lacking t(14;18) are classified as uncommon FL (uFL).",
      "FL cases with uncommon pathologic features are classified as uncommon FL (uFL).",
      "Uncommon FL (uFL) is treated as classic FL."
    ],
    "evidence_relations": [
      "Uncommon FL (uFL) is t(14;18)-negative or has uncommon pathologic features and is treated as classic FL",
      "Almost all FL cases have a chromosome translocation or excess BCL2 protein",
      "Genetic Alteration of uncommon FL (uFL) is t(14;18)-negative"
    ]
  },
  {
    "id": "Medical-6e3e48fa",
    "source": "Medical",
    "question": "Which diagnostic procedures are essential for confirming a case of cutaneous B-cell lymphoma presenting with skin nodules?",
    "answer": "Skin exam, blood tests, imaging tests, biopsy, and immunophenotyping are essential for confirming CBCL with nodules.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Skin exam is essential for confirming cutaneous B-cell lymphoma with skin nodules.",
      "Blood tests are essential for confirming cutaneous B-cell lymphoma with skin nodules.",
      "Imaging tests are essential for confirming cutaneous B-cell lymphoma with skin nodules.",
      "Biopsy is essential for confirming cutaneous B-cell lymphoma with skin nodules.",
      "Immunophenotyping is essential for confirming cutaneous B-cell lymphoma with skin nodules."
    ],
    "evidence_relations": [
      "Diagnosis of CBCL involves skin exam, blood tests, imaging tests, biopsy, and immunophenotyping",
      "Symptoms of CBCL include skin nodules and papules"
    ]
  },
  {
    "id": "Medical-59ea36ca",
    "source": "Medical",
    "question": "What follow-up procedures are recommended after achieving remission in primary CNS lymphoma?",
    "answer": "Repeat MRI, eye exam, blood tests, and performance status assessment are recommended for surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Repeat MRI is recommended after achieving remission in primary CNS lymphoma.",
      "Eye exam is recommended after achieving remission in primary CNS lymphoma.",
      "Blood tests are recommended after achieving remission in primary CNS lymphoma.",
      "Performance status assessment is recommended after achieving remission in primary CNS lymphoma."
    ],
    "evidence_relations": [
      "Follow-up/Surveillance for Primary CNS lymphoma includes Repeat MRI, Eye exam, Blood tests, Performance status assessment",
      "Remission is a stage after treatment in primary CNS lymphoma"
    ]
  },
  {
    "id": "Medical-640a315c",
    "source": "Medical",
    "question": "Which supportive care interventions are necessary for an AML patient presenting with severe anemia and infection risk?",
    "answer": "Transfusions and infection prevention measures are necessary supportive care interventions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Transfusions are necessary supportive care interventions for AML patients.",
      "Infection prevention measures are necessary supportive care interventions for AML patients."
    ],
    "evidence_relations": [
      "Supportive care includes transfusions, infection prevention, and management of side effects",
      "AML causes a buildup of blasts in bone marrow and blood, leading to low counts of healthy red blood cells, platelets, and white blood cells"
    ]
  },
  {
    "id": "Medical-5fdb115b",
    "source": "Medical",
    "question": "What imaging modalities are used for both staging and surveillance of nasopharyngeal carcinoma?",
    "answer": "CT scan, MRI, PET/CT, and ultrasound are used for both staging and surveillance of NPC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CT scan is used for both staging and surveillance of nasopharyngeal carcinoma.",
      "MRI is used for both staging and surveillance of nasopharyngeal carcinoma.",
      "PET/CT is used for both staging and surveillance of nasopharyngeal carcinoma.",
      "Ultrasound is used for both staging and surveillance of nasopharyngeal carcinoma."
    ],
    "evidence_relations": [
      "Imaging tests such as CT, MRI, PET/CT, and ultrasound are used for staging and surveillance",
      "Diagnosis of NPC involves imaging (CT, MRI, PET/CT, ultrasound)"
    ]
  },
  {
    "id": "Medical-5422875d",
    "source": "Medical",
    "question": "What risk factors should be evaluated in a patient suspected of having ALL and why are these important?",
    "answer": "Genetic syndromes and family history should be evaluated as they increase the risk of developing ALL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic syndromes should be evaluated in patients suspected of having ALL.",
      "Family history should be evaluated in patients suspected of having ALL.",
      "Genetic syndromes increase the risk of developing ALL.",
      "Family history increases the risk of developing ALL."
    ],
    "evidence_relations": [
      "Risk factors for ALL include certain genetic syndromes and family history",
      "ALL is a fast-growing blood cancer that starts in lymphocytes"
    ]
  },
  {
    "id": "Medical-e1deaedc",
    "source": "Medical",
    "question": "Which molecular biomarkers should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy, and why?",
    "answer": "ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, and TMB-H should be tested to guide targeted therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ALK fusion should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy.",
      "NTRK fusion should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy.",
      "BRAF mutation should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy.",
      "RET fusion should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy.",
      "dMMR should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy.",
      "MSI-H should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy.",
      "TMB-H should be tested in recurrent or advanced thyroid cancers not treatable with RAI therapy.",
      "Testing molecular biomarkers guides targeted therapy in recurrent or advanced thyroid cancers."
    ],
    "evidence_relations": [
      "Biomarker testing is recommended for recurrent, advanced, or metastatic cancers not treatable with RAI",
      "Biomarkers include ALK fusion, NTRK fusion, BRAF mutation, RET fusion, dMMR, MSI-H, TMB-H"
    ]
  },
  {
    "id": "Medical-413d4c7e",
    "source": "Medical",
    "question": "What are the main symptoms prompting diagnostic evaluation for cervical cancer, and which diagnostic methods confirm the diagnosis?",
    "answer": "Symptoms like watery vaginal discharge, pelvic pain, and abnormal vaginal bleeding prompt evaluation, confirmed by cervical biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms prompting diagnostic evaluation for cervical cancer include watery vaginal discharge.",
      "Symptoms prompting diagnostic evaluation for cervical cancer include pelvic pain.",
      "Symptoms prompting diagnostic evaluation for cervical cancer include abnormal vaginal bleeding.",
      "Cervical biopsy confirms the diagnosis of cervical cancer."
    ],
    "evidence_relations": [
      "Watery vaginal discharge, pelvic pain, and abnormal vaginal bleeding are symptoms of cervical cancer",
      "Cervical biopsy is the primary diagnostic method for cervical cancer",
      "These symptoms and diagnostic methods are listed for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-41b1601a",
    "source": "Medical",
    "question": "Which two main biomarkers are tested to confirm a diagnosis of CML, and how are they related?",
    "answer": "BCR::ABL1 fusion gene and Philadelphia chromosome are tested, both resulting from the same chromosomal translocation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The BCR::ABL1 fusion gene is tested to confirm a diagnosis of CML.",
      "The Philadelphia chromosome is tested to confirm a diagnosis of CML.",
      "Both the BCR::ABL1 fusion gene and Philadelphia chromosome result from the same chromosomal translocation."
    ],
    "evidence_relations": [
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "Biomarker includes BCR::ABL1 fusion gene and Philadelphia chromosome (Ph)"
    ]
  },
  {
    "id": "Medical-904e0a11",
    "source": "Medical",
    "question": "How does the anatomical structure of the bile duct relate to the spread of cancer to the liver?",
    "answer": "The bile duct is composed of several layers, and cancer can invade through these layers into the liver.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The bile duct is composed of several layers.",
      "Cancer can invade through the layers of the bile duct into the liver."
    ],
    "evidence_relations": [
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
    ]
  },
  {
    "id": "Medical-6a90b47e",
    "source": "Medical",
    "question": "What methods are used to assess both nutritional status and speech/swallowing function in nasopharyngeal carcinoma patients?",
    "answer": "Nutrition assessment and speech and swallowing assessment are used in NPC patients.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Nutrition assessment is used in nasopharyngeal carcinoma (NPC) patients.",
      "Speech and swallowing assessment is used in nasopharyngeal carcinoma (NPC) patients."
    ],
    "evidence_relations": [
      "Nutrition assessment and speech and swallowing assessment are diagnostic methods for NPC",
      "Diagnostic Method in the ontology includes nutrition assessment and speech and swallowing assessment"
    ]
  },
  {
    "id": "Medical-83ff7511",
    "source": "Medical",
    "question": "If liver cancer is found to have both hepatocellular and cholangiocarcinoma components, what is the tumor called and what does this imply about its classification?",
    "answer": "Such a tumor is called a mixed-type tumor, implying it contains both HCC and cholangiocarcinoma features.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A tumor with both hepatocellular and cholangiocarcinoma components is called a mixed-type tumor.",
      "A mixed-type tumor contains both HCC and cholangiocarcinoma features."
    ],
    "evidence_relations": [
      "Mixed-type tumors contain both hepatocellular carcinoma and cholangiocarcinoma components",
      "Cancer Subtype: Mixed-type tumor contains both HCC and cholangiocarcinoma"
    ]
  },
  {
    "id": "Medical-9a34e14c",
    "source": "Medical",
    "question": "In a patient with primary CNS lymphoma and concurrent HIV infection, why is additional laboratory testing necessary?",
    "answer": "HIV blood test is needed because immunodeficiency is a risk factor for primary CNS lymphoma and may influence management.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HIV blood test is needed for patients with primary CNS lymphoma and concurrent HIV infection.",
      "Immunodeficiency is a risk factor for primary CNS lymphoma.",
      "Immunodeficiency may influence management of primary CNS lymphoma."
    ],
    "evidence_relations": [
      "Immunodeficiency disorders, HIV infection, and Epstein-Barr virus are risk factors for primary CNS lymphoma",
      "Laboratory Tests for Primary CNS lymphoma include HIV blood test"
    ]
  },
  {
    "id": "Medical-ab708cf8",
    "source": "Medical",
    "question": "What anatomical sites are included under oropharyngeal cancer, and how does this relate to the diagnosis of throat cancer?",
    "answer": "Oropharyngeal cancer includes the soft palate, tonsils, base of tongue, and side and back walls of the throat, which are common sites where throat cancer arises.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Oropharyngeal cancer includes the soft palate.",
      "Oropharyngeal cancer includes the tonsils.",
      "Oropharyngeal cancer includes the base of tongue.",
      "Oropharyngeal cancer includes the side walls of the throat.",
      "Oropharyngeal cancer includes the back walls of the throat.",
      "Throat cancer commonly arises in the oropharyngeal sites."
    ],
    "evidence_relations": [
      "Oropharyngeal cancer is a subtype of throat cancer",
      "Throat cancer commonly arises in the oropharynx, including the soft palate, tonsils, side and back walls of the throat, and base of the tongue"
    ]
  },
  {
    "id": "Medical-17015c75",
    "source": "Medical",
    "question": "Which subtypes of pancreatic cancer are described, and which is most common?",
    "answer": "Pancreatic ductal adenocarcinoma is the most common subtype, while pancreatic neuroendocrine tumor is less common.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pancreatic ductal adenocarcinoma is the most common subtype of pancreatic cancer.",
      "Pancreatic neuroendocrine tumor is a less common subtype of pancreatic cancer."
    ],
    "evidence_relations": [
      "Pancreatic ductal adenocarcinoma (PDAC) is the most common subtype of pancreatic cancer",
      "Pancreatic neuroendocrine tumor is a less common subtype of pancreatic cancer",
      "Cancer Subtype: Pancreatic ductal adenocarcinoma, Pancreatic neuroendocrine tumor (ontology, rewritten: The main subtypes of pancreatic cancer are pancreatic ductal adenocarcinoma and pancreatic neuroendocrine tumor)"
    ]
  },
  {
    "id": "Medical-8779d729",
    "source": "Medical",
    "question": "What are the main differences in cell type and disease progression risk between classic Hodgkin lymphoma and NLPHL?",
    "answer": "Classic Hodgkin lymphoma has Reed-Sternberg cells and is the most common subtype, while NLPHL has popcorn-shaped cells and can transform into DLBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Classic Hodgkin lymphoma has Reed-Sternberg cells.",
      "Classic Hodgkin lymphoma is the most common subtype.",
      "Nodular lymphocyte-predominant Hodgkin lymphoma has popcorn-shaped cells.",
      "Nodular lymphocyte-predominant Hodgkin lymphoma can transform into diffuse large B-cell lymphoma."
    ],
    "evidence_relations": [
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma",
      "CHL is characterized by Reed-Sternberg cells",
      "NLPHL is characterized by popcorn-shaped cells",
      "NLPHL can transform into diffuse large B-cell lymphoma (DLBCL)"
    ]
  },
  {
    "id": "Medical-3c536762",
    "source": "Medical",
    "question": "Why is tumor size and extent of spread important in staging bile duct cancer?",
    "answer": "Because bile duct cancer staging is based on tumor size and how far it has spread beyond the original location.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Bile duct cancer staging is based on tumor size.",
      "Bile duct cancer staging is based on how far the tumor has spread beyond the original location."
    ],
    "evidence_relations": [
      "Bile duct cancer staging is based on tumor size and extent of spread",
      "Tumor Characteristic includes primary tumor size (cm or mm) and spread to blood vessels, liver, or structures outside the liver"
    ]
  },
  {
    "id": "Medical-bb361e83",
    "source": "Medical",
    "question": "How does the presence of sarcomatoid features influence treatment considerations for RCC?",
    "answer": "Sarcomatoid features indicate more aggressive disease, which is a treatment factor for RCC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Sarcomatoid features indicate more aggressive disease.",
      "Sarcomatoid features are a treatment factor for RCC."
    ],
    "evidence_relations": [
      "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease",
      "Treatment for RCC is based on histology, tumor size, tumor location, and presence of metastasis",
      "Histology, including sarcomatoid RCC, is listed as a treatment factor in the ontology"
    ]
  },
  {
    "id": "Medical-55898188",
    "source": "Medical",
    "question": "Which diagnostic procedures are necessary for a patient with suspected regional CSCC presenting with lymph node involvement?",
    "answer": "Lymph node exam, imaging (CT, PET/CT), and lymph node biopsy are required for regional CSCC with lymph node involvement.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lymph node exam is necessary for a patient with suspected regional CSCC presenting with lymph node involvement.",
      "Imaging (CT, PET/CT) is necessary for a patient with suspected regional CSCC presenting with lymph node involvement.",
      "Lymph node biopsy is necessary for a patient with suspected regional CSCC presenting with lymph node involvement."
    ],
    "evidence_relations": [
      "Regional CSCC (lymph node involvement) is treated with surgery to remove tumor and lymph nodes, often followed by radiation and sometimes systemic therapy",
      "Regional CSCC: Diagnostic Method: Lymph node exam, Imaging (CT, PET/CT), Lymph node biopsy (FNA, core needle biopsy)"
    ]
  },
  {
    "id": "Medical-57f0c93d",
    "source": "Medical",
    "question": "Which combination of therapies may be considered for an AML patient with CD33-positive blasts and why?",
    "answer": "Chemotherapy plus gemtuzumab ozogamicin (GO), a targeted therapy for CD33-positive AML, may be used.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chemotherapy may be considered for an AML patient with CD33-positive blasts.",
      "Gemtuzumab ozogamicin (GO) is a targeted therapy for CD33-positive AML.",
      "Chemotherapy plus gemtuzumab ozogamicin (GO) may be used for an AML patient with CD33-positive blasts."
    ],
    "evidence_relations": [
      "Targeted therapies are used for AML with specific genetic alterations, such as gemtuzumab ozogamicin for CD33-positive AML",
      "Chemotherapy is the standard of care for AML",
      "Biomarker includes CD33"
    ]
  },
  {
    "id": "Medical-e6db1c4b",
    "source": "Medical",
    "question": "Which imaging modalities and biopsy types are recommended for the diagnosis of osteosarcoma?",
    "answer": "Diagnosis of osteosarcoma involves X-ray, bone scan, CT scan, MRI, PET scan, and either core needle or surgical biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of osteosarcoma involves X-ray.",
      "Diagnosis of osteosarcoma involves bone scan.",
      "Diagnosis of osteosarcoma involves CT scan.",
      "Diagnosis of osteosarcoma involves MRI.",
      "Diagnosis of osteosarcoma involves PET scan.",
      "Diagnosis of osteosarcoma involves core needle biopsy.",
      "Diagnosis of osteosarcoma involves surgical biopsy."
    ],
    "evidence_relations": [
      "Osteosarcoma: Diagnostic Method: [\"X-ray\", \"Bone scan\", \"CT scan\", \"MRI\", \"PET scan\", \"Biopsy\"]",
      "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy"
    ]
  },
  {
    "id": "Medical-1024ca84",
    "source": "Medical",
    "question": "How does the treatment strategy for T-ALL differ from BCR::ABL1-positive B-ALL, and what evidence supports this distinction?",
    "answer": "T-ALL is treated with chemotherapy and clinical trials, while BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "T-ALL is treated with chemotherapy and clinical trials.",
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein."
    ],
    "evidence_relations": [
      "T-ALL treatment options include chemotherapy and clinical trials",
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein"
    ]
  },
  {
    "id": "Medical-cf2fbd21",
    "source": "Medical",
    "question": "How do risk factors for oropharyngeal squamous cell carcinoma differ from those for head and neck cancers in general?",
    "answer": "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma, while tobacco and alcohol use are risk factors for head and neck cancers in general.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma.",
      "Tobacco use is a risk factor for head and neck cancers in general.",
      "Alcohol use is a risk factor for head and neck cancers in general."
    ],
    "evidence_relations": [
      "HPV infection, especially HPV16, is a major risk factor for oropharyngeal squamous cell carcinoma",
      "Tobacco and alcohol use are risk factors for head and neck cancers"
    ]
  },
  {
    "id": "Medical-b77d8e3d",
    "source": "Medical",
    "question": "How do follow-up strategies change after initial treatment for NSCLC?",
    "answer": "After initial treatment, follow-up care and surveillance are implemented to monitor for recurrence.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "After initial treatment for NSCLC, follow-up care is implemented.",
      "Surveillance is implemented to monitor for recurrence after initial treatment for NSCLC."
    ],
    "evidence_relations": [
      "Follow-up care is planned after treatment and includes surveillance for recurrence",
      "Follow-up Strategy for NSCLC includes follow-up care and surveillance"
    ]
  },
  {
    "id": "Medical-33494794",
    "source": "Medical",
    "question": "What cellular changes would you expect to find in a patient with CML, and which test would confirm these findings?",
    "answer": "Increased white blood cells (granulocytes) and abnormal platelet counts, confirmed by blood tests.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Increased white blood cells (granulocytes) are expected in a patient with CML.",
      "Abnormal platelet counts are expected in a patient with CML.",
      "Blood tests can confirm the findings of increased white blood cells and abnormal platelet counts."
    ],
    "evidence_relations": [
      "CML is characterized by increased white blood cells (granulocytes) and abnormal platelet counts",
      "Blood tests and bone marrow tests are used to diagnose CML"
    ]
  },
  {
    "id": "Medical-8307a348",
    "source": "Medical",
    "question": "Which surgical procedures are available for early-stage cervical cancer, and how do they relate to fertility preservation?",
    "answer": "Cone biopsy and trachelectomy are surgical options for early-stage disease, with trachelectomy serving as a fertility-sparing procedure.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cone biopsy is a surgical option for early-stage cervical cancer.",
      "Trachelectomy is a surgical option for early-stage cervical cancer.",
      "Trachelectomy serves as a fertility-sparing procedure."
    ],
    "evidence_relations": [
      "Cone biopsy can be both diagnostic and therapeutic for early-stage cervical cancer",
      "Fertility-sparing surgery (e.g., trachelectomy) is an option for selected early-stage cases",
      "Cone biopsy and trachelectomy are listed as surgical procedures for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-32b9ef93",
    "source": "Medical",
    "question": "If a patient presents with seizures and cognitive changes, what diagnostic methods should be prioritized and why?",
    "answer": "A neurological exam and MRI should be prioritized because these symptoms are common in glioma and MRI is the best imaging test.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A neurological exam should be prioritized for patients with seizures and cognitive changes.",
      "An MRI should be prioritized for patients with seizures and cognitive changes.",
      "Seizures and cognitive changes are common symptoms in glioma.",
      "MRI is the best imaging test for glioma."
    ],
    "evidence_relations": [
      "Symptoms of glioma include headache, seizures, fatigue, nausea, vomiting, cognitive changes, weakness, personality changes, and vision problems",
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy",
      "MRI is the most useful imaging test for identifying glioma"
    ]
  },
  {
    "id": "Medical-889e2c6a",
    "source": "Medical",
    "question": "What factors contribute to a poorer prognosis in glioma patients, and how are these factors determined?",
    "answer": "High-grade glioma and glioblastoma contribute to poorer prognosis, determined by histology and grade from biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-grade glioma contributes to poorer prognosis in glioma patients.",
      "Glioblastoma contributes to poorer prognosis in glioma patients.",
      "Prognosis factors are determined by histology and grade from biopsy."
    ],
    "evidence_relations": [
      "High-grade gliomas have poorer prognosis",
      "Glioblastoma is the most aggressive subtype of glioma",
      "Gliomas are classified by histology, grade, and biomarkers",
      "Biopsy is required for definitive diagnosis and molecular testing"
    ]
  },
  {
    "id": "Medical-40446029",
    "source": "Medical",
    "question": "Why are clinical trials particularly preferred for BCR::ABL1-negative or BCR::ABL1-like B-ALL subtypes?",
    "answer": "Because these subtypes may have poorer prognosis or lack targeted therapies, making clinical trials a preferred option.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are preferred for BCR::ABL1-negative B-ALL subtypes.",
      "Clinical trials are preferred for BCR::ABL1-like B-ALL subtypes.",
      "BCR::ABL1-negative or BCR::ABL1-like B-ALL subtypes may have poorer prognosis.",
      "BCR::ABL1-negative or BCR::ABL1-like B-ALL subtypes may lack targeted therapies."
    ],
    "evidence_relations": [
      "Clinical trials are preferred for certain subtypes such as BCR::ABL1-negative or BCR::ABL1-like B-ALL",
      "B-cell ALL (B-ALL) has prognostic groups including BCR::ABL1-negative and BCR::ABL1-like B-ALL"
    ]
  },
  {
    "id": "Medical-ce635798",
    "source": "Medical",
    "question": "Which genetic alterations are characteristic of Ewing sarcoma, and by which diagnostic methods can these be detected?",
    "answer": "Ewing sarcoma is characterized by EWSR1-FLI1 and EWSR1-ERG fusions, detectable via biomarker testing such as PCR or next-generation sequencing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Ewing sarcoma is characterized by EWSR1-FLI1 fusion.",
      "Ewing sarcoma is characterized by EWSR1-ERG fusion.",
      "These fusions can be detected via biomarker testing.",
      "These fusions can be detected via PCR.",
      "These fusions can be detected via next-generation sequencing."
    ],
    "evidence_relations": [
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1",
      "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden",
      "Next-generation sequencing (NGS)",
      "Polymerase chain reaction (PCR)",
      "Ewing sarcoma: Biomarker: [\"EWSR1-FLI1 fusion\", \"EWSR1-ERG fusion\"]"
    ]
  },
  {
    "id": "Medical-9b9b7f4a",
    "source": "Medical",
    "question": "Which diagnostic and molecular tests are used to guide treatment decisions in high-risk localized prostate cancer?",
    "answer": "PSA test, biopsy, MRI, and molecular biomarker testing are used to guide treatment decisions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PSA test is used to guide treatment decisions in high-risk localized prostate cancer.",
      "Biopsy is used to guide treatment decisions in high-risk localized prostate cancer.",
      "MRI is used to guide treatment decisions in high-risk localized prostate cancer.",
      "Molecular biomarker testing is used to guide treatment decisions in high-risk localized prostate cancer."
    ],
    "evidence_relations": [
      "Molecular biomarker testing helps assess risk and guide treatment decisions",
      "Localized prostate cancer diagnostic methods include PSA test, biopsy, and MRI",
      "High-risk group guides prognosis and treatment"
    ]
  },
  {
    "id": "Medical-bea3adf4",
    "source": "Medical",
    "question": "How does the presence of Barrett esophagus influence both risk and diagnostic approach for esophageal adenocarcinoma?",
    "answer": "Barrett esophagus increases risk for esophageal adenocarcinoma and necessitates biomarker and genetic risk testing during diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Barrett esophagus increases the risk for esophageal adenocarcinoma.",
      "Barrett esophagus necessitates biomarker testing during diagnosis.",
      "Barrett esophagus necessitates genetic risk testing during diagnosis."
    ],
    "evidence_relations": [
      "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Esophageal adenocarcinoma has risk factor Barrett esophagus"
    ]
  },
  {
    "id": "Medical-e54f3250",
    "source": "Medical",
    "question": "What are the roles of immunotherapy agents in systemic therapy for advanced bladder cancer?",
    "answer": "Immunotherapy agents like pembrolizumab, nivolumab, avelumab, and atezolizumab are used as systemic therapy for advanced bladder cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Immunotherapy agents are used as systemic therapy for advanced bladder cancer.",
      "Pembrolizumab is an immunotherapy agent for advanced bladder cancer.",
      "Nivolumab is an immunotherapy agent for advanced bladder cancer.",
      "Avelumab is an immunotherapy agent for advanced bladder cancer.",
      "Atezolizumab is an immunotherapy agent for advanced bladder cancer."
    ],
    "evidence_relations": [
      "Systemic therapy includes immunotherapy (checkpoint inhibitors)",
      "Immunotherapy agents include pembrolizumab, nivolumab, avelumab, and atezolizumab",
      "Stage 4 bladder cancer is metastatic and may involve distant organs"
    ]
  },
  {
    "id": "Medical-fa092b30",
    "source": "Medical",
    "question": "What is the significance of imaging in the management of pancreatic cancer, and for which purposes is it used?",
    "answer": "Imaging is used for staging, determining surgical eligibility, and as a diagnostic method in pancreatic cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging is used for staging in pancreatic cancer.",
      "Imaging is used to determine surgical eligibility in pancreatic cancer.",
      "Imaging is used as a diagnostic method in pancreatic cancer."
    ],
    "evidence_relations": [
      "Imaging is used for staging and determining surgical eligibility in pancreatic cancer",
      "Diagnostic methods for pancreatic cancer include imaging",
      "Imaging is a diagnostic method for pancreatic ductal adenocarcinoma (ontology, rewritten: Imaging is used to diagnose and stage pancreatic ductal adenocarcinoma and assess surgical eligibility)"
    ]
  },
  {
    "id": "Medical-aacc98ed",
    "source": "Medical",
    "question": "What histological layers must a tumor penetrate to reach the serosa from the epithelium in the bile duct?",
    "answer": "A tumor must penetrate the lamina propria, muscularis, and perimuscular fibrous tissue to reach the serosa from the epithelium.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A tumor must penetrate the lamina propria to reach the serosa from the epithelium.",
      "A tumor must penetrate the muscularis to reach the serosa from the epithelium.",
      "A tumor must penetrate the perimuscular fibrous tissue to reach the serosa from the epithelium."
    ],
    "evidence_relations": [
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa",
      "Lamina propria is a connective tissue found under the epithelium",
      "Muscularis is a soft tissue layer in the bile duct wall",
      "Perimuscular fibrous tissue surrounds the muscle layer"
    ]
  },
  {
    "id": "Medical-45847608",
    "source": "Medical",
    "question": "Which hereditary syndromes increase the risk for ovarian cancer and how does this affect patient management?",
    "answer": "BRCA1, BRCA2 mutations, and Lynch syndrome increase risk and prompt genetic testing and consideration of targeted therapies.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BRCA1 mutations increase the risk for ovarian cancer.",
      "BRCA2 mutations increase the risk for ovarian cancer.",
      "Lynch syndrome increases the risk for ovarian cancer.",
      "BRCA1, BRCA2 mutations, and Lynch syndrome prompt genetic testing.",
      "BRCA1, BRCA2 mutations, and Lynch syndrome prompt consideration of targeted therapies."
    ],
    "evidence_relations": [
      "BRCA1 and BRCA2 mutations and Lynch syndrome are major hereditary risk factors for ovarian cancer",
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer",
      "Maintenance therapy with PARP inhibitors is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment"
    ]
  },
  {
    "id": "Medical-d2458aa7",
    "source": "Medical",
    "question": "If a patient has multiple tumors in both kidneys, how should these be classified and why?",
    "answer": "They should be treated as separate primary tumors, not metastasis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Multiple tumors in both kidneys should be treated as separate primary tumors.",
      "Multiple tumors in both kidneys should not be classified as metastasis."
    ],
    "evidence_relations": [
      "Multiple tumors in one or both kidneys are treated as separate primary tumors, not metastasis",
      "The ontology distinguishes between local spread/metastasis and primary tumors in classification"
    ]
  },
  {
    "id": "Medical-a660735d",
    "source": "Medical",
    "question": "Why might a patient with pediatric-type follicular lymphoma present differently from an adult with classic FL?",
    "answer": "PTFL usually presents with a single enlarged lymph node and minimal symptoms, unlike classic FL which may have widespread lymphadenopathy and B symptoms.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pediatric-type follicular lymphoma usually presents with a single enlarged lymph node.",
      "Pediatric-type follicular lymphoma usually presents with minimal symptoms.",
      "Classic follicular lymphoma may have widespread lymphadenopathy.",
      "Classic follicular lymphoma may have B symptoms."
    ],
    "evidence_relations": [
      "Pediatric-type FL (PTFL) usually presents with a single enlarged lymph node in the head and neck and minimal symptoms",
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)",
      "classic FL (cFL) is the classification for most adult FL"
    ]
  },
  {
    "id": "Medical-a0cd1d28",
    "source": "Medical",
    "question": "Which genetic alteration is most associated with inherited medullary thyroid cancer and what implication does this have for family members?",
    "answer": "RET gene fusion is most associated, indicating the need for family genetic screening for inherited syndromes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "RET gene fusion is most associated with inherited medullary thyroid cancer.",
      "Family genetic screening for inherited syndromes is indicated due to RET gene fusion."
    ],
    "evidence_relations": [
      "Medullary thyroid cancer can be inherited and is associated with RET gene fusion",
      "Medullary thyroid cancer Risk Factor: Inherited syndromes (MEN, RET mutation)"
    ]
  },
  {
    "id": "Medical-bfe2b31f",
    "source": "Medical",
    "question": "Which imaging and biopsy methods are used together to confirm a diagnosis of primary CNS lymphoma localized to the brain?",
    "answer": "MRI with gadolinium contrast and stereotactic biopsy are used together for diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MRI with gadolinium contrast is used to confirm a diagnosis of primary CNS lymphoma localized to the brain.",
      "Stereotactic biopsy is used to confirm a diagnosis of primary CNS lymphoma localized to the brain."
    ],
    "evidence_relations": [
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma",
      "Stereotactic biopsy is the standard diagnostic procedure for primary CNS lymphoma",
      "Disease Location for Primary CNS lymphoma includes Brain"
    ]
  },
  {
    "id": "Medical-2d14639d",
    "source": "Medical",
    "question": "How does the grade of follicular lymphoma influence its classification and treatment approach?",
    "answer": "Grades 1 and 2 are classified as classic FL and treated accordingly, while grade 3B is classified and treated as DLBCL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Grades 1 and 2 of follicular lymphoma are classified as classic FL.",
      "Grades 1 and 2 of follicular lymphoma are treated accordingly.",
      "Grade 3B of follicular lymphoma is classified and treated as DLBCL."
    ],
    "evidence_relations": [
      "Grades 1 and 2 FL are classified as classic FL (cFL) according to ICC",
      "Grade 3B FL is treated as DLBCL",
      "The type of cells in FL determines the grade, which guides treatment decisions"
    ]
  },
  {
    "id": "Medical-18fc35e5",
    "source": "Medical",
    "question": "What are the recommended initial treatments for most stages of epithelial ovarian cancer?",
    "answer": "Surgery (hysterectomy with bilateral salpingo-oophorectomy) followed by chemotherapy (typically paclitaxel and carboplatin) is recommended.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surgery is recommended for most stages of epithelial ovarian cancer.",
      "Hysterectomy with bilateral salpingo-oophorectomy is a recommended surgical procedure.",
      "Chemotherapy is recommended after surgery for epithelial ovarian cancer.",
      "Paclitaxel and carboplatin are typically used in chemotherapy for epithelial ovarian cancer."
    ],
    "evidence_relations": [
      "Surgery (hysterectomy with bilateral salpingo-oophorectomy) is the standard initial treatment for most ovarian cancers",
      "Chemotherapy (typically paclitaxel and carboplatin) is recommended after surgery for most stages",
      "Epithelial ovarian cancer is the most common type of ovarian cancer"
    ]
  },
  {
    "id": "Medical-402f416c",
    "source": "Medical",
    "question": "Which chemotherapy regimens are recommended as part of chemoradiation for a patient with Stage II anal squamous cell carcinoma?",
    "answer": "Mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin are recommended regimens.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mitomycin and capecitabine are recommended chemotherapy regimens for Stage II anal squamous cell carcinoma.",
      "Mitomycin and 5-FU are recommended chemotherapy regimens for Stage II anal squamous cell carcinoma.",
      "5-FU and cisplatin are recommended chemotherapy regimens for Stage II anal squamous cell carcinoma."
    ],
    "evidence_relations": [
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)",
      "Recommended chemotherapy regimens with radiation include mitomycin and capecitabine, mitomycin and 5-FU, or 5-FU and cisplatin",
      "Anal squamous cell carcinoma is the most common subtype of anal cancer"
    ]
  },
  {
    "id": "Medical-b200a90c",
    "source": "Medical",
    "question": "Which bladder cancer subtypes are less common and how does this affect the overall classification of the disease?",
    "answer": "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common subtypes, with urothelial carcinoma being the most common.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Squamous cell carcinoma is a less common subtype of bladder cancer.",
      "Adenocarcinoma is a less common subtype of bladder cancer.",
      "Small cell carcinoma is a less common subtype of bladder cancer.",
      "Urothelial carcinoma is the most common subtype of bladder cancer."
    ],
    "evidence_relations": [
      "Urothelial carcinoma is the most common subtype of bladder cancer",
      "Squamous cell carcinoma, adenocarcinoma, and small cell carcinoma are less common subtypes of bladder cancer"
    ]
  },
  {
    "id": "Medical-1a7ab06f",
    "source": "Medical",
    "question": "What combination of symptoms and test results would suggest an aldosteronoma rather than a cortisol-producing adenoma?",
    "answer": "Excess aldosterone on biochemical testing without Cushing syndrome symptoms suggests aldosteronoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Excess aldosterone on biochemical testing suggests aldosteronoma.",
      "The absence of Cushing syndrome symptoms suggests aldosteronoma.",
      "Cortisol-producing adenoma typically presents with Cushing syndrome symptoms."
    ],
    "evidence_relations": [
      "Aldosteronoma produces excess aldosterone",
      "Adenoma producing excess cortisol causes Cushing syndrome",
      "Cortisol-producing adenoma is associated with Cushing syndrome"
    ]
  },
  {
    "id": "Medical-618ab93c",
    "source": "Medical",
    "question": "If a patient is diagnosed with a slow-growing primary cutaneous lymphoma of B-cell origin, which subtypes are likely?",
    "answer": "Primary cutaneous marginal zone lymphoma and primary cutaneous follicle center lymphoma are likely, as most CBCLs are indolent.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary cutaneous marginal zone lymphoma is a likely subtype of slow-growing primary cutaneous lymphoma of B-cell origin.",
      "Primary cutaneous follicle center lymphoma is a likely subtype of slow-growing primary cutaneous lymphoma of B-cell origin.",
      "Most cutaneous B-cell lymphomas (CBCLs) are indolent."
    ],
    "evidence_relations": [
      "Most primary cutaneous B-cell lymphomas are indolent or slow-growing",
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "CBCL starts in B cells"
    ]
  },
  {
    "id": "Medical-2b2dd1fb",
    "source": "Medical",
    "question": "What combination of symptoms and diagnostic methods would most likely lead to an ALL diagnosis involving the central nervous system?",
    "answer": "Symptoms like organ involvement combined with lumbar puncture and imaging tests would indicate CNS involvement in ALL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms like organ involvement would indicate CNS involvement in ALL.",
      "A lumbar puncture would indicate CNS involvement in ALL.",
      "Imaging tests would indicate CNS involvement in ALL."
    ],
    "evidence_relations": [
      "ALL can be found in bone marrow, blood, testicles, and central nervous system",
      "Symptoms of ALL may include organ involvement",
      "Diagnosis of ALL involves imaging tests and lumbar puncture"
    ]
  },
  {
    "id": "Medical-9528082d",
    "source": "Medical",
    "question": "Why is detecting either the Philadelphia chromosome or BCR::ABL1 gene sufficient for diagnosing CML?",
    "answer": "Because both result from the same chromosomal translocation specific to CML and serve as key biomarkers.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Detecting the Philadelphia chromosome is sufficient for diagnosing CML.",
      "Detecting the BCR::ABL1 gene is sufficient for diagnosing CML.",
      "Both the Philadelphia chromosome and BCR::ABL1 gene result from the same chromosomal translocation specific to CML.",
      "The Philadelphia chromosome and BCR::ABL1 gene serve as key biomarkers for CML."
    ],
    "evidence_relations": [
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation"
    ]
  },
  {
    "id": "Medical-80912696",
    "source": "Medical",
    "question": "Why should fertility counseling be considered for patients undergoing treatment for nasopharyngeal carcinoma?",
    "answer": "Fertility counseling should be considered because NPC treatment can affect fertility.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility counseling should be considered for patients undergoing treatment for nasopharyngeal carcinoma.",
      "Nasopharyngeal carcinoma treatment can affect fertility."
    ],
    "evidence_relations": [
      "Fertility may be affected by NPC treatment and should be discussed before therapy",
      "Fertility counseling is part of the diagnostic and planning process for NPC",
      "Fertility counseling and impact of treatment on fertility are listed under Fertility Consideration in the ontology"
    ]
  },
  {
    "id": "Medical-39012a36",
    "source": "Medical",
    "question": "Which treatments may be considered for a glioma patient after surgical resection and how is this decision guided?",
    "answer": "Radiation therapy, chemotherapy, or clinical trials may be considered after surgery, guided by grade and performance status.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Radiation therapy may be considered for a glioma patient after surgical resection.",
      "Chemotherapy may be considered for a glioma patient after surgical resection.",
      "Clinical trials may be considered for a glioma patient after surgical resection.",
      "The decision for treatment is guided by the grade of the glioma.",
      "The decision for treatment is guided by the performance status of the patient."
    ],
    "evidence_relations": [
      "Treatment options for glioma include surgery, radiation therapy, chemotherapy, and clinical trials",
      "High-grade gliomas require additional therapy after surgery",
      "Performance status is assessed to determine treatment eligibility"
    ]
  },
  {
    "id": "Medical-193a4b7f",
    "source": "Medical",
    "question": "What chromosomal abnormality must be present for a diagnosis of chronic myeloid leukemia (CML)?",
    "answer": "The Philadelphia chromosome (Ph), resulting from a translocation between chromosome 9 and chromosome 22, must be present.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The Philadelphia chromosome must be present for a diagnosis of CML.",
      "The Philadelphia chromosome results from a translocation between chromosome 9 and chromosome 22."
    ],
    "evidence_relations": [
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22"
    ]
  },
  {
    "id": "Medical-aba4e30c",
    "source": "Medical",
    "question": "Which stages of pancreatic ductal adenocarcinoma may involve lymph node spread, and how does this affect staging?",
    "answer": "Stage II involves spread to 1-3 lymph nodes, while Stage III involves spread to 4 or more lymph nodes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage II pancreatic ductal adenocarcinoma may involve spread to 1-3 lymph nodes.",
      "Stage III pancreatic ductal adenocarcinoma may involve spread to 4 or more lymph nodes."
    ],
    "evidence_relations": [
      "Stage II pancreatic cancer is a tumor larger than 4 cm or has spread to 1-3 nearby lymph nodes",
      "Stage III pancreatic cancer has grown to nearby major arteries or spread to 4 or more lymph nodes",
      "Stage: Stage II: Tumor >4 cm or spread to 1-3 lymph nodes; Stage III: Spread to major arteries or ≥4 lymph nodes (ontology, rewritten: Stage II involves 1-3 lymph nodes; Stage III involves 4 or more lymph nodes)"
    ]
  },
  {
    "id": "Medical-a5d38351",
    "source": "Medical",
    "question": "How does the presence of distant metastasis affect treatment planning for esophageal cancer?",
    "answer": "Distant metastasis classifies the cancer as metastatic, which alters treatment planning based on stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The presence of distant metastasis affects treatment planning for esophageal cancer.",
      "Distant metastasis classifies the cancer as metastatic.",
      "The classification of cancer as metastatic alters treatment planning based on stage."
    ],
    "evidence_relations": [
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain",
      "Treatment planning is based on cancer type, location, and stage"
    ]
  },
  {
    "id": "Medical-705f9e89",
    "source": "Medical",
    "question": "If a patient aged 25 presents with swollen lymph nodes in the upper body, what cancer type should be highly suspected and why?",
    "answer": "Hodgkin lymphoma should be suspected because it usually starts in upper body lymph nodes and is common between ages 15 to 30.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hodgkin lymphoma should be suspected in a patient aged 25 with swollen lymph nodes in the upper body.",
      "Hodgkin lymphoma usually starts in upper body lymph nodes.",
      "Hodgkin lymphoma is common between ages 15 to 30."
    ],
    "evidence_relations": [
      "Hodgkin lymphoma usually starts in lymph nodes in the upper body",
      "Most people are diagnosed between ages 15 to 30 or after age 55"
    ]
  },
  {
    "id": "Medical-787b9c0b",
    "source": "Medical",
    "question": "If a tumor in the bile duct is only found in the muscularis layer, how does this affect its staging compared to a tumor confined to the epithelium?",
    "answer": "A tumor in the muscularis is a more advanced stage than one confined to the epithelium (Tis).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A tumor in the muscularis layer is a more advanced stage than one confined to the epithelium.",
      "A tumor confined to the epithelium is classified as Tis."
    ],
    "evidence_relations": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "Muscularis is a soft tissue layer in the bile duct wall",
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa"
    ]
  },
  {
    "id": "Medical-a0699e9e",
    "source": "Medical",
    "question": "Which side effects might a patient experience after radical cystectomy and urinary diversion for bladder cancer?",
    "answer": "Patients may experience urinary incontinence, sexual dysfunction, infection, and fatigue after radical cystectomy and urinary diversion.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Patients may experience urinary incontinence after radical cystectomy and urinary diversion.",
      "Patients may experience sexual dysfunction after radical cystectomy and urinary diversion.",
      "Patients may experience infection after radical cystectomy and urinary diversion.",
      "Patients may experience fatigue after radical cystectomy and urinary diversion."
    ],
    "evidence_relations": [
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Urinary diversion procedures include ileal conduit, neobladder, and continent cutaneous pouch",
      "Common side effects of treatment include urinary incontinence, sexual dysfunction, infection, and fatigue"
    ]
  },
  {
    "id": "Medical-60acb9ee",
    "source": "Medical",
    "question": "Which patients with throat cancer should undergo dental health assessment and why?",
    "answer": "All patients should have dental health assessment before treatment as dental health impacts treatment planning and outcomes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "All patients with throat cancer should undergo dental health assessment.",
      "Dental health assessment impacts treatment planning for throat cancer.",
      "Dental health assessment impacts outcomes for throat cancer."
    ],
    "evidence_relations": [
      "Dental health assessment is important before treatment",
      "Surveillance includes dental health assessment"
    ]
  },
  {
    "id": "Medical-32861246",
    "source": "Medical",
    "question": "Which combination of diagnostic methods is necessary to confirm and stage anal cancer after a patient presents with rectal bleeding and an anal lump?",
    "answer": "Digital rectal exam (DRE), anoscopy or high-resolution anoscopy (HRA), biopsy, and imaging (CT, MRI, PET) are necessary to confirm and stage anal cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Digital rectal exam (DRE) is necessary to confirm and stage anal cancer.",
      "Anoscopy or high-resolution anoscopy (HRA) is necessary to confirm and stage anal cancer.",
      "Biopsy is necessary to confirm and stage anal cancer.",
      "Imaging (CT, MRI, PET) is necessary to confirm and stage anal cancer."
    ],
    "evidence_relations": [
      "Anal cancer is diagnosed by biopsy after abnormal findings on DRE or anoscopy",
      "Digital rectal exam (DRE), high-resolution anoscopy (HRA), and imaging (CT, MRI, PET) are used for diagnosis and staging",
      "Common symptoms of anal cancer include rectal bleeding, anal itching, pain, and a lump near the anus"
    ]
  },
  {
    "id": "Medical-09eac393",
    "source": "Medical",
    "question": "Why is radioactive iodine therapy not used for medullary thyroid cancer after total thyroidectomy, and what alternative therapies are recommended?",
    "answer": "RAI therapy is ineffective for medullary thyroid cancer, so targeted therapy and thyroid hormone replacement are recommended alternatives.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Radioactive iodine (RAI) therapy is ineffective for medullary thyroid cancer.",
      "Targeted therapy is recommended for medullary thyroid cancer.",
      "Thyroid hormone replacement is recommended for medullary thyroid cancer."
    ],
    "evidence_relations": [
      "RAI therapy is not effective for medullary or anaplastic thyroid cancer",
      "Medullary thyroid cancer Treatment: Total thyroidectomy, Neck dissection, Targeted therapy (if advanced/metastatic), Thyroid hormone replacement therapy"
    ]
  },
  {
    "id": "Medical-56f4cb0b",
    "source": "Medical",
    "question": "How does the involvement of blood vessels or liver affect the classification of bile duct cancer compared to a tumor confined to the epithelium?",
    "answer": "Involvement of blood vessels or liver indicates a higher stage than a tumor confined to the epithelium (Tis).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Involvement of blood vessels or liver indicates a higher stage of bile duct cancer.",
      "A tumor confined to the epithelium is classified as Tis."
    ],
    "evidence_relations": [
      "Tumor Characteristic includes spread to blood vessels and liver",
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium"
    ]
  },
  {
    "id": "Medical-86e095c3",
    "source": "Medical",
    "question": "How does smoking status influence both the risk and treatment outcomes of cervical cancer?",
    "answer": "Smoking increases the risk of cervical cancer, and smoking cessation improves treatment outcomes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Smoking increases the risk of cervical cancer.",
      "Smoking cessation improves treatment outcomes for cervical cancer."
    ],
    "evidence_relations": [
      "Smoking increases the risk of cervical cancer",
      "Smoking cessation improves treatment outcomes",
      "Smoking is listed as a risk factor for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-8435c9f6",
    "source": "Medical",
    "question": "How would the treatment approach change for a primary CNS lymphoma patient with both brain and eye involvement?",
    "answer": "The patient would receive standard CNS-directed therapy plus intraocular chemotherapy or radiation for eye involvement.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The treatment approach for a primary CNS lymphoma patient with both brain and eye involvement would change.",
      "The patient would receive standard CNS-directed therapy.",
      "The patient would receive intraocular chemotherapy or radiation for eye involvement."
    ],
    "evidence_relations": [
      "Primary CNS lymphoma most commonly affects the brain, but can also involve the eyes",
      "Intraocular chemotherapy or radiation may be used if the eyes are involved",
      "Treatment options for primary CNS lymphoma include chemotherapy and radiation therapy"
    ]
  },
  {
    "id": "Medical-01abc791",
    "source": "Medical",
    "question": "Why is intestinal type adenocarcinoma more likely to benefit from targeted therapy compared to diffuse type?",
    "answer": "Because intestinal type more often has mutations treatable with targeted therapy, while diffuse type is less common and lacks these features.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Intestinal type adenocarcinoma is more likely to benefit from targeted therapy.",
      "Intestinal type adenocarcinoma often has mutations that are treatable with targeted therapy.",
      "Diffuse type adenocarcinoma is less common.",
      "Diffuse type adenocarcinoma lacks mutations that are treatable with targeted therapy."
    ],
    "evidence_relations": [
      "Intestinal type adenocarcinoma forms tube- and gland-shaped structures and is more likely to have mutations treatable with targeted therapy",
      "Diffuse type adenocarcinoma consists of scattered cells and is less common",
      "There are two major subtypes of stomach adenocarcinoma: intestinal and diffuse"
    ]
  },
  {
    "id": "Medical-ec4712e3",
    "source": "Medical",
    "question": "Why is a panoramic dental x-ray (Panorex) included in diagnostic evaluation for mouth cancer?",
    "answer": "A Panorex is used to assess dental health, which is affected by mouth cancer and its treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A panoramic dental x-ray (Panorex) is used to assess dental health.",
      "Dental health is affected by mouth cancer.",
      "Dental health is affected by the treatment of mouth cancer."
    ],
    "evidence_relations": [
      "Dental health is affected by head and neck cancer and its treatment",
      "Panoramic dental x-ray (Panorex) is listed as a diagnostic method in the ontology for SCC"
    ]
  },
  {
    "id": "Medical-647b438f",
    "source": "Medical",
    "question": "Which biomarkers must be tested to guide targeted therapy decisions in invasive ductal carcinoma, and why?",
    "answer": "Estrogen receptor, progesterone receptor, HER2, BRCA1/2, PIK3CA, MSI-H/dMMR, and PD-L1 must be tested to guide targeted therapy in invasive ductal carcinoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Estrogen receptor must be tested to guide targeted therapy in invasive ductal carcinoma.",
      "Progesterone receptor must be tested to guide targeted therapy in invasive ductal carcinoma.",
      "HER2 must be tested to guide targeted therapy in invasive ductal carcinoma.",
      "BRCA1/2 must be tested to guide targeted therapy in invasive ductal carcinoma.",
      "PIK3CA must be tested to guide targeted therapy in invasive ductal carcinoma.",
      "MSI-H/dMMR must be tested to guide targeted therapy in invasive ductal carcinoma.",
      "PD-L1 must be tested to guide targeted therapy in invasive ductal carcinoma."
    ],
    "evidence_relations": [
      "Hormone receptor status (ER, PR) and HER2 status are key biomarkers for breast cancer",
      "PIK3CA mutation can be targeted with specific therapies",
      "MSI-H/dMMR status may influence immunotherapy options",
      "PD-L1 expression may guide immunotherapy use",
      "Invasive ductal carcinoma biomarkers include ER, PR, HER2, BRCA1 mutation, BRCA2 mutation, PIK3CA mutation, MSI-H, dMMR, and PD-L1"
    ]
  },
  {
    "id": "Medical-a5435dbc",
    "source": "Medical",
    "question": "Why is colonoscopy recommended after rectal cancer surgery, and what risk factor may increase its importance?",
    "answer": "Colonoscopy is recommended for surveillance after surgery, especially important in patients with familial adenomatous polyposis (FAP) due to high polyp risk.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Colonoscopy is recommended for surveillance after rectal cancer surgery.",
      "Colonoscopy is especially important in patients with familial adenomatous polyposis (FAP).",
      "Patients with FAP have a high risk of polyps."
    ],
    "evidence_relations": [
      "Colonoscopy is recommended after surgery for surveillance",
      "Familial adenomatous polyposis (FAP) is a genetic syndrome causing multiple polyps and increased rectal cancer risk"
    ]
  },
  {
    "id": "Medical-2a61ebd2",
    "source": "Medical",
    "question": "How does the identification of the PML::RARA fusion gene influence both the classification and treatment of AML?",
    "answer": "Detection of PML::RARA classifies the AML as acute promyelocytic leukemia (APL), which is treated with chemotherapy and targeted therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Detection of the PML::RARA fusion gene classifies the AML as acute promyelocytic leukemia (APL).",
      "Acute promyelocytic leukemia (APL) is treated with chemotherapy.",
      "Acute promyelocytic leukemia (APL) is treated with targeted therapy."
    ],
    "evidence_relations": [
      "Acute promyelocytic leukemia (APL) is a subtype of AML characterized by the PML::RARA fusion gene",
      "AML subtypes are defined by gene mutations or abnormal chromosomes",
      "Acute promyelocytic leukemia (APL) is a subtype of AML characterized by the PML::RARA fusion gene",
      "Acute promyelocytic leukemia (APL) is treated with chemotherapy and targeted therapy"
    ]
  },
  {
    "id": "Medical-ad078f77",
    "source": "Medical",
    "question": "Which treatments are available to all patients with pancreatic ductal adenocarcinoma, regardless of stage?",
    "answer": "Drug treatment, clinical trials, and supportive care are available to all patients with pancreatic ductal adenocarcinoma, regardless of stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Drug treatment is available to all patients with pancreatic ductal adenocarcinoma.",
      "Clinical trials are available to all patients with pancreatic ductal adenocarcinoma.",
      "Supportive care is available to all patients with pancreatic ductal adenocarcinoma.",
      "These treatments are available regardless of stage."
    ],
    "evidence_relations": [
      "Drug treatment is most often used to control growth and reduce symptoms in pancreatic cancer",
      "Clinical trials are available for pancreatic cancer patients",
      "Drug treatment: All stages, especially advanced; Clinical trial: All stages; Supportive care: All stages (ontology, rewritten: Drug treatment, clinical trials, and supportive care are available to all stages of pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-e9ac42f1",
    "source": "Medical",
    "question": "How does the BCR::ABL1 fusion gene relate to both the diagnosis and treatment of CML?",
    "answer": "The BCR::ABL1 fusion gene is required for diagnosis and is also the target of CML treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The BCR::ABL1 fusion gene is required for the diagnosis of CML.",
      "The BCR::ABL1 fusion gene is the target of CML treatment."
    ],
    "evidence_relations": [
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis",
      "CML is caused by the BCR::ABL1 fusion gene",
      "Treatment for CML aims to inhibit BCR::ABL1 protein activity"
    ]
  },
  {
    "id": "Medical-6d335c18",
    "source": "Medical",
    "question": "What histological subtypes are found under RCC and how are they organized in the classification?",
    "answer": "Clear cell RCC, non-clear cell RCC (with papillary, chromophobe, collecting duct, renal medullary carcinoma, clear cell papillary, fumarate hydratase-deficient, ELOC-mutated), and sarcomatoid RCC are all histological subtypes under RCC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clear cell RCC is a histological subtype under RCC.",
      "Non-clear cell RCC is a histological subtype under RCC.",
      "Papillary RCC is a subtype of non-clear cell RCC.",
      "Chromophobe RCC is a subtype of non-clear cell RCC.",
      "Collecting duct RCC is a subtype of non-clear cell RCC.",
      "Renal medullary carcinoma is a subtype of non-clear cell RCC.",
      "Clear cell papillary is a subtype of non-clear cell RCC.",
      "Fumarate hydratase-deficient RCC is a subtype of non-clear cell RCC.",
      "ELOC-mutated RCC is a subtype of non-clear cell RCC.",
      "Sarcomatoid RCC is a histological subtype under RCC."
    ],
    "evidence_relations": [
      "Clear cell RCC is the most common subtype of RCC",
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
      "Histology for RCC in the ontology lists clear cell RCC, non-clear cell RCC (with its subtypes), and sarcomatoid RCC"
    ]
  },
  {
    "id": "Medical-9b3c8ac0",
    "source": "Medical",
    "question": "Why should fertility preservation be discussed before starting treatment for bone cancer in young patients?",
    "answer": "Some treatments for bone cancer can affect fertility, so fertility preservation should be discussed prior to treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Some treatments for bone cancer can affect fertility.",
      "Fertility preservation should be discussed prior to treatment for bone cancer."
    ],
    "evidence_relations": [
      "Some treatments for bone cancer can affect fertility; fertility preservation should be discussed before treatment",
      "Fertility Consideration: [\"Fertility preservation\"]"
    ]
  },
  {
    "id": "Medical-38fe5331",
    "source": "Medical",
    "question": "How does the detection of increased blasts in blood or bone marrow influence the classification of CML phase?",
    "answer": "Increased blasts indicate progression to blast phase CML (BP-CML), an advanced disease stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Increased blasts in blood or bone marrow indicate progression to blast phase CML.",
      "Blast phase CML (BP-CML) is an advanced disease stage."
    ],
    "evidence_relations": [
      "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts",
      "Blast phase CML (BP-CML) includes myeloid progenitor cells, lymphoid progenitor cells, and blasts"
    ]
  },
  {
    "id": "Medical-833304f8",
    "source": "Medical",
    "question": "How does the anatomical location of a tumor help distinguish between esophageal squamous cell carcinoma and adenocarcinoma?",
    "answer": "Squamous cell carcinoma is more common in the upper/middle esophagus, while adenocarcinoma is more common in the lower/middle esophagus.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Esophageal squamous cell carcinoma is more common in the upper esophagus.",
      "Esophageal squamous cell carcinoma is more common in the middle esophagus.",
      "Esophageal adenocarcinoma is more common in the lower esophagus.",
      "Esophageal adenocarcinoma is more common in the middle esophagus."
    ],
    "evidence_relations": [
      "Esophageal squamous cell carcinoma: Anatomical Location: Upper esophagus, Middle esophagus, Lower esophagus",
      "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus"
    ]
  },
  {
    "id": "Medical-48cb097c",
    "source": "Medical",
    "question": "Which anatomical locations are most associated with esophageal squamous cell carcinoma and esophageal adenocarcinoma, and how does this affect treatment planning?",
    "answer": "Squamous cell carcinoma often occurs in the upper/middle esophagus, adenocarcinoma in the lower/middle, and treatment planning considers these locations.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Esophageal squamous cell carcinoma often occurs in the upper esophagus.",
      "Esophageal squamous cell carcinoma often occurs in the middle esophagus.",
      "Esophageal adenocarcinoma often occurs in the lower esophagus.",
      "Esophageal adenocarcinoma often occurs in the middle esophagus.",
      "Treatment planning considers the anatomical locations of the tumors."
    ],
    "evidence_relations": [
      "Esophageal squamous cell carcinoma starts in squamous cells of the esophagus",
      "Esophageal adenocarcinoma starts in mucus-secreting cells of the esophagus",
      "Esophageal squamous cell carcinoma: Anatomical Location: Upper esophagus, Middle esophagus, Lower esophagus",
      "Esophageal adenocarcinoma: Anatomical Location: Lower esophagus, Middle esophagus",
      "Treatment planning is based on cancer type, location, and stage"
    ]
  },
  {
    "id": "Medical-8e0c15db",
    "source": "Medical",
    "question": "What combination of findings would indicate the need for genetic testing in a patient with an adrenal tumor?",
    "answer": "If there is a family history or features of hereditary syndromes in a patient with an adrenal tumor, genetic testing should be performed.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A family history of hereditary syndromes indicates the need for genetic testing in a patient with an adrenal tumor.",
      "Features of hereditary syndromes indicate the need for genetic testing in a patient with an adrenal tumor."
    ],
    "evidence_relations": [
      "Certain hereditary syndromes increase the risk of adrenal tumors",
      "Genetic testing may be performed to identify hereditary risk factors",
      "Risk factors for adrenal tumor include hereditary syndromes and family history"
    ]
  },
  {
    "id": "Medical-e2ac8ec4",
    "source": "Medical",
    "question": "How does the addition of bevacizumab to chemotherapy alter the management of metastatic cervical cancer?",
    "answer": "Bevacizumab may be added to chemotherapy to improve outcomes in metastatic cervical cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Bevacizumab may be added to chemotherapy.",
      "The addition of bevacizumab aims to improve outcomes in metastatic cervical cancer."
    ],
    "evidence_relations": [
      "Bevacizumab may be added to chemotherapy for metastatic cervical cancer",
      "Systemic therapy options include platinum-based chemotherapy, targeted therapy, and immunotherapy",
      "Bevacizumab is listed as a systemic therapy for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-bd7c7e1a",
    "source": "Medical",
    "question": "Which patients with recurrent or metastatic cervical cancer are eligible for immunotherapy, and what biomarker guides this decision?",
    "answer": "Patients with recurrent or metastatic cervical cancer who are PD-L1 positive are eligible for immunotherapy such as pembrolizumab.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Patients with recurrent or metastatic cervical cancer who are PD-L1 positive are eligible for immunotherapy.",
      "Pembrolizumab is an example of immunotherapy for eligible patients."
    ],
    "evidence_relations": [
      "Biomarker testing (e.g., PD-L1, MSI, TMB, MMR, HER2, RET, NTRK) is recommended for recurrent or metastatic cervical cancer",
      "PD-L1 positivity guides the use of immunotherapy (e.g., pembrolizumab)",
      "PD-L1 is a biomarker for cervical cancer according to the ontology"
    ]
  },
  {
    "id": "Medical-e9ef7d6f",
    "source": "Medical",
    "question": "What distinguishes secondary liver cancer from primary liver cancer in terms of origin and anatomical structure involved?",
    "answer": "Primary liver cancer originates in the liver, while secondary liver cancer spreads to the liver from other organs.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary liver cancer originates in the liver.",
      "Secondary liver cancer spreads to the liver from other organs."
    ],
    "evidence_relations": [
      "Primary liver cancer originates in the liver",
      "Secondary liver cancer is cancer that has spread to the liver from another organ",
      "Secondary liver cancer: Origin: Other primary cancers (e.g., colon cancer)"
    ]
  },
  {
    "id": "Medical-99dd217e",
    "source": "Medical",
    "question": "What distinguishes early-stage esophageal cancer from locoregional and metastatic disease in terms of anatomical spread and diagnostic requirements?",
    "answer": "Early-stage is limited to the esophagus without lymph node involvement, while locoregional and metastatic involve spread to nodes or distant organs, requiring imaging and biopsy for staging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Early-stage esophageal cancer is limited to the esophagus.",
      "Early-stage esophageal cancer does not involve lymph nodes.",
      "Locoregional disease involves spread to lymph nodes.",
      "Metastatic disease involves spread to distant organs.",
      "Locoregional and metastatic disease require imaging for staging.",
      "Locoregional and metastatic disease require biopsy for staging."
    ],
    "evidence_relations": [
      "Early-stage esophageal cancer is contained within the esophagus and not in lymph nodes",
      "Locoregional esophageal cancer has invaded the esophagus wall and/or spread to nearby lymph nodes or organs",
      "Metastatic esophageal cancer has spread to distant organs such as liver, lung, bone, and brain",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing"
    ]
  },
  {
    "id": "Medical-91c35427",
    "source": "Medical",
    "question": "What is the standard surgical procedure for muscle-invasive bladder cancer, and what urinary diversion options may follow?",
    "answer": "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer, followed by urinary diversion procedures such as ileal conduit, neobladder, or continent cutaneous pouch.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer.",
      "Urinary diversion procedures may follow radical cystectomy.",
      "Ileal conduit is a urinary diversion option after radical cystectomy.",
      "Neobladder is a urinary diversion option after radical cystectomy.",
      "Continent cutaneous pouch is a urinary diversion option after radical cystectomy."
    ],
    "evidence_relations": [
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Urinary diversion procedures include ileal conduit, neobladder, and continent cutaneous pouch",
      "Stages 2, 3, and 4 bladder cancers are muscle-invasive"
    ]
  },
  {
    "id": "Medical-96bb3762",
    "source": "Medical",
    "question": "How does the treatment approach differ between Stage 1 and Stage 2 NSCLC?",
    "answer": "Stage 1 NSCLC is treated with surgery and possibly radiation therapy, while Stage 2 NSCLC may require surgery and chemoradiation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 1 NSCLC is treated with surgery.",
      "Stage 1 NSCLC may be treated with radiation therapy.",
      "Stage 2 NSCLC may require surgery.",
      "Stage 2 NSCLC may require chemoradiation."
    ],
    "evidence_relations": [
      "Stage 1 NSCLC is considered early stage",
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible",
      "Radiation therapy is used for some early NSCLC cases",
      "Stage 2 and Stage 3 NSCLC are considered locally advanced",
      "Chemoradiation is used for some locally advanced NSCLC cases"
    ]
  },
  {
    "id": "Medical-02d254bc",
    "source": "Medical",
    "question": "For which stages of cervical cancer is surgery the primary treatment, and when is chemoradiation preferred?",
    "answer": "Surgery is primary for early-stage cervical cancer, while chemoradiation is preferred for locally advanced stages.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Surgery is the primary treatment for early-stage cervical cancer.",
      "Chemoradiation is preferred for locally advanced stages of cervical cancer."
    ],
    "evidence_relations": [
      "Surgery is the main treatment for early-stage cervical cancer",
      "Chemoradiation (concurrent EBRT and platinum-based chemotherapy) is recommended for locally advanced cervical cancer",
      "The ontology lists surgical procedures and chemoradiation as treatments for cervical cancer by stage"
    ]
  },
  {
    "id": "Medical-a56d528c",
    "source": "Medical",
    "question": "How does the origin of RCC differ from that of urothelial carcinoma within the kidney?",
    "answer": "RCC starts in the cells lining the renal tubules, while urothelial carcinoma starts in the cells lining the renal pelvis and ureter.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "RCC starts in the cells lining the renal tubules.",
      "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter."
    ],
    "evidence_relations": [
      "RCC starts in the cells that line the renal tubules",
      "Urothelial carcinoma starts in the cells lining the renal pelvis and ureter"
    ]
  },
  {
    "id": "Medical-c6a7964c",
    "source": "Medical",
    "question": "How do risk factors for primary liver cancer differ from those for secondary liver cancer according to the ontology?",
    "answer": "Primary liver cancer risk factors include cirrhosis, hepatitis B, hepatitis C, and others, while secondary liver cancer originates from cancers in other organs.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary liver cancer risk factors include cirrhosis.",
      "Primary liver cancer risk factors include hepatitis B.",
      "Primary liver cancer risk factors include hepatitis C.",
      "Secondary liver cancer originates from cancers in other organs."
    ],
    "evidence_relations": [
      "Risk Factor: Primary liver cancer is associated with cirrhosis, hepatitis B virus (HBV), hepatitis C virus (HCV), alcohol use, non-alcoholic fatty liver disease (NAFLD), genetic hemochromatosis, alpha-1-antitrypsin deficiency, and stage 4 primary biliary cholangitis",
      "Secondary liver cancer: Origin: Other primary cancers (e.g., colon cancer)"
    ]
  },
  {
    "id": "Medical-96508468",
    "source": "Medical",
    "question": "Why are both immunophenotyping and biopsy necessary in the diagnostic workup of follicular lymphoma?",
    "answer": "Both are required to identify cell type and confirm the diagnosis, as FL arises from abnormal B lymphocytes and is graded based on cell proportions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Both immunophenotyping and biopsy are necessary in the diagnostic workup of follicular lymphoma.",
      "Immunophenotyping is required to identify cell type.",
      "Biopsy is required to confirm the diagnosis.",
      "Follicular lymphoma arises from abnormal B lymphocytes.",
      "Follicular lymphoma is graded based on cell proportions."
    ],
    "evidence_relations": [
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping",
      "FL develops from abnormal B lymphocytes forming clusters in lymph nodes and other tissues",
      "FL is graded based on the proportion of centrocytes and centroblasts"
    ]
  },
  {
    "id": "Medical-141fd876",
    "source": "Medical",
    "question": "Why are both flow cytometry and immunophenotyping required in the diagnostic process for ALL?",
    "answer": "Both are required to accurately identify the lineage and subtype of ALL cells by analyzing their surface markers.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Flow cytometry is required in the diagnostic process for ALL.",
      "Immunophenotyping is required in the diagnostic process for ALL.",
      "Both methods analyze surface markers of ALL cells.",
      "Both methods help accurately identify the lineage and subtype of ALL cells."
    ],
    "evidence_relations": [
      "Diagnosis of ALL involves flow cytometry and immunophenotyping",
      "There are two main subtypes of ALL: B-cell ALL (B-ALL) and T-cell ALL (T-ALL)"
    ]
  },
  {
    "id": "Medical-ca3e2437",
    "source": "Medical",
    "question": "Which diagnostic procedures are necessary to both confirm an AML diagnosis and determine the specific subtype?",
    "answer": "Bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, and molecular/cytogenetic testing are required.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Bone marrow aspirate and biopsy are necessary to confirm an AML diagnosis.",
      "Flow cytometry is necessary to confirm an AML diagnosis.",
      "Immunophenotyping is necessary to confirm an AML diagnosis.",
      "Molecular/cytogenetic testing is necessary to confirm an AML diagnosis.",
      "These procedures are required to determine the specific subtype of AML."
    ],
    "evidence_relations": [
      "AML is diagnosed by the presence of ≥20% myeloblasts in bone marrow or blood",
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies",
      "Genetic and biomarker tests are used to determine AML subtype and guide treatment"
    ]
  },
  {
    "id": "Medical-ade34649",
    "source": "Medical",
    "question": "Which diagnostic procedures are used for tissue sampling in throat cancer, and why are they important?",
    "answer": "Fine-needle aspiration, core needle biopsy, and endoscopic biopsies are used to obtain tissue for definitive diagnosis and biomarker testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fine-needle aspiration is used for tissue sampling in throat cancer.",
      "Core needle biopsy is used for tissue sampling in throat cancer.",
      "Endoscopic biopsies are used for tissue sampling in throat cancer.",
      "Tissue sampling is important for definitive diagnosis.",
      "Tissue sampling is important for biomarker testing."
    ],
    "evidence_relations": [
      "Fine-needle aspiration (FNA), core needle biopsy (CNB), and endoscopic biopsies are used for tissue sampling",
      "Biopsy is required for definitive diagnosis and biomarker testing"
    ]
  },
  {
    "id": "Medical-6108fa72",
    "source": "Medical",
    "question": "What follow-up strategies are recommended for CLL patients not requiring immediate therapy, and what is their purpose?",
    "answer": "Watch and wait, regular monitoring, and supportive care are used to track disease progression and manage symptoms.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Watch and wait is a follow-up strategy for CLL patients not requiring immediate therapy.",
      "Regular monitoring is a follow-up strategy for CLL patients not requiring immediate therapy.",
      "Supportive care is a follow-up strategy for CLL patients not requiring immediate therapy.",
      "The purpose of these strategies is to track disease progression.",
      "The purpose of these strategies is to manage symptoms."
    ],
    "evidence_relations": [
      "Follow-up strategies include watch and wait, regular monitoring, and supportive care",
      "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression"
    ]
  },
  {
    "id": "Medical-bcfc4592",
    "source": "Medical",
    "question": "What surveillance methods are recommended after complete remission of Stage III anal cancer, and how does the frequency of these methods vary?",
    "answer": "DRE and inguinal lymph node exams every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, and imaging yearly for 3 years are recommended.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "DRE and inguinal lymph node exams are recommended every 3-6 months for 5 years after complete remission of Stage III anal cancer.",
      "Anoscopy is recommended every 6-12 months for 3 years after complete remission of Stage III anal cancer.",
      "Imaging is recommended yearly for 3 years after complete remission of Stage III anal cancer."
    ],
    "evidence_relations": [
      "Surveillance after treatment includes DRE, lymph node exams, anoscopy, and imaging",
      "Complete remission: DRE every 3-6 months for 5 years, inguinal lymph node exam every 3-6 months for 5 years, anoscopy every 6-12 months for 3 years, imaging yearly for 3 years (stage II/III)"
    ]
  },
  {
    "id": "Medical-b272ce63",
    "source": "Medical",
    "question": "Which anatomical structures are directly involved in the spread of kidney cancer and how are these structures classified?",
    "answer": "Renal vein, renal artery, Gerota’s fascia, adrenal gland, and lymph nodes are anatomical structures involved in local spread or metastasis of kidney cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Renal vein is involved in the spread of kidney cancer.",
      "Renal artery is involved in the spread of kidney cancer.",
      "Gerota’s fascia is involved in the spread of kidney cancer.",
      "Adrenal gland is involved in the spread of kidney cancer.",
      "Lymph nodes are involved in the spread of kidney cancer."
    ],
    "evidence_relations": [
      "Kidney cancer can spread locally to surrounding fat, blood vessels, lymph nodes, adrenal glands, and Gerota’s fascia",
      "Anatomical Structure in the ontology includes renal vein, renal artery, Gerota’s fascia, adrenal gland, and lymph nodes"
    ]
  },
  {
    "id": "Medical-1e1b5f1d",
    "source": "Medical",
    "question": "What diagnostic procedures are necessary to confirm follicular lymphoma and why are multiple methods required?",
    "answer": "Diagnosis requires blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping to fully characterize the disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of follicular lymphoma requires blood tests.",
      "Diagnosis requires a bone marrow aspirate and biopsy.",
      "Diagnosis requires imaging studies.",
      "Diagnosis requires immunophenotyping to fully characterize the disease."
    ],
    "evidence_relations": [
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping",
      "Follicular lymphoma (FL) is a slow-growing B-cell non-Hodgkin lymphoma",
      "FL develops from abnormal B lymphocytes forming clusters in lymph nodes and other tissues"
    ]
  },
  {
    "id": "Medical-af6105a0",
    "source": "Medical",
    "question": "What are the recommended fertility preservation options for rectal cancer patients, and why might these be important?",
    "answer": "Sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition are recommended, important due to risks of premature ovarian insufficiency from treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Sperm banking is a recommended fertility preservation option for rectal cancer patients.",
      "Egg freezing is a recommended fertility preservation option for rectal cancer patients.",
      "Ovarian tissue banking is a recommended fertility preservation option for rectal cancer patients.",
      "Ovarian transposition is a recommended fertility preservation option for rectal cancer patients.",
      "Fertility preservation options are important due to risks of premature ovarian insufficiency from treatment."
    ],
    "evidence_relations": [
      "Fertility preservation options include sperm banking, egg freezing, ovarian tissue banking, and ovarian transposition",
      "Premature ovarian insufficiency (POI) is a risk after some cancer treatments"
    ]
  },
  {
    "id": "Medical-c92bbd26",
    "source": "Medical",
    "question": "Why is immunophenotyping by flow cytometry essential in the diagnosis of CLL?",
    "answer": "It identifies CLL cells by their surface proteins (CD20, CD200, LEF1), confirming the diagnosis after initial blood tests.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Immunophenotyping by flow cytometry identifies CLL cells.",
      "Immunophenotyping by flow cytometry identifies CLL cells by their surface proteins.",
      "Surface proteins CD20, CD200, and LEF1 are used to confirm the diagnosis of CLL.",
      "Immunophenotyping is done after initial blood tests."
    ],
    "evidence_relations": [
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "Immunophenotyping identifies CLL cells by surface proteins such as CD20, CD200, and LEF1",
      "In the ontology, flow cytometry with immunophenotype markers is a diagnostic method for CLL"
    ]
  },
  {
    "id": "Medical-9626892c",
    "source": "Medical",
    "question": "If a patient with a history of cervical cancer presents with anal pain and is found to have HSIL on biopsy, what does this indicate about their risk and disease status?",
    "answer": "They have an increased risk for anal cancer and HSIL represents a precancerous lesion (Stage 0).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A patient with a history of cervical cancer and anal pain has an increased risk for anal cancer.",
      "HSIL represents a precancerous lesion (Stage 0)."
    ],
    "evidence_relations": [
      "History of cervical, vulvar, or vaginal cancer or precancer increases anal cancer risk",
      "HSIL (high-grade squamous intraepithelial lesion) is a precancerous lesion for anal cancer",
      "Stage 0 is carcinoma in situ or anal dysplasia"
    ]
  },
  {
    "id": "Medical-e1ede6d6",
    "source": "Medical",
    "question": "What distinguishes stage 4 colon cancer from earlier stages in terms of spread and treatment approach?",
    "answer": "Stage 4 colon cancer has spread to distant organs like the liver or lungs, requiring different treatment strategies compared to localized or regional disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 4 colon cancer has spread to distant organs like the liver or lungs.",
      "Stage 4 colon cancer requires different treatment strategies compared to localized or regional disease."
    ],
    "evidence_relations": [
      "Stage 4 colon cancer has spread to distant organs (commonly liver or lungs)",
      "AJCC TNM system is used to stage colon cancer"
    ]
  },
  {
    "id": "Medical-32fce5f0",
    "source": "Medical",
    "question": "What are the standard hormone replacement options after total thyroidectomy and why are they necessary?",
    "answer": "Levothyroxine, Levoxyl, or Synthroid are necessary to replace lost thyroid hormone after total thyroidectomy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Levothyroxine is a standard hormone replacement option after total thyroidectomy.",
      "Levoxyl is a standard hormone replacement option after total thyroidectomy.",
      "Synthroid is a standard hormone replacement option after total thyroidectomy.",
      "Hormone replacement is necessary after total thyroidectomy to replace lost thyroid hormone."
    ],
    "evidence_relations": [
      "Thyroid hormone replacement therapy is required after total thyroidectomy",
      "Thyroid hormone replacement therapy: Levothyroxine, Levoxyl, Synthroid"
    ]
  },
  {
    "id": "Medical-84ec68f0",
    "source": "Medical",
    "question": "Why is it important to perform both biomarker and genetic risk testing in the diagnosis of stomach cancer?",
    "answer": "Because diagnosis requires comprehensive assessment, including identification of treatable mutations and genetic risk factors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "It is important to perform biomarker testing in the diagnosis of stomach cancer.",
      "It is important to perform genetic risk testing in the diagnosis of stomach cancer.",
      "Diagnosis of stomach cancer requires comprehensive assessment.",
      "Diagnosis of stomach cancer includes identification of treatable mutations.",
      "Diagnosis of stomach cancer includes identification of genetic risk factors."
    ],
    "evidence_relations": [
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Intestinal type adenocarcinoma is more likely to have mutations treatable with targeted therapy",
      "Family history is a risk factor for stomach cancer"
    ]
  },
  {
    "id": "Medical-cb781b83",
    "source": "Medical",
    "question": "What sequence of diagnostic steps is required to confirm a glioma diagnosis and classify its grade and biomarker status?",
    "answer": "A neurological exam, imaging with MRI, and a biopsy for histology and molecular testing are required.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A neurological exam is required to confirm a glioma diagnosis.",
      "Imaging with MRI is required to confirm a glioma diagnosis.",
      "A biopsy for histology is required to confirm a glioma diagnosis.",
      "Molecular testing is required to classify glioma grade and biomarker status."
    ],
    "evidence_relations": [
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy",
      "MRI is the most useful imaging test for identifying glioma",
      "Biopsy is required for definitive diagnosis and molecular testing",
      "Gliomas are classified by histology, grade, and biomarkers"
    ]
  },
  {
    "id": "Medical-d42f24b5",
    "source": "Medical",
    "question": "What is the sequence of diagnostic steps for a patient presenting with symptoms of ulcer or mass suspected to be stomach cancer?",
    "answer": "Imaging tests, endoscopy, and biopsy are performed, followed by biomarker and genetic risk testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The sequence of diagnostic steps includes imaging tests.",
      "The sequence of diagnostic steps includes endoscopy.",
      "The sequence of diagnostic steps includes biopsy.",
      "Biomarker testing is performed after the initial diagnostic steps.",
      "Genetic risk testing is performed after the initial diagnostic steps."
    ],
    "evidence_relations": [
      "Symptoms can include ulcer or mass formation in the stomach",
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Biopsy is a diagnostic method for stomach cancer (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-2350fb33",
    "source": "Medical",
    "question": "What diagnostic methods should be employed to confirm a suspected case of metastatic stomach cancer with a family history of the disease?",
    "answer": "Imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing should be used.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging tests should be used to confirm a suspected case of metastatic stomach cancer.",
      "Endoscopy should be used to confirm a suspected case of metastatic stomach cancer.",
      "Biopsy should be used to confirm a suspected case of metastatic stomach cancer.",
      "Biomarker testing should be used to confirm a suspected case of metastatic stomach cancer.",
      "Genetic risk testing should be used to confirm a suspected case of metastatic stomach cancer."
    ],
    "evidence_relations": [
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes",
      "Family history is a risk factor for stomach cancer"
    ]
  },
  {
    "id": "Medical-74b73ed7",
    "source": "Medical",
    "question": "What distant organs are common sites of kidney cancer metastasis, and how is this reflected in the classification?",
    "answer": "Lungs, lymph nodes, bones, liver, and brain are common distant metastatic sites.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lungs are common sites of kidney cancer metastasis.",
      "Lymph nodes are common sites of kidney cancer metastasis.",
      "Bones are common sites of kidney cancer metastasis.",
      "Liver is a common site of kidney cancer metastasis.",
      "Brain is a common site of kidney cancer metastasis."
    ],
    "evidence_relations": [
      "Kidney cancer can metastasize to distant sites such as lungs, lymph nodes, bones, liver, and brain",
      "Stage in the ontology includes metastasis to lungs, lymph nodes, bones, liver, and brain"
    ]
  },
  {
    "id": "Medical-5581adb2",
    "source": "Medical",
    "question": "What combination of symptoms and diagnostic findings would suggest follicular lymphoma with bone marrow involvement?",
    "answer": "Symptoms like fatigue and weight loss, combined with abnormal findings on bone marrow aspirate and biopsy, suggest FL with bone marrow involvement.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms like fatigue suggest follicular lymphoma with bone marrow involvement.",
      "Symptoms like weight loss suggest follicular lymphoma with bone marrow involvement.",
      "Abnormal findings on bone marrow aspirate suggest follicular lymphoma with bone marrow involvement.",
      "Abnormal findings on bone marrow biopsy suggest follicular lymphoma with bone marrow involvement."
    ],
    "evidence_relations": [
      "Diagnosis of FL involves blood tests, bone marrow aspirate and biopsy, imaging studies, and immunophenotyping",
      "Symptoms of FL include fatigue and weight loss (B symptoms)",
      "Disease Site of FL includes bone marrow"
    ]
  },
  {
    "id": "Medical-6a1c421a",
    "source": "Medical",
    "question": "What diagnostic procedures are essential for confirming ALL in children and why are multiple tests necessary?",
    "answer": "Blood tests, bone marrow tests, imaging tests, heart tests, lumbar puncture, biomarker testing, and pharmacogenomic testing are all necessary because diagnosis requires both identifying lymphoblasts and assessing disease extent and subtype.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood tests are necessary for confirming ALL in children.",
      "Bone marrow tests are necessary for confirming ALL in children.",
      "Imaging tests are necessary for confirming ALL in children.",
      "Heart tests are necessary for confirming ALL in children.",
      "Lumbar puncture is necessary for confirming ALL in children.",
      "Biomarker testing is necessary for confirming ALL in children.",
      "Pharmacogenomic testing is necessary for confirming ALL in children.",
      "Diagnosis of ALL requires identifying lymphoblasts.",
      "Diagnosis of ALL requires assessing disease extent and subtype."
    ],
    "evidence_relations": [
      "ALL is diagnosed using blood tests, bone marrow tests, imaging tests, heart tests, and lumbar puncture",
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow",
      "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management",
      "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes"
    ]
  },
  {
    "id": "Medical-b503f3f3",
    "source": "Medical",
    "question": "What combination of diagnostic methods is typically used to confirm Hodgkin lymphoma and assess its extent?",
    "answer": "Excisional lymph node biopsy, blood tests, and imaging tests are used together for diagnosis and staging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Excisional lymph node biopsy is used to confirm Hodgkin lymphoma.",
      "Blood tests are used to confirm Hodgkin lymphoma.",
      "Imaging tests are used to confirm Hodgkin lymphoma.",
      "These methods are used together for diagnosis and staging."
    ],
    "evidence_relations": [
      "Diagnosis of Hodgkin lymphoma is made by excisional lymph node biopsy",
      "Blood tests and imaging tests are used in the diagnostic workup"
    ]
  },
  {
    "id": "Medical-3d54d9e7",
    "source": "Medical",
    "question": "Which diagnostic methods are necessary to confirm a diagnosis of ALL and why must both bone marrow and blood tests be used?",
    "answer": "Both bone marrow and blood tests are necessary because ALL is diagnosed when lymphoblasts are present in the bone marrow and can also be detected in the blood.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Both bone marrow and blood tests are necessary to confirm a diagnosis of ALL.",
      "ALL is diagnosed when lymphoblasts are present in the bone marrow.",
      "Lymphoblasts can also be detected in the blood."
    ],
    "evidence_relations": [
      "ALL is diagnosed when 20 percent or more lymphoblasts are present in the bone marrow",
      "Diagnosis of ALL involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, genetic and biomarker testing, imaging tests, and lumbar puncture"
    ]
  },
  {
    "id": "Medical-4f5a8531",
    "source": "Medical",
    "question": "Why might a patient with actinic keratosis require ongoing dermatologic surveillance even after lesion treatment?",
    "answer": "Because actinic keratosis can progress to CSCC and regular skin exams are recommended for surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Actinic keratosis can progress to CSCC.",
      "Regular skin exams are recommended for surveillance after lesion treatment."
    ],
    "evidence_relations": [
      "Actinic keratosis is a precancerous lesion that can progress to CSCC",
      "Clinical Management: Surveillance: Regular skin and lymph node exams"
    ]
  },
  {
    "id": "Medical-104b2f70",
    "source": "Medical",
    "question": "For a patient with a first-degree relative with colorectal cancer, what risk factors and inherited syndromes should be considered?",
    "answer": "A first-degree relative is a risk factor, and inherited syndromes like Lynch syndrome and FAP should be evaluated for increased colon cancer risk.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A first-degree relative with colorectal cancer is a risk factor.",
      "Inherited syndromes like Lynch syndrome and FAP should be evaluated for increased colon cancer risk."
    ],
    "evidence_relations": [
      "Family history of colorectal cancer is a risk factor",
      "Risk Factor includes inherited syndromes such as Lynch syndrome and FAP"
    ]
  },
  {
    "id": "Medical-443e3d36",
    "source": "Medical",
    "question": "If a patient with chronic hepatitis C and cirrhosis develops elevated AFP, which cancer type and diagnostic methods should be considered?",
    "answer": "Primary liver cancer should be considered, and diagnosis should be confirmed with imaging tests and possibly biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary liver cancer should be considered if a patient has chronic hepatitis C and cirrhosis with elevated AFP.",
      "Diagnosis of primary liver cancer should be confirmed with imaging tests.",
      "Diagnosis of primary liver cancer may require a biopsy."
    ],
    "evidence_relations": [
      "Chronic hepatitis C infection increases the risk of liver cancer",
      "Cirrhosis is a major risk factor for developing liver cancer",
      "Elevated AFP may indicate primary liver cancer",
      "Diagnosis of liver cancer is usually confirmed with imaging tests",
      "Biopsy may be needed to confirm liver cancer"
    ]
  },
  {
    "id": "Medical-d163acf5",
    "source": "Medical",
    "question": "How does the function of lymphocytes as white blood cells relate to the pathogenesis of cutaneous B-cell lymphoma?",
    "answer": "Lymphocytes are white blood cells that help fight infection, and their unregulated growth can lead to cutaneous B-cell lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lymphocytes are white blood cells.",
      "Lymphocytes help fight infection.",
      "Unregulated growth of lymphocytes can lead to cutaneous B-cell lymphoma."
    ],
    "evidence_relations": [
      "Lymphocytes are a type of white blood cell that help fight infection",
      "Unregulated growth of lymphocytes can develop into lymphoma",
      "CBCL starts in B cells"
    ]
  },
  {
    "id": "Medical-575e6d7f",
    "source": "Medical",
    "question": "Which phases make up the standard treatment course for AML and what is their primary goal?",
    "answer": "Induction, consolidation, and maintenance phases make up AML treatment, aiming for remission.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The standard treatment course for AML includes induction phases.",
      "The standard treatment course for AML includes consolidation phases.",
      "The standard treatment course for AML includes maintenance phases.",
      "The primary goal of AML treatment is to achieve remission."
    ],
    "evidence_relations": [
      "Treatment for AML is delivered in phases with the goal of achieving remission",
      "Treatment Phase includes induction, consolidation, and maintenance"
    ]
  },
  {
    "id": "Medical-e0f29bbd",
    "source": "Medical",
    "question": "What are the preferred systemic therapy options for metastatic CSCC, and when might surgery or radiation be considered?",
    "answer": "Preferred systemic therapies for metastatic CSCC are PD-1 inhibitors, with surgery or radiation considered if feasible.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Preferred systemic therapies for metastatic CSCC are PD-1 inhibitors.",
      "Surgery or radiation may be considered if feasible."
    ],
    "evidence_relations": [
      "Metastatic CSCC is treated with systemic therapy (immunotherapy preferred), and surgery or radiation if feasible",
      "Systemic therapy options include platinum-based chemotherapy, EGFR inhibitors (cetuximab), and PD-1 inhibitors (cemiplimab, pembrolizumab)",
      "Metastatic CSCC: Treatment: Systemic therapy (PD-1 inhibitor preferred), Surgery or radiation if feasible"
    ]
  },
  {
    "id": "Medical-d1c9cdcd",
    "source": "Medical",
    "question": "What are the common genetic alterations associated with bladder cancer, and how might these influence targeted therapy options?",
    "answer": "Genetic alterations such as FGFR3, CDKN2A, PIK3CA, and ERBB mutations are associated with bladder cancer and may be targeted by therapies like erdafitinib and enfortumab vedotin-ejfv.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic alterations associated with bladder cancer include FGFR3.",
      "Genetic alterations associated with bladder cancer include CDKN2A.",
      "Genetic alterations associated with bladder cancer include PIK3CA.",
      "Genetic alterations associated with bladder cancer include ERBB mutations.",
      "Therapies like erdafitinib may target genetic alterations in bladder cancer.",
      "Therapies like enfortumab vedotin-ejfv may target genetic alterations in bladder cancer."
    ],
    "evidence_relations": [
      "Genetic alterations such as mutations in CDKN2A, FGFR3, PIK3CA, and ERBB genes are associated with bladder cancer",
      "Targeted therapies include enfortumab vedotin-ejfv (Padcev), erdafitinib (Balversa), and sacituzumab govitecan-hziy (Trodelvy)",
      "FGFR3 mutation is a genetic alteration linked to bladder cancer"
    ]
  },
  {
    "id": "Medical-6bed629f",
    "source": "Medical",
    "question": "How does the management of recurrent ovarian cancer differ based on platinum sensitivity?",
    "answer": "Platinum-sensitive recurrence is managed with platinum-based chemotherapy and possibly surgery, while platinum-resistant recurrence uses non-platinum chemotherapy or targeted agents.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Platinum-sensitive recurrence is managed with platinum-based chemotherapy.",
      "Platinum-sensitive recurrence may involve surgery.",
      "Platinum-resistant recurrence is managed with non-platinum chemotherapy.",
      "Platinum-resistant recurrence may involve targeted agents."
    ],
    "evidence_relations": [
      "Recurrence is managed based on platinum sensitivity, biomarker status, and may include surgery, chemotherapy, targeted therapy, immunotherapy, or clinical trial enrollment",
      "Platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab, and may include secondary cytoreductive surgery",
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies"
    ]
  },
  {
    "id": "Medical-a3c6c911",
    "source": "Medical",
    "question": "How does the presence of BCR::ABL1 in B-ALL influence both the prognosis and the treatment approach?",
    "answer": "BCR::ABL1 in B-ALL defines a prognostic subgroup and requires therapies targeting the BCR::ABL protein.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BCR::ABL1 in B-ALL defines a prognostic subgroup.",
      "BCR::ABL1 in B-ALL requires therapies targeting the BCR::ABL protein."
    ],
    "evidence_relations": [
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein",
      "B-cell ALL (B-ALL) has prognostic groups including BCR::ABL1-positive B-ALL",
      "B-cell ALL (B-ALL) has biomarkers such as BCR::ABL1"
    ]
  },
  {
    "id": "Medical-7dd235f1",
    "source": "Medical",
    "question": "What is the significance of extranodal extension in regional lymph nodes for mouth cancer staging?",
    "answer": "Extranodal extension indicates cancer spread outside the lymph node and affects staging and prognosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Extranodal extension indicates cancer spread outside the lymph node.",
      "Extranodal extension affects staging of mouth cancer.",
      "Extranodal extension affects prognosis of mouth cancer."
    ],
    "evidence_relations": [
      "Regional lymph node involvement includes extranodal extension",
      "Extranodal extension is defined as cancer spread outside lymph node in the ontology"
    ]
  },
  {
    "id": "Medical-020cc551",
    "source": "Medical",
    "question": "How does the presence of a BRCA1 mutation influence both risk assessment and treatment in HER2-negative breast cancer?",
    "answer": "BRCA1 mutation increases breast cancer risk and enables the use of PARP inhibitors for HER2-negative disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BRCA1 mutation increases breast cancer risk.",
      "BRCA1 mutation enables the use of PARP inhibitors for HER2-negative breast cancer."
    ],
    "evidence_relations": [
      "BRCA1 and BRCA2 mutations increase the risk of breast cancer",
      "PARP inhibitors are used for BRCA-mutated, HER2-negative breast cancer"
    ]
  },
  {
    "id": "Medical-1c34ae24",
    "source": "Medical",
    "question": "What is the clinical significance of PD-L1 expression in the management of metastatic breast cancer?",
    "answer": "PD-L1 expression may guide immunotherapy use in metastatic breast cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PD-L1 expression may guide immunotherapy use in metastatic breast cancer."
    ],
    "evidence_relations": [
      "PD-L1 expression may guide immunotherapy use",
      "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs",
      "Immunotherapy is a treatment option for metastatic breast cancer"
    ]
  },
  {
    "id": "Medical-43a4d872",
    "source": "Medical",
    "question": "What symptoms in an adult patient should prompt evaluation for glioma using imaging and neurological examination?",
    "answer": "Symptoms like headache, seizures, and cognitive changes in adults should prompt MRI and neurological exam for glioma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms like headache should prompt evaluation for glioma.",
      "Symptoms like seizures should prompt evaluation for glioma.",
      "Symptoms like cognitive changes should prompt evaluation for glioma.",
      "MRI and neurological exam should be used for glioma evaluation."
    ],
    "evidence_relations": [
      "Gliomas are more common in adults than children",
      "Symptoms of glioma include headache, seizures, fatigue, nausea, vomiting, cognitive changes, weakness, personality changes, and vision problems",
      "Diagnosis of glioma involves neurological exam, imaging (MRI, CT), and biopsy"
    ]
  },
  {
    "id": "Medical-569780c4",
    "source": "Medical",
    "question": "How is IDH mutation status relevant for classifying both astrocytoma and oligodendroglioma, and what procedure is necessary to determine this status?",
    "answer": "IDH mutation is a biomarker used to classify both astrocytoma and oligodendroglioma, and biopsy is necessary to determine this status.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "IDH mutation status is relevant for classifying astrocytoma.",
      "IDH mutation status is relevant for classifying oligodendroglioma.",
      "A biopsy is necessary to determine IDH mutation status."
    ],
    "evidence_relations": [
      "IDH mutation is a biomarker used to classify gliomas",
      "Astrocytoma and oligodendroglioma have IDH mutation as a biomarker",
      "Biopsy is required for definitive diagnosis and molecular testing"
    ]
  },
  {
    "id": "Medical-219da1ba",
    "source": "Medical",
    "question": "Why should fertility preservation be discussed before chemoradiation in a young patient with Stage II anal cancer?",
    "answer": "Because chemoradiation can cause infertility and Stage II anal cancer is treated with chemoradiation, so fertility preservation options should be considered.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fertility preservation should be discussed before chemoradiation in a young patient with Stage II anal cancer.",
      "Chemoradiation can cause infertility.",
      "Stage II anal cancer is treated with chemoradiation.",
      "Fertility preservation options should be considered."
    ],
    "evidence_relations": [
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)",
      "Radiation and chemotherapy can cause infertility; fertility preservation options should be discussed",
      "Fertility Preservation includes sperm banking, egg freezing, ovarian tissue banking, and oophoropexy"
    ]
  },
  {
    "id": "Medical-48e987ed",
    "source": "Medical",
    "question": "How do risk factors and symptoms together contribute to the early detection of CLL?",
    "answer": "Older age and family history increase risk, and the presence of symptoms like swollen glands or incidental findings on blood tests aid early detection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Older age increases the risk of CLL.",
      "Family history increases the risk of CLL.",
      "Symptoms like swollen glands aid in early detection of CLL.",
      "Incidental findings on blood tests aid in early detection of CLL."
    ],
    "evidence_relations": [
      "Risk factors for CLL include older age and family history of CLL",
      "Symptoms of CLL include swollen glands, fatigue, night sweats, fever, recurrent infections, early satiety, and unintentional weight loss",
      "CLL may be asymptomatic and discovered incidentally on routine blood testing"
    ]
  },
  {
    "id": "Medical-0a8d750c",
    "source": "Medical",
    "question": "What are the key factors influencing the selection of treatment in AML patients?",
    "answer": "Genetic alterations, performance status, and general health are key factors influencing treatment selection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic alterations are key factors influencing treatment selection in AML patients.",
      "Performance status is a key factor influencing treatment selection in AML patients.",
      "General health is a key factor influencing treatment selection in AML patients."
    ],
    "evidence_relations": [
      "Genetic and biomarker tests are used to determine AML subtype and guide treatment",
      "Performance status and general health influence treatment selection",
      "Prognostic Factor includes genetic alterations and performance status"
    ]
  },
  {
    "id": "Medical-223def84",
    "source": "Medical",
    "question": "What factors determine whether a newly diagnosed CLL patient should begin treatment immediately or undergo watchful waiting?",
    "answer": "Treatment is based on symptoms, blood counts, and disease progression, so asymptomatic or stable patients may be managed with watch and wait.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment for newly diagnosed CLL patients is based on symptoms.",
      "Treatment for newly diagnosed CLL patients is based on blood counts.",
      "Treatment for newly diagnosed CLL patients is based on disease progression.",
      "Asymptomatic patients may be managed with watchful waiting.",
      "Stable patients may be managed with watchful waiting."
    ],
    "evidence_relations": [
      "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression",
      "Follow-up strategies include watch and wait, regular monitoring, and supportive care",
      "CLL may be asymptomatic and discovered incidentally on routine blood testing"
    ]
  },
  {
    "id": "Medical-16a39fa8",
    "source": "Medical",
    "question": "What role do anatomical layers of the esophagus play in distinguishing early-stage from locoregional esophageal cancer?",
    "answer": "Early-stage is confined to the esophagus, while locoregional involves invasion through esophageal layers and nearby structures.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Anatomical layers of the esophagus help distinguish early-stage from locoregional esophageal cancer.",
      "Early-stage esophageal cancer is confined to the esophagus.",
      "Locoregional esophageal cancer involves invasion through esophageal layers.",
      "Locoregional esophageal cancer involves invasion into nearby structures."
    ],
    "evidence_relations": [
      "Early-stage esophageal cancer is contained within the esophagus and not in lymph nodes",
      "Locoregional esophageal cancer has invaded the esophagus wall and/or spread to nearby lymph nodes or organs"
    ]
  },
  {
    "id": "Medical-ade4b34a",
    "source": "Medical",
    "question": "If a patient with primary CNS lymphoma presents with memory problems and confusion, what imaging modality is most useful and why?",
    "answer": "MRI with gadolinium contrast is most useful because it best identifies CNS lesions causing these symptoms.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MRI with gadolinium contrast is the most useful imaging modality for a patient with primary CNS lymphoma presenting with memory problems and confusion.",
      "MRI with gadolinium contrast best identifies CNS lesions causing memory problems and confusion."
    ],
    "evidence_relations": [
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma",
      "Primary CNS lymphoma can cause neurological symptoms such as memory problems and confusion",
      "Diagnostic Method for Primary CNS lymphoma includes MRI and Gadolinium contrast"
    ]
  },
  {
    "id": "Medical-222ee61b",
    "source": "Medical",
    "question": "Why is the diagnostic threshold of 20 percent or more lymphoblasts in bone marrow important for ALL diagnosis?",
    "answer": "It ensures that the diagnosis of ALL is based on a significant proportion of malignant lymphoblasts in the bone marrow.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The diagnostic threshold of 20 percent or more lymphoblasts in bone marrow is important for ALL diagnosis.",
      "This threshold ensures that the diagnosis of ALL is based on a significant proportion of malignant lymphoblasts."
    ],
    "evidence_relations": [
      "Diagnosis of ALL generally requires 20 percent or more lymphoblasts in the bone marrow",
      "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes",
      "Bone marrow test is a diagnostic method for ALL"
    ]
  },
  {
    "id": "Medical-c218fffa",
    "source": "Medical",
    "question": "Which supportive care approaches are important for pancreatic cancer management, and what symptoms might require them?",
    "answer": "Supportive care including symptom management and palliative care is important, particularly for symptoms like jaundice.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Supportive care is important for pancreatic cancer management.",
      "Symptom management is a part of supportive care for pancreatic cancer.",
      "Palliative care is a part of supportive care for pancreatic cancer.",
      "Jaundice is a symptom that might require supportive care."
    ],
    "evidence_relations": [
      "Supportive care is an important part of pancreatic cancer management",
      "Symptoms of pancreatic cancer may include jaundice (yellowed skin or eyes)",
      "Supportive Care: Symptom management, Palliative care (ontology, rewritten: Symptom management and palliative care are supportive care approaches for pancreatic cancer)"
    ]
  },
  {
    "id": "Medical-f3af6f24",
    "source": "Medical",
    "question": "For a patient with primary CNS lymphoma and cerebrospinal fluid involvement, which specialized treatment is indicated and how is the involvement detected?",
    "answer": "Intrathecal chemotherapy is indicated, with CSF involvement detected by lumbar puncture.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Intrathecal chemotherapy is indicated for a patient with primary CNS lymphoma and cerebrospinal fluid involvement.",
      "CSF involvement is detected by lumbar puncture."
    ],
    "evidence_relations": [
      "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid",
      "Primary CNS lymphoma is diagnosed using lumbar puncture",
      "Disease Location for Primary CNS lymphoma includes Cerebrospinal fluid (CSF)"
    ]
  },
  {
    "id": "Medical-eb7624ca",
    "source": "Medical",
    "question": "What is the recommended follow-up strategy after treatment for regional CSCC compared to local low-risk CSCC?",
    "answer": "Regional CSCC requires more frequent skin and lymph node exams than local low-risk CSCC, especially in the first two years.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Regional CSCC requires more frequent skin exams than local low-risk CSCC.",
      "Regional CSCC requires more frequent lymph node exams than local low-risk CSCC.",
      "More frequent exams are especially needed in the first two years after treatment."
    ],
    "evidence_relations": [
      "Regional CSCC: Follow-up Strategy: Skin and lymph node exams every 2-3 months for 1 year, every 2-4 months for year 2, every 4-6 months for 3 years, then every 6-12 months",
      "Low-risk: Follow-up Strategy: Skin and lymph node exams every 3-12 months for 2 years, then every 6-12 months for 3 years, then annually"
    ]
  },
  {
    "id": "Medical-d7765001",
    "source": "Medical",
    "question": "Which symptoms should prompt evaluation for possible ovarian cancer using tumor markers and imaging?",
    "answer": "Symptoms such as persistent bloating, pelvic pain, trouble eating, and urinary urgency should prompt evaluation with tumor markers and imaging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Persistent bloating should prompt evaluation for possible ovarian cancer.",
      "Pelvic pain should prompt evaluation for possible ovarian cancer.",
      "Trouble eating should prompt evaluation for possible ovarian cancer.",
      "Urinary urgency should prompt evaluation for possible ovarian cancer."
    ],
    "evidence_relations": [
      "Common symptoms of ovarian cancer include bloating, pelvic or abdominal pain, trouble eating or feeling full quickly, urinary urgency or frequency, and pain during sex",
      "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET), abdominal and pelvic exam, biopsy, and blood tests including tumor markers"
    ]
  },
  {
    "id": "Medical-c2af5dd7",
    "source": "Medical",
    "question": "Which two risk factors for liver cancer are also major causes of cirrhosis, further increasing cancer risk?",
    "answer": "Alcohol use and non-alcoholic fatty liver disease (NAFLD) are both risk factors for cirrhosis and liver cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Alcohol use is a risk factor for liver cancer.",
      "Alcohol use is a major cause of cirrhosis.",
      "Non-alcoholic fatty liver disease (NAFLD) is a risk factor for liver cancer.",
      "Non-alcoholic fatty liver disease (NAFLD) is a major cause of cirrhosis."
    ],
    "evidence_relations": [
      "Alcohol use is a risk factor for cirrhosis and liver cancer",
      "Non-alcoholic fatty liver disease (NAFLD) is a risk factor for cirrhosis and liver cancer"
    ]
  },
  {
    "id": "Medical-8f1032c7",
    "source": "Medical",
    "question": "What diagnostic steps should be taken for a woman presenting with persistent bloating and pelvic pain suggestive of ovarian cancer?",
    "answer": "Imaging such as ultrasound or CT, abdominal and pelvic exam, biopsy, and tumor marker blood tests should be performed.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging such as ultrasound should be performed for a woman with persistent bloating and pelvic pain.",
      "CT imaging should be performed for a woman with persistent bloating and pelvic pain.",
      "An abdominal and pelvic exam should be performed for a woman with persistent bloating and pelvic pain.",
      "A biopsy should be performed for a woman with persistent bloating and pelvic pain.",
      "Tumor marker blood tests should be performed for a woman with persistent bloating and pelvic pain."
    ],
    "evidence_relations": [
      "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET), abdominal and pelvic exam, biopsy, and blood tests including tumor markers",
      "Common symptoms of ovarian cancer include bloating and pelvic or abdominal pain",
      "The ontology lists 'persistent bloating' and 'pelvic pain' as symptoms and includes diagnostic methods such as imaging, biopsy, and tumor marker tests"
    ]
  },
  {
    "id": "Medical-f25adcc2",
    "source": "Medical",
    "question": "If a primary tumor in intrahepatic bile duct cancer is found in the perimuscular fibrous tissue, why can it not be staged as Tis?",
    "answer": "Because Tis is defined as a tumor confined to the epithelium, and perimuscular fibrous tissue is a deeper layer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tis is defined as a tumor confined to the epithelium.",
      "Perimuscular fibrous tissue is a deeper layer."
    ],
    "evidence_relations": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "Perimuscular fibrous tissue surrounds the muscle layer",
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa"
    ]
  },
  {
    "id": "Medical-66e7fe35",
    "source": "Medical",
    "question": "Which diagnostic methods are necessary to confirm a case of Ewing sarcoma, and which biomarker supports the diagnosis?",
    "answer": "Diagnosis of Ewing sarcoma requires imaging tests and biopsy, with EWSR1-FLI1 fusion serving as a supporting biomarker.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of Ewing sarcoma requires imaging tests.",
      "Diagnosis of Ewing sarcoma requires a biopsy.",
      "EWSR1-FLI1 fusion serves as a supporting biomarker for Ewing sarcoma."
    ],
    "evidence_relations": [
      "Ewing sarcoma is characterized by EWSR1-ETS gene fusions, most commonly EWSR1-FLI1",
      "Imaging tests for bone cancer include X-ray, bone scan, CT scan, MRI, and PET scan",
      "Diagnosis of bone cancer is confirmed by core needle or surgical biopsy",
      "Ewing sarcoma: Diagnostic Method: [\"X-ray\", \"Bone scan\", \"CT scan\", \"MRI\", \"PET scan\", \"Biopsy\"]"
    ]
  },
  {
    "id": "Medical-8b16a7bd",
    "source": "Medical",
    "question": "What is the rationale for targeting BCR::ABL1 protein activity in CML treatment?",
    "answer": "Since CML is caused by the BCR::ABL1 fusion gene, inhibiting its protein product addresses the underlying cause.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CML is caused by the BCR::ABL1 fusion gene.",
      "Targeting BCR::ABL1 protein activity addresses the underlying cause of CML."
    ],
    "evidence_relations": [
      "CML is caused by the BCR::ABL1 fusion gene",
      "Treatment for CML aims to inhibit BCR::ABL1 protein activity"
    ]
  },
  {
    "id": "Medical-c4772f49",
    "source": "Medical",
    "question": "How do the submucosa and muscle layer relate to the progression from early-stage to locoregional stomach cancer?",
    "answer": "Progression from early-stage to locoregional involves invasion beyond the mucosa into the submucosa and muscle layer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Progression from early-stage stomach cancer involves invasion beyond the mucosa.",
      "Invasion beyond the mucosa includes the submucosa.",
      "Invasion beyond the mucosa includes the muscle layer."
    ],
    "evidence_relations": [
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes",
      "Locoregional or locally advanced stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs",
      "Stomach Wall Layer includes mucosa, submucosa, muscle layer, subserosa, and serosa (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-c0103315",
    "source": "Medical",
    "question": "What differentiates a functional from a nonfunctioning adrenal adenoma, and how does this impact patient symptoms?",
    "answer": "Functional adenomas secrete excess hormones and cause symptoms, while nonfunctioning adenomas do not secrete hormones and are usually asymptomatic.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Functional adrenal adenomas secrete excess hormones.",
      "Functional adrenal adenomas cause symptoms.",
      "Nonfunctioning adrenal adenomas do not secrete hormones.",
      "Nonfunctioning adrenal adenomas are usually asymptomatic."
    ],
    "evidence_relations": [
      "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning",
      "Functional adrenal tumors may produce excess hormones"
    ]
  },
  {
    "id": "Medical-a0a1a141",
    "source": "Medical",
    "question": "Which imaging modalities are used for both diagnosis and staging of throat cancer, and what is their role?",
    "answer": "CT scan, MRI, PET/CT, and ultrasound are used for both diagnosis and staging to assess tumor extent and spread.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CT scan is used for both diagnosis and staging of throat cancer.",
      "MRI is used for both diagnosis and staging of throat cancer.",
      "PET/CT is used for both diagnosis and staging of throat cancer.",
      "Ultrasound is used for both diagnosis and staging of throat cancer.",
      "These imaging modalities assess tumor extent and spread."
    ],
    "evidence_relations": [
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M)"
    ]
  },
  {
    "id": "Medical-f7ce6257",
    "source": "Medical",
    "question": "How does the treatment approach differ between T1 and T2 rectal tumors according to surgical recommendations?",
    "answer": "T1 tumors are treated with local excision or endoscopic methods, while T2 tumors require transabdominal surgery.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "T1 rectal tumors are treated with local excision or endoscopic methods.",
      "T2 rectal tumors require transabdominal surgery."
    ],
    "evidence_relations": [
      "Endoscopic submucosal dissection (ESD) is recommended for T1 rectal tumors",
      "Transanal local excision is an option for T1 tumors at the end of the rectum",
      "Transabdominal surgery is recommended for T2 and some T1/T3 tumors"
    ]
  },
  {
    "id": "Medical-ac73c113",
    "source": "Medical",
    "question": "What combination of diagnostic tools is recommended for staging and detecting metastasis in rectal cancer?",
    "answer": "MRI of the pelvis and CT scan of chest and abdomen are recommended for staging and detecting metastasis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MRI of the pelvis is recommended for staging and detecting metastasis in rectal cancer.",
      "CT scan of the chest and abdomen is recommended for staging and detecting metastasis in rectal cancer."
    ],
    "evidence_relations": [
      "MRI of the pelvis is recommended for staging rectal cancer",
      "CT scan of chest and abdomen is used to detect metastasis",
      "Rectal cancer diagnostic methods include MRI and CT scan"
    ]
  },
  {
    "id": "Medical-ee09c8e9",
    "source": "Medical",
    "question": "Why is performance status (ECOG) considered in treatment selection for mouth cancer?",
    "answer": "Performance status (ECOG) is used to guide treatment selection based on the patient's ability to tolerate therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status (ECOG) is used to guide treatment selection for mouth cancer.",
      "Performance status (ECOG) is based on the patient's ability to tolerate therapy."
    ],
    "evidence_relations": [
      "Performance status (ECOG) is considered in treatment selection",
      "Clinical Assessment includes Performance status (ECOG) in the ontology for squamous cell carcinoma (SCC) of the mouth"
    ]
  },
  {
    "id": "Medical-423d4257",
    "source": "Medical",
    "question": "Which risk factors are shared by cervical cancer and its precursor lesions, and how do they contribute to disease development?",
    "answer": "HPV infection, smoking, and immunosuppression are risk factors for both cervical cancer and cervical dysplasia, contributing to disease progression.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HPV infection is a risk factor for both cervical cancer and cervical dysplasia.",
      "Smoking is a risk factor for both cervical cancer and cervical dysplasia.",
      "Immunosuppression is a risk factor for both cervical cancer and cervical dysplasia.",
      "These risk factors contribute to disease progression."
    ],
    "evidence_relations": [
      "Most cervical cancers are caused by long-term infection with human papillomavirus (HPV)",
      "Smoking increases the risk of cervical cancer",
      "Immunosuppression (e.g., HIV infection) increases the risk of cervical cancer",
      "Cervical dysplasia (CIN) can progress to cervical cancer if untreated",
      "HPV infection, smoking, and immunosuppression are listed as risk factors for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-6e4da4de",
    "source": "Medical",
    "question": "What are the main routes of metastasis in throat cancer and which distant sites are commonly involved?",
    "answer": "Throat cancer can spread to lymph nodes in the neck and to distant sites such as lungs, liver, or spine.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Throat cancer can spread to lymph nodes in the neck.",
      "Throat cancer can spread to distant sites such as the lungs.",
      "Throat cancer can spread to distant sites such as the liver.",
      "Throat cancer can spread to distant sites such as the spine."
    ],
    "evidence_relations": [
      "Cancer can spread to lymph nodes in the neck and to distant sites such as lungs, liver, or spine",
      "Metastasis includes lungs, liver, and spine"
    ]
  },
  {
    "id": "Medical-5a2c0504",
    "source": "Medical",
    "question": "Which anatomical sites are most commonly affected by metastasis from primary liver cancer, and how is this supported by the ontology?",
    "answer": "The lung and bone are the most common metastasis sites for primary liver cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The lung is a common site for metastasis from primary liver cancer.",
      "Bone is a common site for metastasis from primary liver cancer."
    ],
    "evidence_relations": [
      "Liver cancer most often metastasizes to the lung or bone",
      "Metastasis Site: Primary liver cancer commonly spreads to lung and bone"
    ]
  },
  {
    "id": "Medical-3d9e3424",
    "source": "Medical",
    "question": "In what situations is a lumbar puncture indicated during the diagnosis of ALL, and what does its use suggest about disease spread?",
    "answer": "A lumbar puncture is indicated to assess CNS involvement, suggesting possible spread of ALL to the central nervous system.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A lumbar puncture is indicated to assess CNS involvement.",
      "A lumbar puncture suggests possible spread of ALL to the central nervous system."
    ],
    "evidence_relations": [
      "Diagnosis of ALL involves lumbar puncture",
      "ALL can be found in bone marrow, blood, testicles, and central nervous system"
    ]
  },
  {
    "id": "Medical-45173331",
    "source": "Medical",
    "question": "How does the age of onset relate to the risk factors for Hodgkin lymphoma according to the ontology?",
    "answer": "Ages 15 to 30 and after age 55 are risk factors for Hodgkin lymphoma, matching the typical age of diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Ages 15 to 30 are risk factors for Hodgkin lymphoma.",
      "Ages over 55 are risk factors for Hodgkin lymphoma.",
      "These ages match the typical age of diagnosis for Hodgkin lymphoma."
    ],
    "evidence_relations": [
      "Most people are diagnosed between ages 15 to 30 or after age 55",
      "Risk Factor: ages 15 to 30, age 55"
    ]
  },
  {
    "id": "Medical-0bd26353",
    "source": "Medical",
    "question": "What are the main components of trimodal therapy for bladder cancer and in which clinical context is it used?",
    "answer": "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach for muscle-invasive bladder cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Trimodal therapy combines TURBT.",
      "Trimodal therapy combines chemotherapy.",
      "Trimodal therapy combines radiation.",
      "Trimodal therapy is used as a bladder-preserving approach for muscle-invasive bladder cancer."
    ],
    "evidence_relations": [
      "Trimodal therapy combines TURBT, chemotherapy, and radiation as a bladder-preserving approach",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Trimodal therapy is an alternative to radical cystectomy for bladder preservation"
    ]
  },
  {
    "id": "Medical-ade95016",
    "source": "Medical",
    "question": "Which risk factors should be considered for an older adult with a history of organ transplant who develops primary CNS lymphoma?",
    "answer": "Older age and organ transplant are both risk factors for primary CNS lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Older age is a risk factor for primary CNS lymphoma.",
      "Organ transplant is a risk factor for primary CNS lymphoma."
    ],
    "evidence_relations": [
      "Immunodeficiency disorders, organ transplant, and older age are risk factors for primary CNS lymphoma",
      "Risk Factor for Primary CNS lymphoma includes Older adult and Organ transplant"
    ]
  },
  {
    "id": "Medical-38a8b852",
    "source": "Medical",
    "question": "Why might a patient with genetic hemochromatosis require regular liver cancer screening, and which methods are used?",
    "answer": "Because genetic hemochromatosis is a risk factor for cirrhosis and liver cancer, screening with ultrasound and AFP test is recommended.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Genetic hemochromatosis is a risk factor for cirrhosis.",
      "Genetic hemochromatosis is a risk factor for liver cancer.",
      "Screening with ultrasound is recommended for patients with genetic hemochromatosis.",
      "Screening with AFP test is recommended for patients with genetic hemochromatosis."
    ],
    "evidence_relations": [
      "Genetic hemochromatosis is a risk factor for cirrhosis and liver cancer",
      "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months"
    ]
  },
  {
    "id": "Medical-97e7a1d0",
    "source": "Medical",
    "question": "If a kidney tumor is found to have sarcomatoid features, what does this indicate regarding its subtype and disease aggressiveness?",
    "answer": "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Sarcomatoid features can occur in any subtype of renal cell carcinoma (RCC).",
      "Sarcomatoid features are associated with more aggressive disease."
    ],
    "evidence_relations": [
      "Sarcomatoid features can occur in any RCC subtype and are associated with more aggressive disease",
      "Sarcomatoid RCC (sRCC) is included under Histology for RCC in the ontology"
    ]
  },
  {
    "id": "Medical-ac86bfad",
    "source": "Medical",
    "question": "How does the treatment approach differ between muscle-invasive and non–muscle-invasive bladder cancer?",
    "answer": "Muscle-invasive bladder cancer is treated with radical cystectomy and may require urinary diversion, while non–muscle-invasive bladder cancer is treated with TURBT and intravesical therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Muscle-invasive bladder cancer is treated with radical cystectomy.",
      "Muscle-invasive bladder cancer may require urinary diversion.",
      "Non-muscle-invasive bladder cancer is treated with TURBT.",
      "Non-muscle-invasive bladder cancer is treated with intravesical therapy."
    ],
    "evidence_relations": [
      "Stages 2, 3, and 4 bladder cancers are muscle-invasive",
      "Radical cystectomy is the standard surgery for muscle-invasive bladder cancer",
      "Stage 0 and Stage 1 bladder cancers are non–muscle-invasive",
      "TURBT is used for tumor removal in non–muscle-invasive bladder cancer",
      "Intravesical therapy (BCG or chemotherapy) is used for non–muscle-invasive bladder cancer"
    ]
  },
  {
    "id": "Medical-d186c439",
    "source": "Medical",
    "question": "What distinguishes T-cell lymphoblastic lymphoma (T-LL, T-LBL) from T-cell ALL in terms of disease location?",
    "answer": "T-cell lymphoblastic lymphoma involves T-cell lymphoblasts growing in the thymus, while T-cell ALL primarily involves bone marrow and blood.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "T-cell lymphoblastic lymphoma involves T-cell lymphoblasts growing in the thymus.",
      "T-cell ALL primarily involves bone marrow.",
      "T-cell ALL primarily involves blood."
    ],
    "evidence_relations": [
      "T-cell lymphoblasts growing in the thymus is called T-cell lymphoblastic lymphoma (T-LL or T-LBL)",
      "Acute lymphoblastic leukemia (ALL) can be found in bone marrow, blood, testicles, or central nervous system (CNS)",
      "T-cell ALL (T-ALL) starts in T-cell lymphocytes"
    ]
  },
  {
    "id": "Medical-4ff142d9",
    "source": "Medical",
    "question": "How does the starting location of renal cell carcinoma compare to that of renal sarcoma within the kidney?",
    "answer": "RCC starts in the renal tubules, while renal sarcoma starts in the blood vessels or connective tissue of the kidney.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "RCC starts in the renal tubules.",
      "Renal sarcoma starts in the blood vessels or connective tissue of the kidney."
    ],
    "evidence_relations": [
      "RCC starts in the cells that line the renal tubules",
      "Renal sarcoma starts in the blood vessels or connective tissue of the kidney"
    ]
  },
  {
    "id": "Medical-63b4b70c",
    "source": "Medical",
    "question": "Which subtypes of cutaneous B-cell lymphoma should be considered when a biopsy confirms B-cell origin in a patient with skin papules?",
    "answer": "Primary cutaneous marginal zone lymphoma, primary cutaneous follicle center lymphoma, and primary cutaneous diffuse large B-cell lymphoma, leg type should be considered.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary cutaneous marginal zone lymphoma should be considered when a biopsy confirms B-cell origin in a patient with skin papules.",
      "Primary cutaneous follicle center lymphoma should be considered when a biopsy confirms B-cell origin in a patient with skin papules.",
      "Primary cutaneous diffuse large B-cell lymphoma, leg type should be considered when a biopsy confirms B-cell origin in a patient with skin papules."
    ],
    "evidence_relations": [
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "CBCL starts in B cells",
      "CBCL appears as nodules or papules under the skin"
    ]
  },
  {
    "id": "Medical-0e2be889",
    "source": "Medical",
    "question": "How does the AJCC TNM system contribute to the staging of nasopharyngeal carcinoma, and what aspects does it assess?",
    "answer": "The AJCC TNM system stages NPC by assessing tumor size (T), lymph node involvement (N), and distant metastasis (M).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The AJCC TNM system stages nasopharyngeal carcinoma (NPC).",
      "The AJCC TNM system assesses tumor size (T) in NPC.",
      "The AJCC TNM system assesses lymph node involvement (N) in NPC.",
      "The AJCC TNM system assesses distant metastasis (M) in NPC."
    ],
    "evidence_relations": [
      "NPC is staged using the AJCC TNM system, which includes tumor size (T), lymph node involvement (N), and distant metastasis (M)",
      "Stage in the ontology includes AJCC TNM system"
    ]
  },
  {
    "id": "Medical-5c6a1008",
    "source": "Medical",
    "question": "Which combination of therapies might be considered for a patient with metastatic prostate cancer and a BRCA2 mutation?",
    "answer": "Androgen deprivation therapy, chemotherapy, and targeted therapy may be considered for metastatic prostate cancer with BRCA2 mutation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Androgen deprivation therapy may be considered for metastatic prostate cancer with BRCA2 mutation.",
      "Chemotherapy may be considered for metastatic prostate cancer with BRCA2 mutation.",
      "Targeted therapy may be considered for metastatic prostate cancer with BRCA2 mutation."
    ],
    "evidence_relations": [
      "Metastatic prostate cancer treatment includes ADT, chemotherapy, targeted therapy",
      "BRCA2 mutation increases risk of prostate cancer",
      "Metastatic prostate cancer includes BRCA2 as a genetic alteration"
    ]
  },
  {
    "id": "Medical-819d9c6c",
    "source": "Medical",
    "question": "What distinguishes intrahepatic cholangiocarcinoma from other primary liver cancer subtypes in terms of anatomical origin?",
    "answer": "Intrahepatic cholangiocarcinoma arises from the bile ducts within the liver, unlike HCC or mixed-type tumors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Intrahepatic cholangiocarcinoma arises from the bile ducts within the liver.",
      "HCC is a different subtype of primary liver cancer.",
      "Mixed-type tumors are different from intrahepatic cholangiocarcinoma."
    ],
    "evidence_relations": [
      "Intrahepatic cholangiocarcinoma is a primary liver cancer of the bile ducts",
      "Anatomical Structure: Bile ducts are a part of the liver"
    ]
  },
  {
    "id": "Medical-2be4d7f3",
    "source": "Medical",
    "question": "Which stages of pancreatic ductal adenocarcinoma are eligible for surgery, and what is the criterion for eligibility at Stage III?",
    "answer": "Stages I, II, and selected cases of Stage III pancreatic ductal adenocarcinoma are eligible for surgery, with eligibility at Stage III depending on tumor spread to major arteries or lymph nodes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stages I and II pancreatic ductal adenocarcinoma are eligible for surgery.",
      "Selected cases of Stage III pancreatic ductal adenocarcinoma are eligible for surgery.",
      "Eligibility at Stage III depends on tumor spread to major arteries.",
      "Eligibility at Stage III depends on tumor spread to lymph nodes."
    ],
    "evidence_relations": [
      "Surgery is a treatment option for some patients with stage I, II, or III pancreatic cancer",
      "Stage III pancreatic cancer has grown to nearby major arteries or spread to 4 or more lymph nodes",
      "Surgery: Stage I, Stage II, Stage III (selected cases) (ontology, rewritten: Surgery is a treatment for Stage I, Stage II, and selected Stage III pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-68ea8206",
    "source": "Medical",
    "question": "What is the relationship between Pap smear screening and the detection of cervical dysplasia and cancer?",
    "answer": "Pap smear is used for cervical cancer screening and can detect cervical dysplasia, which may progress to cancer if untreated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pap smear is used for cervical cancer screening.",
      "Pap smear can detect cervical dysplasia.",
      "Cervical dysplasia may progress to cancer if untreated."
    ],
    "evidence_relations": [
      "Pap smear is used for cervical cancer screening",
      "Cervical dysplasia (CIN) can progress to cervical cancer if untreated",
      "Pap smear is listed as a screening diagnostic method for cervical cancer in the ontology"
    ]
  },
  {
    "id": "Medical-bce86fcf",
    "source": "Medical",
    "question": "How are germline mutations relevant to bone cancer risk, and what testing modality is used to identify them?",
    "answer": "Germline mutations are risk factors for bone cancer and can be identified by genetic cancer risk testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Germline mutations are risk factors for bone cancer.",
      "Germline mutations can be identified by genetic cancer risk testing."
    ],
    "evidence_relations": [
      "Genetic cancer risk testing identifies germline mutations associated with increased cancer risk",
      "Risk Factor: [\"Family history of cancer\", \"Germline mutations\"]"
    ]
  },
  {
    "id": "Medical-33af9785",
    "source": "Medical",
    "question": "What is the relationship between H. pylori infection, precancerous mucosal changes, and stomach cancer development?",
    "answer": "H. pylori infection is a risk factor that can lead to precancerous mucosal changes, which may progress to stomach cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "H. pylori infection is a risk factor for stomach cancer.",
      "H. pylori infection can lead to precancerous mucosal changes.",
      "Precancerous mucosal changes may progress to stomach cancer."
    ],
    "evidence_relations": [
      "H. pylori infection is a risk factor for stomach cancer",
      "Precancerous changes often occur in the mucosa before cancer develops",
      "Stomach cancer is a type of cancer that arises in the stomach"
    ]
  },
  {
    "id": "Medical-7b4429ac",
    "source": "Medical",
    "question": "What findings on risk assessment would classify a local CSCC as high-risk, and how does this affect treatment choices?",
    "answer": "Features such as perineural invasion, lymphovascular invasion, or high tumor grade classify local CSCC as high-risk, requiring Mohs surgery or systemic therapy if surgery/radiation is not possible.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Perineural invasion classifies local CSCC as high-risk.",
      "Lymphovascular invasion classifies local CSCC as high-risk.",
      "High tumor grade classifies local CSCC as high-risk.",
      "High-risk local CSCC requires Mohs surgery.",
      "High-risk local CSCC may require systemic therapy if surgery or radiation is not possible."
    ],
    "evidence_relations": [
      "Risk assessment for CSCC is based on tumor location, size, border definition, recurrence, depth, perineural invasion, lymphovascular invasion, tumor grade, and patient immune status",
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible"
    ]
  },
  {
    "id": "Medical-015f2cf7",
    "source": "Medical",
    "question": "How would you distinguish between a functional adenoma and a pheochromocytoma in a patient with an adrenal mass and high blood pressure?",
    "answer": "A pheochromocytoma arises from the adrenal medulla and causes high blood pressure, while functional adenoma does not typically present with high blood pressure.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A pheochromocytoma arises from the adrenal medulla.",
      "A pheochromocytoma causes high blood pressure.",
      "A functional adenoma does not typically present with high blood pressure."
    ],
    "evidence_relations": [
      "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure",
      "Adenoma is the most common type of adrenal gland tumor and can be functioning or nonfunctioning",
      "Functional adenoma subtypes are aldosteronoma and cortisol-producing adenoma"
    ]
  },
  {
    "id": "Medical-70db1204",
    "source": "Medical",
    "question": "How is the stage of mouth cancer determined using both tumor characteristics and lymph node involvement?",
    "answer": "Stage is determined by the TNM system, which includes tumor size and depth, lymph node involvement, and distant metastasis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The stage of mouth cancer is determined by the TNM system.",
      "The TNM system includes tumor size.",
      "The TNM system includes tumor depth.",
      "The TNM system includes lymph node involvement.",
      "The TNM system includes distant metastasis."
    ],
    "evidence_relations": [
      "Cancer staging is based on the TNM system, which includes tumor size and depth (T), lymph node involvement (N), and distant metastasis (M)",
      "TNM Classification includes T, N, and M parameters in the ontology for mouth cancer"
    ]
  },
  {
    "id": "Medical-c41cab28",
    "source": "Medical",
    "question": "How does the identification of Barrett esophagus change the risk profile and surveillance strategy for esophageal cancer?",
    "answer": "Barrett esophagus increases adenocarcinoma risk, so surveillance includes biomarker and genetic risk testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The identification of Barrett esophagus increases adenocarcinoma risk.",
      "Surveillance for esophageal cancer includes biomarker testing.",
      "Surveillance for esophageal cancer includes genetic risk testing."
    ],
    "evidence_relations": [
      "Barrett esophagus is a precancerous condition that increases risk for esophageal adenocarcinoma",
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Barrett esophagus is a risk factor for esophageal adenocarcinoma"
    ]
  },
  {
    "id": "Medical-4e39d9d5",
    "source": "Medical",
    "question": "What steps are necessary to diagnose and fully characterize an AML case with suspected extramedullary involvement?",
    "answer": "Diagnosis requires blood tests, bone marrow evaluation, flow cytometry, molecular/cytogenetic testing, and imaging (CT, MRI, PET/CT) for extramedullary disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Diagnosis of AML with suspected extramedullary involvement requires blood tests.",
      "Diagnosis of AML with suspected extramedullary involvement requires bone marrow evaluation.",
      "Diagnosis of AML with suspected extramedullary involvement requires flow cytometry.",
      "Diagnosis of AML with suspected extramedullary involvement requires molecular/cytogenetic testing.",
      "Imaging (CT, MRI, PET/CT) is required for extramedullary disease."
    ],
    "evidence_relations": [
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies",
      "Imaging (CT, MRI, PET/CT) is used to assess extramedullary disease or complications",
      "Diagnostic Method includes Imaging: CT scan, MRI, PET/CT"
    ]
  },
  {
    "id": "Medical-e99acf57",
    "source": "Medical",
    "question": "For a patient presenting with redness, swelling, and peau d’orange of the breast, what subtype and stage of breast cancer should be suspected and which diagnostic methods are indicated?",
    "answer": "Inflammatory breast cancer (IBC), typically stage III or IV, should be suspected and diagnosis should include physical exam, medical photographs, imaging, and biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Inflammatory breast cancer (IBC) should be suspected for a patient with redness, swelling, and peau d’orange of the breast.",
      "Inflammatory breast cancer is typically stage III or IV.",
      "Diagnosis of inflammatory breast cancer should include a physical exam.",
      "Diagnosis of inflammatory breast cancer should include medical photographs.",
      "Diagnosis of inflammatory breast cancer should include imaging.",
      "Diagnosis of inflammatory breast cancer should include biopsy."
    ],
    "evidence_relations": [
      "Inflammatory breast cancer (IBC) is a rare, aggressive subtype characterized by cancer cells blocking lymph vessels in the skin",
      "IBC symptoms include redness, swelling, and peau d’orange",
      "IBC is diagnosed with physical exam, medical photographs, mammogram, ultrasound, MRI, CT scan, PET scan, biopsy, skin biopsy, and sentinel lymph node biopsy"
    ]
  },
  {
    "id": "Medical-ef8fe744",
    "source": "Medical",
    "question": "Which diagnostic tests are necessary to confirm and further characterize invasive ductal carcinoma presenting with a breast lump?",
    "answer": "Mammogram, ultrasound, MRI, biopsy, and blood tests are necessary to confirm and characterize invasive ductal carcinoma with a breast lump.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mammogram is necessary to confirm invasive ductal carcinoma.",
      "Ultrasound is necessary to confirm invasive ductal carcinoma.",
      "MRI is necessary to confirm invasive ductal carcinoma.",
      "Biopsy is necessary to confirm invasive ductal carcinoma.",
      "Blood tests are necessary to confirm invasive ductal carcinoma."
    ],
    "evidence_relations": [
      "Invasive ductal carcinoma is the most common type of invasive breast cancer",
      "Diagnosis involves imaging (mammogram, ultrasound, MRI, CT, PET), biopsy, and blood tests",
      "Invasive ductal carcinoma uses mammogram, ultrasound, MRI, biopsy, and blood tests as diagnostic methods"
    ]
  },
  {
    "id": "Medical-99cbd976",
    "source": "Medical",
    "question": "What distinguishes mature B-cell ALL (Burkitt leukemia) from typical B-ALL in terms of classification and treatment?",
    "answer": "Mature B-cell ALL (Burkitt leukemia) is a rare subtype of B-ALL and is treated differently than typical B-ALL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mature B-cell ALL (Burkitt leukemia) is a rare subtype of B-ALL.",
      "Mature B-cell ALL (Burkitt leukemia) is treated differently than typical B-ALL."
    ],
    "evidence_relations": [
      "Mature B-cell ALL (Burkitt leukemia) is a rare subtype and is treated differently from B-ALL",
      "B-cell ALL (B-ALL) has subtypes including Mature B-cell ALL (Burkitt leukemia)"
    ]
  },
  {
    "id": "Medical-15b033b6",
    "source": "Medical",
    "question": "How does the origin of ACC differ from that of pheochromocytoma, and how does this affect their typical symptoms?",
    "answer": "ACC arises from the adrenal cortex and can cause a range of hormone-related symptoms, while pheochromocytoma arises from the adrenal medulla and typically causes high blood pressure, headache, rapid heartbeat, and sweating.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adrenocortical carcinoma (ACC) arises from the adrenal cortex.",
      "Adrenocortical carcinoma (ACC) can cause a range of hormone-related symptoms.",
      "Pheochromocytoma arises from the adrenal medulla.",
      "Pheochromocytoma typically causes high blood pressure.",
      "Pheochromocytoma typically causes headache.",
      "Pheochromocytoma typically causes rapid heartbeat.",
      "Pheochromocytoma typically causes sweating."
    ],
    "evidence_relations": [
      "Adrenocortical carcinoma (ACC) is a rare malignant tumor of the adrenal cortex",
      "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure, headache, rapid heartbeat, and sweating"
    ]
  },
  {
    "id": "Medical-c76b58b2",
    "source": "Medical",
    "question": "How is the transformation of follicular lymphoma into a more aggressive disease identified and classified?",
    "answer": "Transformation is identified by the development of DLBCL from FL, which is classified as transformed FL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Transformation of follicular lymphoma is identified by the development of DLBCL from FL.",
      "Transformed FL is classified as transformed FL."
    ],
    "evidence_relations": [
      "FL can transform into DLBCL, a more aggressive lymphoma",
      "transformed FL: Transformation is to diffuse large B-cell lymphoma (DLBCL)",
      "DLBCL is a distinct classification in the ontology"
    ]
  },
  {
    "id": "Medical-29a8ae2e",
    "source": "Medical",
    "question": "Why might a pregnancy test and fertility preservation be considered in the management of CLL?",
    "answer": "They are considered before starting treatment to address potential impacts of therapy on fertility and pregnancy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A pregnancy test may be considered in the management of CLL.",
      "Fertility preservation may be considered in the management of CLL.",
      "These considerations are made before starting treatment.",
      "The purpose is to address potential impacts of therapy on fertility and pregnancy."
    ],
    "evidence_relations": [
      "Pregnancy testing and fertility preservation are considered before starting treatment",
      "In the ontology, pregnancy test and fertility preservation are listed under clinical management for CLL"
    ]
  },
  {
    "id": "Medical-03451b65",
    "source": "Medical",
    "question": "What is the recommended management for a small, noninvasive papillary thyroid carcinoma found to be less than 1 cm with no lymph node involvement?",
    "answer": "Active surveillance or lobectomy are recommended management options.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Active surveillance is a recommended management option for small, noninvasive papillary thyroid carcinoma.",
      "Lobectomy is a recommended management option for small, noninvasive papillary thyroid carcinoma."
    ],
    "evidence_relations": [
      "Active surveillance is an option for very-low-risk papillary thyroid cancers",
      "Lobectomy is an option for small, low-risk differentiated thyroid cancers",
      "Papillary thyroid carcinoma Treatment: Active surveillance (for very-low-risk, small tumors), Lobectomy (for small, noninvasive tumors 1-4 cm, no spread)"
    ]
  },
  {
    "id": "Medical-5a6b98a7",
    "source": "Medical",
    "question": "Why might symptoms of nasopharyngeal carcinoma be absent until advanced stages, and how does this affect the diagnostic process?",
    "answer": "Symptoms may be absent until advanced stage, making imaging and biopsy essential for early diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms of nasopharyngeal carcinoma may be absent until advanced stages.",
      "The absence of symptoms until advanced stages makes imaging essential for early diagnosis.",
      "The absence of symptoms until advanced stages makes biopsy essential for early diagnosis."
    ],
    "evidence_relations": [
      "Symptoms of NPC may be absent until advanced stage and can be similar to other conditions",
      "Diagnosis of NPC involves imaging (CT, MRI, PET/CT, ultrasound) and biopsy"
    ]
  },
  {
    "id": "Medical-f5089b0a",
    "source": "Medical",
    "question": "What symptoms, if present together, should prompt diagnostic testing for rectal cancer using imaging and endoscopic methods?",
    "answer": "Changes in bowel habits, rectal bleeding, and abdominal pain should prompt MRI, EUS, and colonoscopy for diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Changes in bowel habits should prompt diagnostic testing for rectal cancer.",
      "Rectal bleeding should prompt diagnostic testing for rectal cancer.",
      "Abdominal pain should prompt diagnostic testing for rectal cancer.",
      "MRI is recommended for diagnosing rectal cancer.",
      "EUS is recommended for diagnosing rectal cancer.",
      "Colonoscopy is recommended for diagnosing rectal cancer."
    ],
    "evidence_relations": [
      "Symptoms of rectal cancer may include changes in bowel habits, rectal bleeding, and abdominal pain",
      "MRI of the pelvis is recommended for staging rectal cancer",
      "Endorectal ultrasound (EUS) can assess tumor extent and guide biopsy",
      "Colonoscopy is a diagnostic method for rectal cancer"
    ]
  },
  {
    "id": "Medical-b94e5d8e",
    "source": "Medical",
    "question": "If a thyroid cancer patient develops brain and bone metastases, which treatment options should be considered?",
    "answer": "External beam radiation therapy, targeted therapy, and clinical trial participation should be considered.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "External beam radiation therapy should be considered for a thyroid cancer patient with brain and bone metastases.",
      "Targeted therapy should be considered for a thyroid cancer patient with brain and bone metastases.",
      "Clinical trial participation should be considered for a thyroid cancer patient with brain and bone metastases."
    ],
    "evidence_relations": [
      "Metastatic thyroid cancer most commonly spreads to lungs, liver, bones, brain, and spinal cord",
      "Metastasis Treatment: External beam radiation therapy, Targeted therapy, Clinical trial"
    ]
  },
  {
    "id": "Medical-4124f00f",
    "source": "Medical",
    "question": "If a patient with primary CNS lymphoma relapses in the spinal cord, which diagnostic and treatment strategies should be considered?",
    "answer": "Imaging (MRI), lumbar puncture, and possible intrathecal chemotherapy should be considered for spinal cord relapse.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging (MRI) should be considered for spinal cord relapse in primary CNS lymphoma.",
      "Lumbar puncture should be considered for spinal cord relapse in primary CNS lymphoma.",
      "Possible intrathecal chemotherapy should be considered for spinal cord relapse in primary CNS lymphoma."
    ],
    "evidence_relations": [
      "Primary CNS lymphoma can relapse in the brain, spinal cord, or eyes",
      "MRI with gadolinium contrast is the most useful imaging technique for identifying primary CNS lymphoma",
      "Intrathecal chemotherapy may be used if cancer cells are found in the cerebrospinal fluid",
      "Lumbar puncture is a diagnostic method for Primary CNS lymphoma"
    ]
  },
  {
    "id": "Medical-23e6b6df",
    "source": "Medical",
    "question": "What are the two main phases of primary CNS lymphoma treatment, and which therapies are typically administered in each?",
    "answer": "Induction phase uses high-dose methotrexate and rituximab, while consolidation phase uses whole-brain radiation therapy or stem cell rescue.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The two main phases of primary CNS lymphoma treatment are induction phase and consolidation phase.",
      "The induction phase uses high-dose methotrexate and rituximab.",
      "The consolidation phase uses whole-brain radiation therapy or stem cell rescue."
    ],
    "evidence_relations": [
      "Treatment is typically given in phases: induction and consolidation",
      "High-dose methotrexate is the main chemotherapy drug used for primary CNS lymphoma",
      "Rituximab is the main immunotherapy drug used for primary CNS lymphoma",
      "Whole-brain radiation therapy (WBRT) is the most commonly used radiation technique for primary CNS lymphoma",
      "Consolidation phase includes whole-brain radiation therapy (WBRT) and stem cell rescue"
    ]
  },
  {
    "id": "Medical-032223d5",
    "source": "Medical",
    "question": "Why might a patient with a stomach mass and positive family history undergo genetic risk testing in addition to biopsy?",
    "answer": "Because family history is a genetic risk factor and diagnosis requires both tissue confirmation and risk assessment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A patient with a stomach mass and positive family history may undergo genetic risk testing.",
      "Family history is a genetic risk factor.",
      "Diagnosis requires tissue confirmation.",
      "Diagnosis requires risk assessment."
    ],
    "evidence_relations": [
      "Family history is a risk factor for stomach cancer",
      "Diagnosis involves imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Genetic risk testing is a diagnostic method for stomach cancer (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-27281f31",
    "source": "Medical",
    "question": "If a patient develops lymph node recurrence after initial treatment for anal cancer, what are the recommended interventions?",
    "answer": "Groin dissection, chemotherapy, and radiation (if not previously given) are recommended for lymph node recurrence.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Groin dissection is recommended for lymph node recurrence after initial treatment for anal cancer.",
      "Chemotherapy is recommended for lymph node recurrence after initial treatment for anal cancer.",
      "Radiation is recommended for lymph node recurrence if not previously given after initial treatment for anal cancer."
    ],
    "evidence_relations": [
      "Lymph node recurrence: Groin dissection, chemotherapy, radiation (if not previously given)",
      "Groin dissection: Indication: Lymph node recurrence"
    ]
  },
  {
    "id": "Medical-6624a28a",
    "source": "Medical",
    "question": "How is clinical stage of throat cancer determined prior to treatment?",
    "answer": "Clinical stage is determined by physical exam, imaging, and biopsy before treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical stage of throat cancer is determined by physical exam.",
      "Clinical stage of throat cancer is determined by imaging.",
      "Clinical stage of throat cancer is determined by biopsy.",
      "Clinical stage is determined before treatment."
    ],
    "evidence_relations": [
      "Clinical stage is determined before treatment using physical exam, imaging, and biopsy",
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging"
    ]
  },
  {
    "id": "Medical-2e2c9c8e",
    "source": "Medical",
    "question": "If a rectal cancer patient has dMMR or MSI-H, what does this indicate regarding their tumor, and what testing is required?",
    "answer": "It indicates a biomarker status relevant for management, and all rectal tumors should be tested for dMMR or MSI-H.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "dMMR or MSI-H indicates a biomarker status relevant for management of rectal cancer.",
      "All rectal tumors should be tested for dMMR.",
      "All rectal tumors should be tested for MSI-H."
    ],
    "evidence_relations": [
      "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer",
      "All rectal tumors should be tested for dMMR or MSI-H"
    ]
  },
  {
    "id": "Medical-727f425f",
    "source": "Medical",
    "question": "What follow-up strategies are recommended for a patient on active surveillance for localized prostate cancer?",
    "answer": "Regular PSA testing, repeat biopsy, and imaging as indicated are recommended for active surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Regular PSA testing is recommended for a patient on active surveillance for localized prostate cancer.",
      "Repeat biopsy is recommended for a patient on active surveillance for localized prostate cancer.",
      "Imaging as indicated is recommended for a patient on active surveillance for localized prostate cancer."
    ],
    "evidence_relations": [
      "Follow-up includes regular PSA testing, imaging, and biopsies as needed",
      "Localized prostate cancer follow-up strategy includes regular PSA testing, repeat biopsy, and imaging as indicated",
      "Active surveillance is a management option for low-risk, early-stage prostate cancer"
    ]
  },
  {
    "id": "Medical-7c1c087a",
    "source": "Medical",
    "question": "How does the presence of serosa impact the potential for cancer to spread outside the gallbladder or bile duct?",
    "answer": "The serosa acts as the last anatomical barrier before cancer can spread to structures outside the organ.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The serosa acts as the last anatomical barrier.",
      "The serosa prevents cancer from spreading to structures outside the organ."
    ],
    "evidence_relations": [
      "Serosa is the outer membrane covering the gallbladder and bile ducts",
      "Cancer can invade nearby blood vessels, liver, or structures outside the liver"
    ]
  },
  {
    "id": "Medical-24373ebe",
    "source": "Medical",
    "question": "How does the disease phase of CML affect the types of blood cells present?",
    "answer": "Blast phase CML is characterized by increased blasts and progenitor cells, while chronic phase has increased mature granulocytes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blast phase CML is characterized by increased blasts.",
      "Blast phase CML is characterized by increased progenitor cells.",
      "Chronic phase CML has increased mature granulocytes."
    ],
    "evidence_relations": [
      "Blast phase CML (BP-CML) is an advanced form of CML with increased blasts",
      "Blast phase CML (BP-CML) includes myeloid progenitor cells, lymphoid progenitor cells, and blasts",
      "CML is characterized by increased white blood cells (granulocytes)"
    ]
  },
  {
    "id": "Medical-ee49f3e8",
    "source": "Medical",
    "question": "Why is surgery not typically a treatment option for Stage 4 NSCLC?",
    "answer": "Because Stage 4 NSCLC is metastatic at diagnosis, making local treatments like surgery ineffective.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 4 NSCLC is metastatic at diagnosis.",
      "Local treatments like surgery are ineffective for Stage 4 NSCLC."
    ],
    "evidence_relations": [
      "Stage 4 NSCLC is metastatic at diagnosis",
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible"
    ]
  },
  {
    "id": "Medical-f078c897",
    "source": "Medical",
    "question": "Why is the lamina propria not included in the definition of carcinoma in situ for intrahepatic bile duct cancer?",
    "answer": "Because carcinoma in situ is restricted to the epithelium, and the lamina propria is a connective tissue beneath it.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Carcinoma in situ is restricted to the epithelium.",
      "The lamina propria is a connective tissue beneath the epithelium.",
      "The lamina propria is not included in the definition of carcinoma in situ."
    ],
    "evidence_relations": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "Lamina propria is a connective tissue found under the epithelium"
    ]
  },
  {
    "id": "Medical-732c4e13",
    "source": "Medical",
    "question": "How does performance status influence treatment eligibility for glioma patients, and how is it assessed?",
    "answer": "Performance status is assessed clinically and determines eligibility for glioma treatments.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status is assessed clinically.",
      "Performance status determines eligibility for glioma treatments."
    ],
    "evidence_relations": [
      "Performance status is assessed to determine treatment eligibility",
      "Clinical Evaluation includes performance status and neurological exam"
    ]
  },
  {
    "id": "Medical-d256aef2",
    "source": "Medical",
    "question": "If a patient with nasopharyngeal carcinoma presents with enlarged lymph nodes, what does this indicate about possible disease spread and staging?",
    "answer": "Enlarged lymph nodes suggest lymph node metastasis, which is included in the TNM staging system for NPC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Enlarged lymph nodes suggest lymph node metastasis.",
      "Lymph node metastasis is included in the TNM staging system for nasopharyngeal carcinoma."
    ],
    "evidence_relations": [
      "Symptoms of NPC include enlarged lymph nodes",
      "NPC commonly spreads to lymph nodes in the neck",
      "NPC is staged using the AJCC TNM system, which includes lymph node involvement (N)"
    ]
  },
  {
    "id": "Medical-55f0c0e2",
    "source": "Medical",
    "question": "Why is actinic keratosis considered a risk factor for CSCC, and how is it managed to prevent progression?",
    "answer": "Actinic keratosis is a precancerous lesion that can progress to CSCC and is managed with photodynamic therapy, cryotherapy, or topical treatments.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Actinic keratosis is a precancerous lesion.",
      "Actinic keratosis can progress to CSCC.",
      "Actinic keratosis is managed with photodynamic therapy.",
      "Actinic keratosis is managed with cryotherapy.",
      "Actinic keratosis is managed with topical treatments."
    ],
    "evidence_relations": [
      "Actinic keratosis is a precancerous lesion that can progress to CSCC",
      "Photodynamic therapy, cryotherapy, and topical therapies (5-fluorouracil, imiquimod, tirbanibulin) are used for actinic keratoses and superficial CSCC"
    ]
  },
  {
    "id": "Medical-0d237b40",
    "source": "Medical",
    "question": "Which metastatic sites are most common in nasopharyngeal carcinoma and how is this reflected in the ontology?",
    "answer": "Lymph node and lung are the most common metastatic sites for NPC, as indicated in the ontology.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lymph node is a common metastatic site for nasopharyngeal carcinoma (NPC).",
      "Lung is a common metastatic site for nasopharyngeal carcinoma (NPC).",
      "The ontology indicates lymph node and lung as common metastatic sites for NPC."
    ],
    "evidence_relations": [
      "NPC commonly spreads to lymph nodes in the neck and less frequently to the lungs",
      "Metastasis in the ontology for NPC includes lymph node and lung"
    ]
  },
  {
    "id": "Medical-f4972c91",
    "source": "Medical",
    "question": "Which treatments are used for metastatic differentiated thyroid cancer that is iodine-avid and which are considered if the disease is not iodine-avid?",
    "answer": "RAI therapy is used for iodine-avid disease, while targeted therapy and external beam radiation therapy are used if the disease is not iodine-avid.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "RAI therapy is used for iodine-avid metastatic differentiated thyroid cancer.",
      "Targeted therapy is used for metastatic differentiated thyroid cancer that is not iodine-avid.",
      "External beam radiation therapy is used for metastatic differentiated thyroid cancer that is not iodine-avid."
    ],
    "evidence_relations": [
      "RAI therapy is used after total thyroidectomy for differentiated thyroid cancers that take up iodine",
      "Targeted therapy (kinase inhibitors) is used for cancers not responsive to surgery or RAI, or with metastasis",
      "Stage Distant metastasis Treatment: RAI therapy (if iodine-avid), Targeted therapy, External beam radiation therapy"
    ]
  },
  {
    "id": "Medical-f79d978d",
    "source": "Medical",
    "question": "How does the presence of a lung nodule on imaging affect the diagnostic workflow for lung cancer?",
    "answer": "A lung nodule detected by imaging prompts further assessment, including biopsy, to confirm or exclude cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A lung nodule detected by imaging prompts further assessment.",
      "Further assessment of a lung nodule includes a biopsy.",
      "A biopsy is performed to confirm or exclude cancer in the presence of a lung nodule."
    ],
    "evidence_relations": [
      "Lung nodules may be detected by imaging and require further assessment to determine malignancy",
      "Biopsy is used to confirm lung cancer diagnosis"
    ]
  },
  {
    "id": "Medical-82f4c628",
    "source": "Medical",
    "question": "How does the disease site differ between B-cell lymphoblastic lymphoma and T-cell lymphoblastic lymphoma, and what does this imply for clinical presentation?",
    "answer": "B-cell lymphoblastic lymphoma mainly affects lymph nodes, while T-cell lymphoblastic lymphoma primarily involves the thymus, affecting clinical symptoms.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "B-cell lymphoblastic lymphoma mainly affects lymph nodes.",
      "T-cell lymphoblastic lymphoma primarily involves the thymus.",
      "The disease site affects clinical symptoms."
    ],
    "evidence_relations": [
      "B-cell lymphoblastic lymphoma (B-LL/B-LBL) occurs when B-cell lymphoblasts grow mostly in lymph nodes",
      "T-cell lymphoblastic lymphoma (T-LL/T-LBL) occurs when T-cell lymphoblasts grow mostly in the thymus"
    ]
  },
  {
    "id": "Medical-648df362",
    "source": "Medical",
    "question": "What distinguishes Wilms tumor from other kidney cancer subtypes in terms of patient population and classification?",
    "answer": "Wilms tumor is a distinct kidney cancer type that usually occurs in young children, unlike other subtypes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Wilms tumor is a distinct type of kidney cancer.",
      "Wilms tumor usually occurs in young children.",
      "Wilms tumor is different from other kidney cancer subtypes."
    ],
    "evidence_relations": [
      "Wilms tumor usually occurs in young children and is a distinct kidney cancer type",
      "Wilms tumor (nephroblastoma) is listed as a separate subtype under Cancer Type: Kidney cancer in the ontology"
    ]
  },
  {
    "id": "Medical-95283550",
    "source": "Medical",
    "question": "Which metastatic anal cancer patients are eligible for immunotherapy, and which drugs are recommended in this setting?",
    "answer": "Patients with metastatic anal cancer that progresses after chemotherapy are eligible for immunotherapy with nivolumab or pembrolizumab.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Patients with metastatic anal cancer that progresses after chemotherapy are eligible for immunotherapy.",
      "Nivolumab is a recommended drug for immunotherapy in metastatic anal cancer.",
      "Pembrolizumab is a recommended drug for immunotherapy in metastatic anal cancer."
    ],
    "evidence_relations": [
      "Immunotherapy (nivolumab, pembrolizumab) is recommended for metastatic anal cancer that progresses after chemotherapy",
      "Metastatic (Stage IV): Immunotherapy: Nivolumab, Pembrolizumab"
    ]
  },
  {
    "id": "Medical-daeae948",
    "source": "Medical",
    "question": "What are the most common and less common subtypes of RCC, and how are they organized?",
    "answer": "Clear cell RCC is the most common subtype, while non-clear cell RCC includes papillary, chromophobe, collecting duct RCC, and renal medullary carcinoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clear cell RCC is the most common subtype of RCC.",
      "Non-clear cell RCC includes several subtypes.",
      "Papillary RCC is a subtype of non-clear cell RCC.",
      "Chromophobe RCC is a subtype of non-clear cell RCC.",
      "Collecting duct RCC is a subtype of non-clear cell RCC.",
      "Renal medullary carcinoma is a subtype of non-clear cell RCC."
    ],
    "evidence_relations": [
      "Clear cell RCC is the most common subtype of RCC",
      "Non-clear cell RCC includes papillary RCC, chromophobe RCC, collecting duct RCC, and renal medullary carcinoma",
      "Clear cell RCC (ccRCC) and Non-clear cell RCC (nccRCC) with its subtypes are listed under Histology for RCC in the ontology"
    ]
  },
  {
    "id": "Medical-fbc9e7ec",
    "source": "Medical",
    "question": "What supportive care measures are recommended at any stage for primary CNS lymphoma patients experiencing severe side effects from treatment?",
    "answer": "Symptom management, palliative care, and quality of life interventions are recommended at any disease stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptom management is recommended for primary CNS lymphoma patients experiencing severe side effects from treatment.",
      "Palliative care is recommended for primary CNS lymphoma patients experiencing severe side effects from treatment.",
      "Quality of life interventions are recommended for primary CNS lymphoma patients experiencing severe side effects from treatment."
    ],
    "evidence_relations": [
      "Supportive care is provided to relieve symptoms and side effects at any stage of disease",
      "Supportive Care for Primary CNS lymphoma includes Symptom management, Palliative care, Quality of life interventions"
    ]
  },
  {
    "id": "Medical-18263083",
    "source": "Medical",
    "question": "Which risk factors should be considered when assessing a patient's likelihood of developing bladder cancer?",
    "answer": "Smoking, secondhand smoke, age, family history, Lynch syndrome, and chemical exposure should be considered.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Smoking is a risk factor for developing bladder cancer.",
      "Secondhand smoke is a risk factor for developing bladder cancer.",
      "Age is a risk factor for developing bladder cancer.",
      "Family history is a risk factor for developing bladder cancer.",
      "Lynch syndrome is a risk factor for developing bladder cancer.",
      "Chemical exposure is a risk factor for developing bladder cancer."
    ],
    "evidence_relations": [
      "Smoking is the greatest risk factor for bladder cancer",
      "Other risk factors include age, family history, Lynch syndrome, and chemical exposure"
    ]
  },
  {
    "id": "Medical-2529e505",
    "source": "Medical",
    "question": "What distinguishes cutaneous B-cell lymphoma from cutaneous T-cell lymphoma in terms of cell of origin and cancer subtype?",
    "answer": "CBCL originates from B lymphocytes and includes subtypes like PCMZL, PCFCL, and PC-DLBCL leg type, while CTCL originates from T lymphocytes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cutaneous B-cell lymphoma originates from B lymphocytes.",
      "Cutaneous B-cell lymphoma includes subtypes like PCMZL, PCFCL, and PC-DLBCL leg type.",
      "Cutaneous T-cell lymphoma originates from T lymphocytes."
    ],
    "evidence_relations": [
      "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
      "CBCL subtypes include primary cutaneous marginal zone lymphoma (PCMZL), primary cutaneous follicle center lymphoma (PCFCL), and primary cutaneous diffuse large B-cell lymphoma, leg type (PC-DLBCL, leg type)",
      "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
    ]
  },
  {
    "id": "Medical-213bbcca",
    "source": "Medical",
    "question": "What are the main histological subtypes of cervical cancer and how do their frequencies compare?",
    "answer": "Squamous cell carcinoma is the most common, while adenocarcinoma, adenosquamous carcinoma, and NECC are less common or rare.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Squamous cell carcinoma is the most common histological subtype of cervical cancer.",
      "Adenocarcinoma is less common than squamous cell carcinoma.",
      "Adenosquamous carcinoma is less common than squamous cell carcinoma.",
      "NECC is rare compared to squamous cell carcinoma."
    ],
    "evidence_relations": [
      "Squamous cell carcinoma is the most common subtype of cervical cancer",
      "Adenocarcinoma and adenosquamous carcinoma are less common subtypes",
      "Neuroendocrine carcinoma of the cervix (NECC) is a rare and aggressive subtype",
      "The ontology lists these as subtypes under cervical cancer"
    ]
  },
  {
    "id": "Medical-30e7caf0",
    "source": "Medical",
    "question": "Which diagnostic methods are required to confirm throat cancer and determine its biomarkers?",
    "answer": "Imaging studies and biopsy are required for diagnosis, and biopsy enables biomarker testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging studies are required to confirm throat cancer.",
      "A biopsy is required to confirm throat cancer.",
      "A biopsy enables biomarker testing."
    ],
    "evidence_relations": [
      "Imaging studies such as CT scan, MRI, PET/CT, and ultrasound are used for diagnosis and staging",
      "Biopsy is required for definitive diagnosis and biomarker testing"
    ]
  },
  {
    "id": "Medical-a7fb4f11",
    "source": "Medical",
    "question": "How does the management plan for CLL change if a patient develops Richter transformation?",
    "answer": "Richter transformation requires a shift to therapies targeting aggressive lymphomas such as DLBCL or Hodgkin lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Richter transformation requires a shift to therapies targeting aggressive lymphomas.",
      "Therapies targeting DLBCL are required for Richter transformation.",
      "Therapies targeting Hodgkin lymphoma are required for Richter transformation."
    ],
    "evidence_relations": [
      "Richter transformation is a complication where CLL transforms into a more aggressive lymphoma such as DLBCL or Hodgkin lymphoma",
      "In the ontology, Richter transformation is a complication of CLL with subtypes DLBCL and Hodgkin lymphoma"
    ]
  },
  {
    "id": "Medical-0a90f1f2",
    "source": "Medical",
    "question": "How does the management of recurrent basal cell carcinoma differ from initial treatment, and what factors influence this?",
    "answer": "Management of recurrence depends on risk and recurrence site, with treatment options tailored accordingly.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Management of recurrent basal cell carcinoma depends on risk.",
      "Management of recurrent basal cell carcinoma depends on the recurrence site.",
      "Treatment options for recurrent basal cell carcinoma are tailored accordingly."
    ],
    "evidence_relations": [
      "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites",
      "Management of recurrence involves treatment options based on risk and recurrence",
      "Surgery is the most common treatment for BCC"
    ]
  },
  {
    "id": "Medical-4e5d3831",
    "source": "Medical",
    "question": "What role does imaging play in the diagnosis and surveillance of ovarian cancer?",
    "answer": "Imaging is used for initial diagnosis (ultrasound, CT, MRI, PET) and for surveillance as indicated after treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Imaging is used for the initial diagnosis of ovarian cancer.",
      "Ultrasound is used for the initial diagnosis of ovarian cancer.",
      "CT is used for the initial diagnosis of ovarian cancer.",
      "MRI is used for the initial diagnosis of ovarian cancer.",
      "PET is used for the initial diagnosis of ovarian cancer.",
      "Imaging is used for surveillance after treatment as indicated."
    ],
    "evidence_relations": [
      "Diagnosis of ovarian cancer involves imaging (ultrasound, CT, MRI, PET)",
      "Surveillance after treatment includes regular physical and pelvic exams, and monitoring of CA-125 or other tumor markers, and imaging as indicated",
      "The ontology lists imaging modalities under diagnostic methods and surveillance"
    ]
  },
  {
    "id": "Medical-321f2f6d",
    "source": "Medical",
    "question": "What staging system is used for throat cancer, and which parameters does it incorporate?",
    "answer": "The AJCC TNM system is used, incorporating tumor size (T), lymph node involvement (N), and metastasis (M).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The AJCC TNM system is used for throat cancer staging.",
      "The AJCC TNM system incorporates tumor size (T).",
      "The AJCC TNM system incorporates lymph node involvement (N).",
      "The AJCC TNM system incorporates metastasis (M)."
    ],
    "evidence_relations": [
      "Cancer staging uses the AJCC TNM system, incorporating tumor size (T), lymph node involvement (N), and metastasis (M)",
      "AJCC TNM staging includes Tis, T1, T2, T3, T4a, and T4b for tumor classification"
    ]
  },
  {
    "id": "Medical-50fe4cfa",
    "source": "Medical",
    "question": "Why should all rectal tumors be tested for mismatch repair deficiency or microsatellite instability-high, especially in patients with Lynch syndrome?",
    "answer": "Because dMMR/MSI-H are biomarkers for rectal cancer and Lynch syndrome is a genetic risk factor, making testing essential for management.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "All rectal tumors should be tested for mismatch repair deficiency or microsatellite instability-high.",
      "dMMR/MSI-H are biomarkers for rectal cancer.",
      "Lynch syndrome is a genetic risk factor for rectal cancer.",
      "Testing for dMMR/MSI-H is essential for management in patients with Lynch syndrome."
    ],
    "evidence_relations": [
      "All rectal tumors should be tested for dMMR or MSI-H",
      "Mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H) are biomarkers in rectal cancer",
      "Lynch syndrome is a genetic risk factor for rectal cancer"
    ]
  },
  {
    "id": "Medical-ec0be6f4",
    "source": "Medical",
    "question": "How is the treatment approach different for a patient with Stage III anal cancer compared to one with Stage IV disease?",
    "answer": "Stage III is treated with chemoradiation while Stage IV requires systemic chemotherapy and possibly immunotherapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage III anal cancer is treated with chemoradiation.",
      "Stage IV anal cancer requires systemic chemotherapy.",
      "Stage IV anal cancer may require immunotherapy."
    ],
    "evidence_relations": [
      "Chemoradiation is the recommended primary treatment for most non-metastatic anal cancers (stages I-III)",
      "Metastatic anal cancer is treated with systemic chemotherapy (e.g., carboplatin and paclitaxel, FOLFOX, FOLFCIS, DCF, 5-FU and cisplatin)",
      "Immunotherapy (nivolumab, pembrolizumab) is recommended for metastatic anal cancer that progresses after chemotherapy"
    ]
  },
  {
    "id": "Medical-ac502742",
    "source": "Medical",
    "question": "How can PD-L1 expression influence the treatment of throat cancer?",
    "answer": "PD-L1 expression may guide immunotherapy treatment decisions in throat cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PD-L1 expression may guide immunotherapy treatment decisions in throat cancer."
    ],
    "evidence_relations": [
      "PD-L1 expression may guide immunotherapy treatment decisions",
      "Biomarker testing includes PD-L1"
    ]
  },
  {
    "id": "Medical-79d13dd8",
    "source": "Medical",
    "question": "What follow-up and surveillance methods are recommended after initial treatment of non–muscle-invasive bladder cancer?",
    "answer": "Regular cystoscopy, urine cytology, imaging, and biomarker surveillance are recommended for follow-up after non–muscle-invasive bladder cancer treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Regular cystoscopy is recommended for follow-up after non-muscle-invasive bladder cancer treatment.",
      "Urine cytology is recommended for follow-up after non-muscle-invasive bladder cancer treatment.",
      "Imaging is recommended for follow-up after non-muscle-invasive bladder cancer treatment.",
      "Biomarker surveillance is recommended for follow-up after non-muscle-invasive bladder cancer treatment."
    ],
    "evidence_relations": [
      "Follow-up and surveillance are required due to high recurrence rates",
      "Biomarker tests may be used for surveillance in non–muscle-invasive bladder cancer",
      "Follow-up/Surveillance includes regular cystoscopy, urine cytology, imaging, and biomarker surveillance"
    ]
  },
  {
    "id": "Medical-ee644399",
    "source": "Medical",
    "question": "Why is lobectomy preferred over total thyroidectomy for some small, low-risk differentiated thyroid cancers?",
    "answer": "Lobectomy is preferred because it is sufficient for small, noninvasive tumors and avoids the need for lifelong thyroid hormone replacement.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Lobectomy is preferred over total thyroidectomy for some small, low-risk differentiated thyroid cancers.",
      "Lobectomy is sufficient for small, noninvasive tumors.",
      "Lobectomy avoids the need for lifelong thyroid hormone replacement."
    ],
    "evidence_relations": [
      "Lobectomy is an option for small, low-risk differentiated thyroid cancers",
      "Total thyroidectomy is recommended for larger, invasive, or high-risk cancers",
      "Thyroid hormone replacement therapy is required after total thyroidectomy"
    ]
  },
  {
    "id": "Medical-31580ac0",
    "source": "Medical",
    "question": "Which liver cancer subtype is most likely to be found in younger patients, and what are the main risk factors for its parent cancer type?",
    "answer": "Fibrolamellar hepatocellular carcinoma (FLHC) is found in younger patients, and its parent type, HCC, is mainly associated with cirrhosis, hepatitis B, and hepatitis C.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fibrolamellar hepatocellular carcinoma (FLHC) is found in younger patients.",
      "The parent type of FLHC is hepatocellular carcinoma (HCC).",
      "Cirrhosis is a main risk factor for HCC.",
      "Hepatitis B is a main risk factor for HCC.",
      "Hepatitis C is a main risk factor for HCC."
    ],
    "evidence_relations": [
      "Fibrolamellar hepatocellular carcinoma (FLHC) is a subtype of HCC that occurs at a younger age",
      "Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer",
      "Cirrhosis is a major risk factor for developing liver cancer",
      "Chronic hepatitis B infection increases the risk of liver cancer",
      "Chronic hepatitis C infection increases the risk of liver cancer"
    ]
  },
  {
    "id": "Medical-fd4cca6e",
    "source": "Medical",
    "question": "When is local excision considered as a treatment option in anal cancer, and what are the tumor characteristics that support this choice?",
    "answer": "Local excision is considered for early-stage, low-grade perianal cancers.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Local excision is considered for early-stage perianal cancers.",
      "Local excision is considered for low-grade perianal cancers."
    ],
    "evidence_relations": [
      "Local excision is an option for some early-stage, low-grade perianal cancers",
      "Anal cancer can start in the anal canal or perianal region"
    ]
  },
  {
    "id": "Medical-0e57f27f",
    "source": "Medical",
    "question": "When should a clinical trial be considered for a thyroid cancer patient, and what disease characteristics warrant this recommendation?",
    "answer": "Clinical trials are recommended for patients with advanced or metastatic thyroid cancer, especially when standard treatments are ineffective.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are recommended for patients with advanced thyroid cancer.",
      "Clinical trials are recommended for patients with metastatic thyroid cancer.",
      "Clinical trials are recommended when standard treatments are ineffective."
    ],
    "evidence_relations": [
      "Clinical trials are recommended for patients with advanced or metastatic thyroid cancer",
      "Metastasis Treatment: Clinical trial"
    ]
  },
  {
    "id": "Medical-3aa8a2c6",
    "source": "Medical",
    "question": "How does the site of disease involvement influence the presentation of follicular lymphoma symptoms?",
    "answer": "Involvement of lymph nodes, spleen, and bone marrow leads to symptoms such as swollen lymph nodes, enlarged spleen, and B symptoms.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Involvement of lymph nodes leads to symptoms of follicular lymphoma.",
      "Involvement of the spleen leads to symptoms of follicular lymphoma.",
      "Involvement of bone marrow leads to symptoms of follicular lymphoma.",
      "Symptoms of follicular lymphoma include swollen lymph nodes, enlarged spleen, and B symptoms."
    ],
    "evidence_relations": [
      "Disease Site of FL includes lymph node, bone marrow, spleen, extranodal sites",
      "Symptoms of FL include swollen lymph nodes, enlarged spleen, fever, night sweats, fatigue, and weight loss (B symptoms)"
    ]
  },
  {
    "id": "Medical-25c17c3d",
    "source": "Medical",
    "question": "What treatments are recommended for advanced or metastatic pancreatic ductal adenocarcinoma?",
    "answer": "Drug treatment, clinical trials, and supportive care are recommended for advanced or metastatic pancreatic ductal adenocarcinoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Drug treatment is recommended for advanced or metastatic pancreatic ductal adenocarcinoma.",
      "Clinical trials are recommended for advanced or metastatic pancreatic ductal adenocarcinoma.",
      "Supportive care is recommended for advanced or metastatic pancreatic ductal adenocarcinoma."
    ],
    "evidence_relations": [
      "Drug treatment is most often used to control growth and reduce symptoms in pancreatic cancer",
      "Stage IV pancreatic cancer is metastatic cancer",
      "Drug treatment: All stages, especially advanced; Clinical trial: All stages; Supportive care: All stages (ontology, rewritten: Drug treatment, clinical trials, and supportive care are recommended for all stages, especially advanced pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-ce7076ea",
    "source": "Medical",
    "question": "Why is a comprehensive metabolic panel and assessment of performance status important before starting CLL treatment?",
    "answer": "These assessments help guide treatment planning and ensure patient suitability for specific therapies.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A comprehensive metabolic panel is important before starting CLL treatment.",
      "Assessment of performance status is important before starting CLL treatment.",
      "These assessments help guide treatment planning.",
      "These assessments ensure patient suitability for specific therapies."
    ],
    "evidence_relations": [
      "Performance status and comprehensive metabolic panel are used in treatment planning",
      "In the ontology, performance status and comprehensive metabolic panel are listed under clinical management and diagnostic methods for CLL"
    ]
  },
  {
    "id": "Medical-322bb52d",
    "source": "Medical",
    "question": "How do medical and family history contribute to the diagnostic process for BCC in a patient with a suspicious skin lesion?",
    "answer": "Both are part of the diagnostic workup to assess risk and guide further testing like biopsy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Medical history contributes to the diagnostic process for BCC.",
      "Family history contributes to the diagnostic process for BCC.",
      "Medical and family history are part of the diagnostic workup.",
      "The diagnostic workup assesses risk for BCC.",
      "The diagnostic workup guides further testing like biopsy."
    ],
    "evidence_relations": [
      "Diagnosis of BCC involves medical and family history, physical exam, skin exam, biopsy",
      "History of skin cancer or family history increases risk of BCC"
    ]
  },
  {
    "id": "Medical-c22fc609",
    "source": "Medical",
    "question": "Why must both performance status and nutritional assessment be included in the diagnostic workup for esophageal cancer?",
    "answer": "Both are required to assess patient suitability for treatment and are listed as diagnostic methods.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status must be included in the diagnostic workup for esophageal cancer.",
      "Nutritional assessment must be included in the diagnostic workup for esophageal cancer.",
      "Both performance status and nutritional assessment are required to assess patient suitability for treatment.",
      "Performance status and nutritional assessment are listed as diagnostic methods."
    ],
    "evidence_relations": [
      "Diagnosis involves blood tests, imaging tests, endoscopy, biopsy, biomarker testing, and genetic risk testing",
      "Nutritional assessment and performance status are diagnostic methods for esophageal cancer"
    ]
  },
  {
    "id": "Medical-0125ebb1",
    "source": "Medical",
    "question": "How do Gleason score and Grade Group contribute to the management of prostate cancer?",
    "answer": "They estimate cancer aggressiveness and help assign risk groups that guide prognosis and treatment decisions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Gleason score estimates cancer aggressiveness.",
      "Grade Group estimates cancer aggressiveness.",
      "Gleason score and Grade Group help assign risk groups.",
      "Risk groups guide prognosis in prostate cancer.",
      "Risk groups guide treatment decisions in prostate cancer."
    ],
    "evidence_relations": [
      "Gleason score and Grade Group are used to estimate cancer aggressiveness",
      "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment",
      "Biomarkers for prostate cancer include Gleason score and Grade Group"
    ]
  },
  {
    "id": "Medical-34a70628",
    "source": "Medical",
    "question": "Which population is most at risk for developing mediastinal gray zone lymphoma based on epidemiology?",
    "answer": "Individuals aged 20 to 40 years assigned male at birth are most at risk for MGZL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Individuals aged 20 to 40 years assigned male at birth are most at risk for MGZL."
    ],
    "evidence_relations": [
      "MGZL commonly affects individuals aged 20 to 40 years, assigned male at birth",
      "Epidemiology of MGZL includes Age 20-40 years and Assigned male at birth"
    ]
  },
  {
    "id": "Medical-56e2a338",
    "source": "Medical",
    "question": "If a stomach cancer is found to be confined to the mucosa and there is no lymph node involvement, what is the stage and which stomach wall layer is affected?",
    "answer": "It is early-stage stomach cancer, affecting only the mucosa.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The cancer is classified as early-stage stomach cancer.",
      "The cancer is confined to the mucosa.",
      "There is no lymph node involvement."
    ],
    "evidence_relations": [
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes",
      "Early-stage stomach cancer: Confined to mucosa, not in lymph nodes (ontology rewritten)",
      "Mucosa is the innermost layer of the stomach wall (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-ad0cc053",
    "source": "Medical",
    "question": "If a nasopharyngeal carcinoma patient has both high EBV DNA levels and poor performance status, what does this indicate about their prognosis?",
    "answer": "High EBV DNA levels and poor performance status are both poor prognostic factors in NPC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High EBV DNA levels are a poor prognostic factor in nasopharyngeal carcinoma (NPC).",
      "Poor performance status is a poor prognostic factor in nasopharyngeal carcinoma (NPC)."
    ],
    "evidence_relations": [
      "EBV DNA level is a prognostic factor",
      "Performance status is a prognostic factor",
      "Biomarker testing for NPC includes EBV DNA"
    ]
  },
  {
    "id": "Medical-ee302181",
    "source": "Medical",
    "question": "Why is it important to perform both flow cytometry and molecular testing in newly diagnosed AML?",
    "answer": "Both tests are essential to identify cell surface markers and genetic alterations for accurate classification and treatment guidance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Flow cytometry is essential in newly diagnosed AML.",
      "Molecular testing is essential in newly diagnosed AML.",
      "Flow cytometry identifies cell surface markers in AML.",
      "Molecular testing identifies genetic alterations in AML.",
      "Both tests provide accurate classification and treatment guidance for AML."
    ],
    "evidence_relations": [
      "Diagnosis of AML involves blood tests, bone marrow aspirate and biopsy, flow cytometry, immunophenotyping, cytogenetic and molecular testing, and imaging studies",
      "Genetic and biomarker tests are used to determine AML subtype and guide treatment"
    ]
  },
  {
    "id": "Medical-c8dd3e29",
    "source": "Medical",
    "question": "How do immune suppression and prior radiation therapy interact to affect BCC risk and management?",
    "answer": "Both are risk factors that increase BCC risk and may necessitate more aggressive management.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Immune suppression is a risk factor that increases basal cell carcinoma risk.",
      "Prior radiation therapy is a risk factor that increases basal cell carcinoma risk.",
      "Both factors may necessitate more aggressive management of basal cell carcinoma."
    ],
    "evidence_relations": [
      "Radiation therapy and immune suppression are risk factors for BCC",
      "Management of recurrence involves treatment options based on risk and recurrence"
    ]
  },
  {
    "id": "Medical-a0c1c9cd",
    "source": "Medical",
    "question": "Why is the anatomical knowledge of layers like lamina propria and muscularis important for understanding tumor invasion in bile duct cancer?",
    "answer": "Because the depth of tumor invasion into these layers determines the cancer stage and treatment approach.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The depth of tumor invasion into anatomical layers determines the cancer stage.",
      "The depth of tumor invasion into anatomical layers affects the treatment approach."
    ],
    "evidence_relations": [
      "Bile duct cancer staging is based on tumor size and extent of spread",
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa"
    ]
  },
  {
    "id": "Medical-1852bc75",
    "source": "Medical",
    "question": "What is the rationale for using both oral medications and IV infusions in the treatment of CLL?",
    "answer": "Combination therapy using oral and IV drugs may be required for optimal disease control based on disease progression and patient factors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Combination therapy using oral medications and IV infusions may be required for CLL treatment.",
      "Optimal disease control may require both oral and IV drugs.",
      "The need for combination therapy is based on disease progression.",
      "The need for combination therapy is based on patient factors."
    ],
    "evidence_relations": [
      "Treatment options include oral medications, IV infusions, and combination therapies",
      "Treatment for CLL/SLL may not be needed immediately and is based on symptoms, blood counts, and disease progression"
    ]
  },
  {
    "id": "Medical-e1ef9e9b",
    "source": "Medical",
    "question": "If a patient presents with enlarged lymph nodes and the diagnosis is B-cell lymphoblastic lymphoma, what does this indicate about the disease site and cell of origin?",
    "answer": "It indicates that B-cell lymphoblasts are primarily growing in lymph nodes and originate from lymphoid progenitor cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "B-cell lymphoblasts are primarily growing in lymph nodes.",
      "B-cell lymphoblasts originate from lymphoid progenitor cells."
    ],
    "evidence_relations": [
      "B-cell lymphoblastic lymphoma (B-LL/B-LBL) occurs when B-cell lymphoblasts grow mostly in lymph nodes",
      "ALL arises from lymphoid progenitor cells"
    ]
  },
  {
    "id": "Medical-370cff35",
    "source": "Medical",
    "question": "How does stomach cancer typically progress from a precancerous state to metastatic disease?",
    "answer": "It begins with mucosal changes, spreads outward through stomach wall layers, and eventually reaches distant organs like the liver.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stomach cancer typically progresses from a precancerous state to metastatic disease.",
      "Stomach cancer begins with mucosal changes.",
      "Stomach cancer spreads outward through stomach wall layers.",
      "Stomach cancer eventually reaches distant organs like the liver."
    ],
    "evidence_relations": [
      "Precancerous changes often occur in the mucosa before cancer develops",
      "Stomach cancer spreads outward through the layers of the stomach wall",
      "Metastatic stomach cancer has spread to distant organs such as the liver, peritoneum, or distant lymph nodes"
    ]
  },
  {
    "id": "Medical-0030eab4",
    "source": "Medical",
    "question": "What combination of cell types is used to determine the grade of follicular lymphoma and how does this affect management?",
    "answer": "The proportion of centrocytes and centroblasts determines the grade, which guides treatment decisions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The proportion of centrocytes determines the grade of follicular lymphoma.",
      "The proportion of centroblasts determines the grade of follicular lymphoma.",
      "The grade of follicular lymphoma guides treatment decisions."
    ],
    "evidence_relations": [
      "FL is graded based on the proportion of centrocytes and centroblasts",
      "The type of cells in FL determines the grade, which guides treatment decisions",
      "Grade 1 and 2 FL have both centrocytes and centroblasts, while grade 3B has only centroblasts"
    ]
  },
  {
    "id": "Medical-58981bbb",
    "source": "Medical",
    "question": "What combination of cell type and clinical presentation would suggest a diagnosis of cutaneous B-cell lymphoma rather than T-cell lymphoma?",
    "answer": "A neoplasm originating from B lymphocytes presenting as nodules or papules under the skin suggests cutaneous B-cell lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A neoplasm originating from B lymphocytes suggests cutaneous B-cell lymphoma.",
      "Nodules or papules under the skin suggest cutaneous B-cell lymphoma."
    ],
    "evidence_relations": [
      "CBCL starts in B cells",
      "CBCL appears as nodules or papules under the skin",
      "Cutaneous T-cell lymphoma (CTCL) develops from abnormal T cells"
    ]
  },
  {
    "id": "Medical-48843076",
    "source": "Medical",
    "question": "How does the location and stage of a mouth tumor influence treatment planning?",
    "answer": "Treatment planning is based on both tumor location and stage.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment planning is based on tumor location.",
      "Treatment planning is based on tumor stage."
    ],
    "evidence_relations": [
      "Treatment planning is based on tumor location and stage",
      "Stage and anatomic site are both specified under SCC in the ontology"
    ]
  },
  {
    "id": "Medical-7718481e",
    "source": "Medical",
    "question": "If imaging and biochemical tests reveal an adrenal mass with excess aldosterone, what is the most probable diagnosis?",
    "answer": "Aldosteronoma is the most probable diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Aldosteronoma is the most probable diagnosis if there is an adrenal mass with excess aldosterone."
    ],
    "evidence_relations": [
      "Aldosteronoma produces excess aldosterone",
      "Imaging tests for adrenal tumors include CT scan, MRI scan, PET scan, FDG-PET/CT, and SSTR-PET/CT",
      "Blood and biochemical tests are used to detect hormone secretion by adrenal tumors"
    ]
  },
  {
    "id": "Medical-26ced7a1",
    "source": "Medical",
    "question": "How are endoscopic and surgical options distinguished for early-stage rectal tumors?",
    "answer": "Endoscopic methods like ESD and EMR are used for T1 tumors, while transabdominal surgery is used for T2 and some T1/T3 tumors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Endoscopic methods like ESD are used for T1 tumors.",
      "Endoscopic methods like EMR are used for T1 tumors.",
      "Transabdominal surgery is used for T2 tumors.",
      "Transabdominal surgery is used for some T1/T3 tumors."
    ],
    "evidence_relations": [
      "Endoscopic submucosal dissection (ESD) is recommended for T1 rectal tumors",
      "Transabdominal surgery is recommended for T2 and some T1/T3 tumors"
    ]
  },
  {
    "id": "Medical-e9900b5c",
    "source": "Medical",
    "question": "Why is androgen deprivation therapy a key component in the management of metastatic prostate cancer?",
    "answer": "Because ADT is a mainstay for advanced disease and is included among treatments for metastatic prostate cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Androgen deprivation therapy (ADT) is a mainstay for advanced prostate cancer.",
      "ADT is included among treatments for metastatic prostate cancer."
    ],
    "evidence_relations": [
      "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment",
      "Metastatic prostate cancer treatment includes ADT"
    ]
  },
  {
    "id": "Medical-f034d77d",
    "source": "Medical",
    "question": "How does UV radiation contribute to both the development and recurrence of basal cell carcinoma?",
    "answer": "UV radiation is a primary risk factor for BCC and continued exposure increases recurrence risk.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "UV radiation is a primary risk factor for basal cell carcinoma.",
      "Continued exposure to UV radiation increases the risk of recurrence of basal cell carcinoma."
    ],
    "evidence_relations": [
      "UV radiation exposure is a primary risk factor for BCC",
      "Recurrence refers to BCC returning to the original site or spreading",
      "Basal cell carcinoma risk factors include UV radiation"
    ]
  },
  {
    "id": "Medical-aa1b8dbb",
    "source": "Medical",
    "question": "How does a patient's performance status influence nasopharyngeal carcinoma treatment planning?",
    "answer": "Performance status is assessed and considered in NPC treatment planning as a prognostic factor.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status is assessed in nasopharyngeal carcinoma treatment planning.",
      "Performance status is considered in nasopharyngeal carcinoma treatment planning.",
      "Performance status is a prognostic factor in nasopharyngeal carcinoma treatment planning."
    ],
    "evidence_relations": [
      "Performance status is considered in NPC treatment planning",
      "Performance status evaluation is a diagnostic method for NPC",
      "Performance status is a prognostic factor for NPC"
    ]
  },
  {
    "id": "Medical-4191d4b2",
    "source": "Medical",
    "question": "Which two diagnostic methods are essential for both initial detection and definitive classification of glioma?",
    "answer": "MRI is essential for initial detection and biopsy for definitive classification of glioma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "MRI is essential for the initial detection of glioma.",
      "Biopsy is essential for the definitive classification of glioma."
    ],
    "evidence_relations": [
      "MRI is the most useful imaging test for identifying glioma",
      "Biopsy is required for definitive diagnosis and molecular testing"
    ]
  },
  {
    "id": "Medical-04e9f25b",
    "source": "Medical",
    "question": "Which imaging modalities are used both for staging and surveillance in cervical cancer management?",
    "answer": "CT scan, MRI, PET/CT, and transvaginal ultrasound are used for staging and can be used for surveillance imaging as indicated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "CT scan is used for staging and surveillance in cervical cancer management.",
      "MRI is used for staging and surveillance in cervical cancer management.",
      "PET/CT is used for staging and surveillance in cervical cancer management.",
      "Transvaginal ultrasound is used for staging and can be used for surveillance imaging."
    ],
    "evidence_relations": [
      "Imaging methods such as CT, MRI, PET/CT, and transvaginal ultrasound are used for staging and assessment",
      "Surveillance after treatment includes regular physical exams and imaging as indicated",
      "CT scan, MRI, PET/CT, and transvaginal ultrasound are listed as imaging diagnostic methods in the ontology"
    ]
  },
  {
    "id": "Medical-b016ff7a",
    "source": "Medical",
    "question": "Why is depth of invasion (DOI) important in the TNM staging of mouth cancer?",
    "answer": "DOI is used to assess tumor extension and is a criterion in T classification for staging.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Depth of invasion (DOI) is used to assess tumor extension.",
      "Depth of invasion (DOI) is a criterion in T classification for staging."
    ],
    "evidence_relations": [
      "Depth of invasion (DOI) is used to assess tumor extension in mouth cancer",
      "TNM Classification uses DOI in the definitions for T1, T2, and T3 in the ontology"
    ]
  },
  {
    "id": "Medical-4d6219bc",
    "source": "Medical",
    "question": "Why is pharmacogenomic and biomarker testing important in the management of pediatric ALL?",
    "answer": "Pharmacogenomic and biomarker testing guide treatment decisions and help tailor therapies for optimal outcomes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pharmacogenomic testing is important in the management of pediatric ALL.",
      "Biomarker testing is important in the management of pediatric ALL.",
      "Pharmacogenomic and biomarker testing guide treatment decisions.",
      "Pharmacogenomic and biomarker testing help tailor therapies for optimal outcomes."
    ],
    "evidence_relations": [
      "Pharmacogenomic testing and biomarker/genetic testing are used in ALL management",
      "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies",
      "Diagnostic Method for ALL includes biomarker testing and pharmacogenomic testing"
    ]
  },
  {
    "id": "Medical-8d55a40b",
    "source": "Medical",
    "question": "Which cancer type is characterized by the development of abnormal lymphocytes in the skin and can originate from either B or T cells?",
    "answer": "Primary cutaneous lymphoma (PCL) is characterized by abnormal lymphocytes in the skin and can originate from B or T cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary cutaneous lymphoma is characterized by abnormal lymphocytes in the skin.",
      "Primary cutaneous lymphoma can originate from B cells.",
      "Primary cutaneous lymphoma can originate from T cells."
    ],
    "evidence_relations": [
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin",
      "PCL develops from abnormal B or T lymphocytes"
    ]
  },
  {
    "id": "Medical-4987de7f",
    "source": "Medical",
    "question": "What are the cellular and molecular hallmarks required to definitively diagnose CML?",
    "answer": "Increased granulocytes and presence of either the Philadelphia chromosome or BCR::ABL1 fusion gene are required.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Increased granulocytes are required to definitively diagnose CML.",
      "The presence of the Philadelphia chromosome is required to definitively diagnose CML.",
      "The presence of the BCR::ABL1 fusion gene is required to definitively diagnose CML."
    ],
    "evidence_relations": [
      "CML is characterized by increased white blood cells (granulocytes)",
      "Presence of the Ph chromosome or BCR::ABL1 gene is required for CML diagnosis"
    ]
  },
  {
    "id": "Medical-41284331",
    "source": "Medical",
    "question": "If a tumor is described as intraductal and confined to the epithelium, what stage and tumor characteristic does it correspond to in intrahepatic bile duct cancer?",
    "answer": "It corresponds to Tis stage and carcinoma in situ tumor characteristic.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A tumor described as intraductal and confined to the epithelium corresponds to Tis stage.",
      "A tumor described as intraductal and confined to the epithelium corresponds to carcinoma in situ tumor characteristic."
    ],
    "evidence_relations": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "Intrahepatic bile duct cancer Tis tumors are described as carcinoma in situ and confined to epithelium"
    ]
  },
  {
    "id": "Medical-2521e4dd",
    "source": "Medical",
    "question": "Why is genetic testing for BRCA mutations recommended for all ovarian cancer patients?",
    "answer": "Because BRCA mutations are major hereditary risk factors and influence eligibility for targeted therapies such as PARP inhibitors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "BRCA mutations are major hereditary risk factors.",
      "BRCA mutations influence eligibility for targeted therapies.",
      "Targeted therapies include PARP inhibitors."
    ],
    "evidence_relations": [
      "Genetic testing for BRCA and other hereditary syndromes is recommended for all patients with ovarian cancer",
      "BRCA1 and BRCA2 mutations are major hereditary risk factors for ovarian cancer",
      "Maintenance therapy with PARP inhibitors is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment"
    ]
  },
  {
    "id": "Medical-a9a52704",
    "source": "Medical",
    "question": "What combination of anatomical location and cell type defines basal cell carcinoma?",
    "answer": "BCC arises from basal cells in the lower part of the epidermis, often in sun-exposed locations.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Basal cell carcinoma arises from basal cells.",
      "Basal cells are located in the lower part of the epidermis.",
      "Basal cell carcinoma often occurs in sun-exposed locations."
    ],
    "evidence_relations": [
      "BCC arises from basal cells in the lower part of the epidermis",
      "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
      "Basal cell carcinoma cell type is basal cells"
    ]
  },
  {
    "id": "Medical-50bafb57",
    "source": "Medical",
    "question": "Which blood cell types are abnormally increased in CML and what underlying cellular process causes this?",
    "answer": "Granulocytes (a type of white blood cell) are increased due to overproduction by myeloid progenitor cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Granulocytes are abnormally increased in CML.",
      "Granulocytes are a type of white blood cell.",
      "Granulocytes are increased due to overproduction by myeloid progenitor cells."
    ],
    "evidence_relations": [
      "CML is characterized by increased white blood cells (granulocytes)",
      "CML arises from blood stem cells producing increased myeloid progenitor cells"
    ]
  },
  {
    "id": "Medical-c69c2732",
    "source": "Medical",
    "question": "What follow-up strategy is recommended for a patient treated for BCC on the neck, and why?",
    "answer": "Annual full skin exams are recommended to monitor for recurrence or new lesions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Annual full skin exams are recommended for patients treated for basal cell carcinoma.",
      "The purpose of annual full skin exams is to monitor for recurrence.",
      "The purpose of annual full skin exams is to monitor for new lesions."
    ],
    "evidence_relations": [
      "BCC most commonly develops in sun-exposed areas such as the neck",
      "Recurrence refers to BCC returning to the original site",
      "Follow-up includes full skin exams with a doctor at least once a year"
    ]
  },
  {
    "id": "Medical-ddde0e24",
    "source": "Medical",
    "question": "For which AML patients is hematopoietic cell transplant considered and what factors influence this decision?",
    "answer": "Hematopoietic cell transplant is considered for eligible patients based on performance status, genetic alterations, and response to induction therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hematopoietic cell transplant is considered for eligible patients.",
      "The decision for hematopoietic cell transplant is based on performance status.",
      "The decision for hematopoietic cell transplant is based on genetic alterations.",
      "The decision for hematopoietic cell transplant is based on response to induction therapy."
    ],
    "evidence_relations": [
      "Hematopoietic cell transplant is considered for eligible patients",
      "Prognostic Factor includes genetic alterations, performance status, and response to induction therapy"
    ]
  },
  {
    "id": "Medical-5459ea22",
    "source": "Medical",
    "question": "Why is a tumor classified as Tis (carcinoma in situ) in intrahepatic bile duct cancer only found in the epithelium and not in deeper layers?",
    "answer": "Because Tis tumors are intraductal and confined to the epithelium, not invading lamina propria or deeper layers.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tis tumors are intraductal.",
      "Tis tumors are confined to the epithelium.",
      "Tis tumors do not invade lamina propria or deeper layers."
    ],
    "evidence_relations": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "The gallbladder and bile ducts are lined by a thin, moist epithelial layer",
      "Intrahepatic bile duct cancer Tis tumors are described as carcinoma in situ and confined to epithelium"
    ]
  },
  {
    "id": "Medical-299b8b83",
    "source": "Medical",
    "question": "How do risk factors and performance status together influence mouth cancer management?",
    "answer": "Risk factors like tobacco and alcohol use increase risk and affect outcomes, while performance status helps guide treatment selection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk factors like tobacco use increase the risk of mouth cancer.",
      "Risk factors like alcohol use increase the risk of mouth cancer.",
      "Risk factors affect outcomes of mouth cancer management.",
      "Performance status helps guide treatment selection for mouth cancer."
    ],
    "evidence_relations": [
      "Tobacco and alcohol use are risk factors for mouth cancer",
      "Performance status (ECOG) is considered in treatment selection"
    ]
  },
  {
    "id": "Medical-f978cb28",
    "source": "Medical",
    "question": "What is the role of clinical trials in the management of advanced or refractory CSCC?",
    "answer": "Clinical trials are an option for systemic therapy, especially in advanced or refractory CSCC cases.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are an option for systemic therapy.",
      "Clinical trials are especially relevant in advanced CSCC cases.",
      "Clinical trials are especially relevant in refractory CSCC cases."
    ],
    "evidence_relations": [
      "Clinical trials are an option for systemic therapy, especially in advanced or refractory CSCC",
      "Metastatic CSCC: Treatment: Clinical trial"
    ]
  },
  {
    "id": "Medical-604c9d44",
    "source": "Medical",
    "question": "Why is a patient with fair skin and a history of organ transplant at particularly high risk for developing basal cell carcinoma?",
    "answer": "Because both fair skin and immune suppression from organ transplant are independent risk factors for BCC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Fair skin is an independent risk factor for basal cell carcinoma (BCC).",
      "Immune suppression from organ transplant is an independent risk factor for basal cell carcinoma (BCC)."
    ],
    "evidence_relations": [
      "Fair skin, light hair, and light eye color increase the risk of BCC",
      "Immune suppression is a risk factor for BCC",
      "Basal cell carcinoma risk factors include fair skin and organ transplant"
    ]
  },
  {
    "id": "Medical-1c53b384",
    "source": "Medical",
    "question": "What combination of risk factors should prompt clinicians to consider nasopharyngeal carcinoma in a differential diagnosis?",
    "answer": "Epstein-Barr virus infection, tobacco use, alcohol use, and geographic origin (Asia, Native America, North Africa) should prompt consideration of NPC.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Epstein-Barr virus infection should prompt consideration of nasopharyngeal carcinoma (NPC).",
      "Tobacco use should prompt consideration of nasopharyngeal carcinoma (NPC).",
      "Alcohol use should prompt consideration of nasopharyngeal carcinoma (NPC).",
      "Geographic origin (Asia, Native America, North Africa) should prompt consideration of nasopharyngeal carcinoma (NPC)."
    ],
    "evidence_relations": [
      "Risk factors for NPC include Epstein-Barr virus (EBV), tobacco use, alcohol use, and geographic origin (Asia, Native America, North Africa)",
      "NPC most often occurs in people from parts of Asia, Native America, and North Africa"
    ]
  },
  {
    "id": "Medical-7faeddee",
    "source": "Medical",
    "question": "If a patient presents with an ulcer and mass in the stomach, what cancer subtype is most likely and what is the cell of origin?",
    "answer": "Adenocarcinoma, originating from mucus-secreting cells lining the stomach.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adenocarcinoma is the most likely cancer subtype if a patient presents with an ulcer and mass in the stomach.",
      "Adenocarcinoma originates from mucus-secreting cells lining the stomach."
    ],
    "evidence_relations": [
      "Most stomach cancers are adenocarcinomas",
      "Adenocarcinomas originate from cells lining the inside of the stomach that secrete mucus",
      "Symptoms can include ulcer or mass formation in the stomach"
    ]
  },
  {
    "id": "Medical-b3fece20",
    "source": "Medical",
    "question": "Why should germline genetic testing be considered for a patient with metastatic prostate cancer?",
    "answer": "Because metastatic prostate cancer is high-risk and may involve genetic mutations like BRCA2, which increase risk and influence treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Germline genetic testing should be considered for a patient with metastatic prostate cancer.",
      "Metastatic prostate cancer is high-risk.",
      "Metastatic prostate cancer may involve genetic mutations.",
      "BRCA2 is a genetic mutation that increases risk in metastatic prostate cancer.",
      "Genetic mutations can influence treatment for metastatic prostate cancer."
    ],
    "evidence_relations": [
      "Germline genetic testing is recommended for patients with high-risk, very-high-risk, regional, or metastatic prostate cancer",
      "BRCA2 mutation increases risk of prostate cancer",
      "Metastatic prostate cancer includes genetic alterations such as BRCA2"
    ]
  },
  {
    "id": "Medical-cdce534a",
    "source": "Medical",
    "question": "In what situation would a pediatric ALL patient receive supportive care in addition to systemic therapy?",
    "answer": "Supportive care is given alongside systemic therapy to manage side effects and complications during ALL treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Supportive care is given alongside systemic therapy for pediatric ALL patients.",
      "Supportive care manages side effects during ALL treatment.",
      "Supportive care manages complications during ALL treatment."
    ],
    "evidence_relations": [
      "Systemic therapy and supportive care are part of ALL treatment",
      "Treatment for ALL includes systemic therapy and supportive care",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy"
    ]
  },
  {
    "id": "Medical-346b12e8",
    "source": "Medical",
    "question": "Why is annual follow-up with full skin exams critical for patients with a history of BCC?",
    "answer": "Because recurrence can occur at the original site or spread, so annual full skin exams help detect new or returning lesions.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Annual follow-up with full skin exams is critical for patients with a history of BCC.",
      "Recurrence of BCC can occur at the original site.",
      "BCC can spread to other areas.",
      "Annual full skin exams help detect new lesions.",
      "Annual full skin exams help detect returning lesions."
    ],
    "evidence_relations": [
      "Recurrence refers to BCC returning to the original site or spreading to lymph nodes or distant sites",
      "Follow-up includes full skin exams with a doctor at least once a year"
    ]
  },
  {
    "id": "Medical-a4ac550d",
    "source": "Medical",
    "question": "What is the rationale for using both steroids and multiagent chemotherapy in the treatment of all pediatric ALL patients?",
    "answer": "All patients receive steroids and multiagent chemotherapy to target lymphoblasts and maximize treatment efficacy regardless of subtype.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "All pediatric ALL patients receive steroids.",
      "All pediatric ALL patients receive multiagent chemotherapy.",
      "Steroids and multiagent chemotherapy target lymphoblasts.",
      "Steroids and multiagent chemotherapy maximize treatment efficacy."
    ],
    "evidence_relations": [
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "Acute lymphoblastic leukemia (ALL) is a fast-growing blood cancer that starts in lymphocytes",
      "B-cell ALL (B-ALL) and T-cell ALL (T-ALL) both list steroids and multiagent chemotherapy as treatment"
    ]
  },
  {
    "id": "Medical-25d1d605",
    "source": "Medical",
    "question": "Why should fertility preservation be discussed with certain mouth cancer patients before treatment?",
    "answer": "Cancer and its treatment can affect fertility, so fertility preservation should be considered before therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cancer can affect fertility.",
      "Treatment for cancer can affect fertility.",
      "Fertility preservation should be discussed with certain mouth cancer patients before treatment."
    ],
    "evidence_relations": [
      "Cancer and its treatment can affect fertility",
      "Fertility preservation is included under Fertility Consideration in the ontology for SCC"
    ]
  },
  {
    "id": "Medical-7fba506d",
    "source": "Medical",
    "question": "How does the anatomical location within the stomach influence the potential spread of cancer to nearby organs?",
    "answer": "Tumors in any stomach region can invade adjacent organs such as the pancreas and spleen through local and distant spread.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tumors in any stomach region can invade adjacent organs.",
      "Adjacent organs include the pancreas.",
      "Adjacent organs include the spleen.",
      "Cancer can spread through local and distant mechanisms."
    ],
    "evidence_relations": [
      "Anatomical Location includes cardia, fundus, body, antrum, pylorus, and esophagogastric junction (ontology rewritten)",
      "Locoregional or locally advanced stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs",
      "Cancer can spread to lymph nodes, veins, arteries, and organs such as the liver, pancreas, and spleen"
    ]
  },
  {
    "id": "Medical-6428d1f1",
    "source": "Medical",
    "question": "Why is chemoradiation the standard of care for locally advanced cervical cancer rather than surgery?",
    "answer": "Because chemoradiation is recommended for locally advanced cervical cancer, while surgery is the main treatment for early-stage disease.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chemoradiation is the standard of care for locally advanced cervical cancer.",
      "Surgery is the main treatment for early-stage cervical cancer."
    ],
    "evidence_relations": [
      "Chemoradiation (concurrent EBRT and platinum-based chemotherapy) is recommended for locally advanced cervical cancer",
      "Surgery is the main treatment for early-stage cervical cancer",
      "Chemoradiation is included under systemic therapy and radiation therapy in the ontology"
    ]
  },
  {
    "id": "Medical-db5aa2e3",
    "source": "Medical",
    "question": "What distinguishes Mohs surgery from other surgical options in the treatment of high-risk local CSCC?",
    "answer": "Mohs surgery is preferred for high-risk local CSCC due to its tissue-sparing and margin-assessing technique.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mohs surgery is preferred for high-risk local CSCC.",
      "Mohs surgery uses a tissue-sparing technique.",
      "Mohs surgery uses a margin-assessing technique."
    ],
    "evidence_relations": [
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible",
      "High-risk: Treatment: Mohs surgery/PDEMA (preferred)"
    ]
  },
  {
    "id": "Medical-984c0f56",
    "source": "Medical",
    "question": "How does the spread of early-stage versus locoregional stomach cancer differ in terms of stomach wall invasion and lymph node involvement?",
    "answer": "Early-stage is confined to mucosa without lymph node involvement, while locoregional invades deeper layers and/or regional lymph nodes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Early-stage stomach cancer is confined to the mucosa.",
      "Early-stage stomach cancer does not involve lymph nodes.",
      "Locoregional stomach cancer invades deeper layers of the stomach wall.",
      "Locoregional stomach cancer may involve regional lymph nodes."
    ],
    "evidence_relations": [
      "Early-stage stomach cancer is confined to the mucosa and is not present in lymph nodes",
      "Locoregional or locally advanced stomach cancer invades other layers of the stomach wall and/or regional lymph nodes or nearby organs",
      "Early-stage stomach cancer: Confined to mucosa, not in lymph nodes (ontology rewritten)",
      "Locoregional stomach cancer: Invades other layers and/or regional lymph nodes or nearby organs (ontology rewritten)"
    ]
  },
  {
    "id": "Medical-2ca88e8f",
    "source": "Medical",
    "question": "What factors determine the specific treatment regimen for a pediatric ALL patient?",
    "answer": "Treatment for ALL depends on subtype, age at diagnosis, and other factors such as biomarkers and genetic alterations.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Treatment for pediatric ALL depends on subtype.",
      "Treatment for pediatric ALL depends on age at diagnosis.",
      "Treatment for pediatric ALL depends on biomarkers.",
      "Treatment for pediatric ALL depends on genetic alterations."
    ],
    "evidence_relations": [
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "Everyone with ALL is treated with steroids and multiagent chemotherapy",
      "BCR::ABL1-positive B-ALL is treated with intensive systemic therapies"
    ]
  },
  {
    "id": "Medical-a13a1285",
    "source": "Medical",
    "question": "What are the distinguishing features between Stage 0 and Stage IV breast cancer in terms of pathology and clinical management?",
    "answer": "Stage 0 is noninvasive (DCIS) and managed with surgery and radiation, while Stage IV is metastatic and managed with systemic therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage 0 breast cancer is noninvasive (DCIS).",
      "Stage 0 breast cancer is managed with surgery.",
      "Stage 0 breast cancer is managed with radiation.",
      "Stage IV breast cancer is metastatic.",
      "Stage IV breast cancer is managed with systemic therapy."
    ],
    "evidence_relations": [
      "Stage 0 breast cancer is noninvasive (DCIS)",
      "Stages I-III are invasive breast cancer",
      "Stage IV is metastatic breast cancer",
      "Treatment options include surgery and radiation for DCIS, and systemic therapy for metastatic breast cancer"
    ]
  },
  {
    "id": "Medical-a73aa030",
    "source": "Medical",
    "question": "Why is polypectomy during colonoscopy considered a preventive strategy for rectal cancer?",
    "answer": "Because most rectal cancers start in adenomatous polyps and polypectomy can remove these polyps to prevent cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Most rectal cancers start in adenomatous polyps.",
      "Polypectomy during colonoscopy can remove adenomatous polyps.",
      "Polypectomy is considered a preventive strategy for rectal cancer."
    ],
    "evidence_relations": [
      "Most rectal cancers start in adenomatous polyps",
      "Polypectomy during colonoscopy can remove most polyps and prevent cancer"
    ]
  },
  {
    "id": "Medical-04fc1c61",
    "source": "Medical",
    "question": "How does the age of a patient influence the management of ALL, and which patient populations are most commonly affected?",
    "answer": "Age influences treatment choices, and ALL is most common in children but also affects adolescents, young adults, and adults.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Age influences treatment choices for ALL.",
      "ALL is most common in children.",
      "ALL also affects adolescents.",
      "ALL affects young adults.",
      "ALL affects adults."
    ],
    "evidence_relations": [
      "Treatment for ALL depends on subtype, age at diagnosis, and other factors",
      "ALL is more common in children but also occurs in adolescents and young adults (AYAs) and adults"
    ]
  },
  {
    "id": "Medical-1eab8fa2",
    "source": "Medical",
    "question": "Why should a patient with a family history of skin cancer and light eye color be particularly vigilant about skin changes?",
    "answer": "Because both family history and light eye color are risk factors for BCC, increasing overall risk.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A family history of skin cancer is a risk factor for basal cell carcinoma.",
      "Light eye color is a risk factor for basal cell carcinoma.",
      "These risk factors increase the overall risk of basal cell carcinoma."
    ],
    "evidence_relations": [
      "Family history increases risk of BCC",
      "Light eye color increases the risk of BCC",
      "Basal cell carcinoma risk factors include family history and light eye color"
    ]
  },
  {
    "id": "Medical-689b17ad",
    "source": "Medical",
    "question": "Which biomarker should be tested both before and after treatment in nasopharyngeal carcinoma patients, and why is this monitoring important?",
    "answer": "EBV DNA should be tested before and after treatment because its level serves as a prognostic factor and is used for surveillance.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "EBV DNA should be tested before treatment in nasopharyngeal carcinoma patients.",
      "EBV DNA should be tested after treatment in nasopharyngeal carcinoma patients.",
      "The level of EBV DNA serves as a prognostic factor.",
      "The level of EBV DNA is used for surveillance."
    ],
    "evidence_relations": [
      "EBV DNA testing is performed before and after treatment for NPC",
      "Biomarker testing for NPC includes EBV DNA",
      "EBV DNA level is a prognostic factor",
      "Surveillance for NPC includes EBV DNA testing"
    ]
  },
  {
    "id": "Medical-fe7f2575",
    "source": "Medical",
    "question": "What two performance status scales are considered when planning treatment for primary bone cancer?",
    "answer": "ECOG performance status and Karnofsky Performance Status (KPS) are considered in treatment planning.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ECOG performance status is considered in treatment planning for primary bone cancer.",
      "Karnofsky Performance Status (KPS) is considered in treatment planning for primary bone cancer."
    ],
    "evidence_relations": [
      "Performance status (ECOG or KPS) is considered in treatment planning",
      "Performance Status: [\"ECOG performance status\", \"Karnofsky Performance Status (KPS)\"]"
    ]
  },
  {
    "id": "Medical-b0ec1abf",
    "source": "Medical",
    "question": "What is the rationale for using both PSA testing and imaging in the follow-up of advanced prostate cancer?",
    "answer": "Because PSA monitoring detects biochemical recurrence, while imaging assesses disease progression or metastasis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PSA monitoring detects biochemical recurrence in advanced prostate cancer.",
      "Imaging assesses disease progression in advanced prostate cancer.",
      "Imaging assesses metastasis in advanced prostate cancer."
    ],
    "evidence_relations": [
      "Follow-up includes regular PSA testing, imaging, and biopsies as needed",
      "Advanced prostate cancer follow-up strategy includes PSA monitoring and imaging",
      "Imaging methods include MRI, CT, PET, bone scan, and PSMA-PET"
    ]
  },
  {
    "id": "Medical-fe83d01e",
    "source": "Medical",
    "question": "What two assessments are necessary for comprehensive care due to the effects of mouth cancer and its treatment on dental health and swallowing?",
    "answer": "Dental exam and speech and swallowing assessment are necessary for comprehensive care.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A dental exam is necessary for comprehensive care due to mouth cancer.",
      "A speech and swallowing assessment is necessary for comprehensive care due to mouth cancer."
    ],
    "evidence_relations": [
      "Dental health is affected by head and neck cancer and its treatment",
      "Dental exam and speech and swallowing assessment are listed as diagnostic methods in the ontology"
    ]
  },
  {
    "id": "Medical-01e3a9ea",
    "source": "Medical",
    "question": "Why might a patient with a shiny bump and a history of radiation therapy require both imaging and biopsy for diagnosis?",
    "answer": "Because radiation therapy is a risk factor for BCC and shiny bumps are a symptom, so both imaging and biopsy help confirm diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A shiny bump can be a symptom of basal cell carcinoma.",
      "A history of radiation therapy is a risk factor for basal cell carcinoma.",
      "Imaging is needed to help confirm the diagnosis of basal cell carcinoma.",
      "A biopsy is needed to help confirm the diagnosis of basal cell carcinoma."
    ],
    "evidence_relations": [
      "Radiation therapy is a risk factor for BCC",
      "BCC presents as shiny bumps",
      "Diagnosis of BCC involves biopsy and sometimes imaging"
    ]
  },
  {
    "id": "Medical-213847bd",
    "source": "Medical",
    "question": "Why is clinical trial enrollment especially considered for certain B-ALL and T-ALL cases in children?",
    "answer": "Clinical trials are preferred for certain B-ALL and T-ALL cases to provide access to novel therapies and tailored treatment approaches.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Clinical trials are preferred for certain B-ALL cases in children.",
      "Clinical trials are preferred for certain T-ALL cases in children.",
      "Clinical trials provide access to novel therapies.",
      "Clinical trials provide tailored treatment approaches."
    ],
    "evidence_relations": [
      "Clinical trials are preferred for certain B-ALL and T-ALL cases",
      "B-cell ALL (B-ALL) and T-cell ALL (T-ALL) are subtypes of ALL",
      "ALL treatment includes clinical trial as an option"
    ]
  },
  {
    "id": "Medical-06055fa9",
    "source": "Medical",
    "question": "How does the TNM system integrate with tumor grade to determine the stage of primary bone cancer?",
    "answer": "The stage of primary bone cancer is determined by combining TNM scores and tumor grade.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The stage of primary bone cancer is determined by TNM scores.",
      "The stage of primary bone cancer is determined by tumor grade."
    ],
    "evidence_relations": [
      "Staging uses the TNM system: T (tumor size/location), N (lymph node involvement), M (metastasis)",
      "Tumor grade (G) describes histologic differentiation",
      "Stage is determined by combining T, N, M, and G scores"
    ]
  },
  {
    "id": "Medical-4d01de98",
    "source": "Medical",
    "question": "How do blood stem cells contribute to the abnormal blood cell profile observed in CML?",
    "answer": "Blood stem cells in CML produce increased myeloid progenitor cells, leading to elevated granulocytes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Blood stem cells in CML produce increased myeloid progenitor cells.",
      "Increased myeloid progenitor cells lead to elevated granulocytes."
    ],
    "evidence_relations": [
      "CML arises from blood stem cells producing increased myeloid progenitor cells",
      "CML is characterized by increased white blood cells (granulocytes)"
    ]
  },
  {
    "id": "Medical-22b8a5ee",
    "source": "Medical",
    "question": "How is small lymphocytic lymphoma (SLL) differentiated from chronic lymphocytic leukemia (CLL) in terms of primary site and diagnostic approach?",
    "answer": "SLL primarily affects lymph nodes and spleen, while CLL affects blood and bone marrow, and both require blood tests and biopsies for diagnosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Small lymphocytic lymphoma (SLL) primarily affects lymph nodes.",
      "Small lymphocytic lymphoma (SLL) primarily affects the spleen.",
      "Chronic lymphocytic leukemia (CLL) primarily affects blood.",
      "Chronic lymphocytic leukemia (CLL) primarily affects bone marrow.",
      "Both SLL and CLL require blood tests for diagnosis.",
      "Both SLL and CLL require biopsies for diagnosis."
    ],
    "evidence_relations": [
      "Small lymphocytic lymphoma (SLL) is the same cancer as CLL but primarily found in lymph nodes and spleen",
      "Chronic lymphocytic leukemia (CLL) is a type of blood cancer affecting B lymphocytes",
      "CLL/SLL is diagnosed by blood test showing ≥5,000 monoclonal B lymphocytes per microliter",
      "CLL is confirmed by blood test, flow cytometry, and may require lymph node or bone marrow biopsy",
      "In the ontology, SLL is listed under CLL as a subtype with primary sites of lymph nodes and spleen, while CLL's primary sites are blood and bone marrow"
    ]
  },
  {
    "id": "Medical-00ef7b5d",
    "source": "Medical",
    "question": "How are dMMR/MSI-H and pMMR/MSS statuses determined and how do they influence therapy choices?",
    "answer": "All colon cancers should be tested for dMMR/MSI-H or pMMR/MSS, with dMMR/MSI-H guiding immunotherapy and pMMR/MSS leading to chemotherapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "All colon cancers should be tested for dMMR/MSI-H or pMMR/MSS.",
      "dMMR/MSI-H status guides immunotherapy.",
      "pMMR/MSS status leads to chemotherapy."
    ],
    "evidence_relations": [
      "All colon cancers should be tested for mismatch repair deficiency (dMMR) or microsatellite instability-high (MSI-H)",
      "dMMR/MSI-H is a biomarker guiding immunotherapy",
      "pMMR/MSS cancers are treated with chemotherapy"
    ]
  },
  {
    "id": "Medical-68c30458",
    "source": "Medical",
    "question": "What is the rationale for recommending molecular testing after a biopsy in glioma diagnosis?",
    "answer": "Molecular testing after biopsy is recommended to determine biomarker status and guide classification and treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Molecular testing is recommended after biopsy in glioma diagnosis.",
      "Molecular testing determines biomarker status.",
      "Molecular testing guides classification and treatment of glioma."
    ],
    "evidence_relations": [
      "Biopsy is required for definitive diagnosis and molecular testing",
      "Gliomas are classified by histology, grade, and biomarkers",
      "IDH mutation is a biomarker used to classify gliomas"
    ]
  },
  {
    "id": "Medical-3447851a",
    "source": "Medical",
    "question": "Why should young adults with colon cancer be counseled about fertility preservation before treatment?",
    "answer": "Young adults should be counseled because treatments like chemotherapy and surgery can impair fertility, and options such as sperm banking, egg freezing, or ovarian tissue banking are available.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Young adults with colon cancer should be counseled about fertility preservation.",
      "Treatments like chemotherapy and surgery can impair fertility.",
      "Options for fertility preservation include sperm banking, egg freezing, and ovarian tissue banking."
    ],
    "evidence_relations": [
      "Young adults should be counseled about fertility risks and preservation options before treatment",
      "Fertility Preservation includes sperm banking, egg freezing, and ovarian tissue banking"
    ]
  },
  {
    "id": "Medical-2e171c34",
    "source": "Medical",
    "question": "How do risk group classification and molecular biomarker testing together influence treatment selection in prostate cancer?",
    "answer": "Risk group classification guides prognosis and initial management, while molecular biomarker testing refines risk assessment and guides therapy choices.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Risk group classification guides prognosis in prostate cancer.",
      "Risk group classification guides initial management in prostate cancer.",
      "Molecular biomarker testing refines risk assessment in prostate cancer.",
      "Molecular biomarker testing guides therapy choices in prostate cancer."
    ],
    "evidence_relations": [
      "Risk groups (very low, low, intermediate, high, very high) guide prognosis and treatment",
      "Molecular biomarker testing helps assess risk and guide treatment decisions",
      "Biomarkers include molecular biomarker tests and are linked to risk group assignment"
    ]
  },
  {
    "id": "Medical-ebfc4679",
    "source": "Medical",
    "question": "What is the relationship between adenocarcinoma, adenomas, and the development of colon cancer?",
    "answer": "Adenocarcinoma, the most common colon cancer subtype, arises from adenomas that can become invasive cancer over many years.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Adenocarcinoma is the most common subtype of colon cancer.",
      "Adenocarcinoma arises from adenomas.",
      "Adenomas can become invasive cancer over many years."
    ],
    "evidence_relations": [
      "Adenocarcinoma is the most common subtype of colon cancer",
      "Adenocarcinoma arises from adenomas",
      "Adenomas can become invasive colon cancer over many years"
    ]
  },
  {
    "id": "Medical-c31057de",
    "source": "Medical",
    "question": "What evidence supports the use of both health history and physical exam in the diagnostic workup for Hodgkin lymphoma?",
    "answer": "Health history and physical exam are part of the diagnostic process for Hodgkin lymphoma and are included in the diagnostic methods for both CHL and NLPHL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Health history is part of the diagnostic process for Hodgkin lymphoma.",
      "Physical exam is part of the diagnostic process for Hodgkin lymphoma.",
      "Health history and physical exam are included in the diagnostic methods for both classic Hodgkin lymphoma and NLPHL."
    ],
    "evidence_relations": [
      "Health history and physical exam are part of the diagnostic process",
      "Classic Hodgkin lymphoma (CHL): Diagnostic Method: health history, physical exam",
      "Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL): Diagnostic Method: health history, physical exam"
    ]
  },
  {
    "id": "Medical-b2b43c1e",
    "source": "Medical",
    "question": "Which bone sarcoma subtype is most likely to originate from cartilage-forming cells, and what biomarker is relevant for its targeted therapy?",
    "answer": "Chondrosarcoma originates from cartilage-forming cells and the IDH1 mutation is relevant for targeted therapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chondrosarcoma originates from cartilage-forming cells.",
      "The IDH1 mutation is relevant for targeted therapy of chondrosarcoma."
    ],
    "evidence_relations": [
      "Chondrosarcoma starts in cartilage-forming cells",
      "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib",
      "Chondrosarcoma: Biomarker: [\"IDH1 mutation\"]"
    ]
  },
  {
    "id": "Medical-669af50b",
    "source": "Medical",
    "question": "How does performance status impact the treatment plan for an AML patient?",
    "answer": "Performance status influences the selection and intensity of AML treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status impacts the treatment plan for an AML patient.",
      "Performance status influences the selection of AML treatment.",
      "Performance status influences the intensity of AML treatment."
    ],
    "evidence_relations": [
      "Performance status and general health influence treatment selection",
      "Performance Status includes Eastern Cooperative Oncology Group (ECOG) score and Karnofsky Performance Status (KPS)"
    ]
  },
  {
    "id": "Medical-8ff5dd5a",
    "source": "Medical",
    "question": "Why might systemic therapy be considered for a patient with BCC that has spread to distant sites?",
    "answer": "Because systemic therapy is a treatment option for BCC that has recurred or spread to distant sites.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Systemic therapy may be considered for patients with BCC that has spread to distant sites.",
      "Systemic therapy is a treatment option for BCC.",
      "Systemic therapy is used for BCC that has recurred."
    ],
    "evidence_relations": [
      "Recurrence refers to BCC spreading to distant sites",
      "Systemic therapy may be used in some cases of BCC"
    ]
  },
  {
    "id": "Medical-97022167",
    "source": "Medical",
    "question": "How does the origin of colon cancer from adenomas influence early detection and prevention strategies?",
    "answer": "Since most colon cancers start in adenomas, early detection and removal of polyps via colonoscopy and polypectomy are crucial for prevention.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Most colon cancers start in adenomas.",
      "Early detection and removal of polyps are crucial for prevention.",
      "Colonoscopy and polypectomy are methods for early detection and removal of polyps."
    ],
    "evidence_relations": [
      "Most colon cancers start in polyps, especially adenomas",
      "Polypectomy removes polyps during colonoscopy"
    ]
  },
  {
    "id": "Medical-7bf81d77",
    "source": "Medical",
    "question": "Why does carcinoma in situ not involve spread to blood vessels or the liver?",
    "answer": "Because carcinoma in situ is by definition confined to the epithelium and does not invade deeper tissues or structures.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Carcinoma in situ is confined to the epithelium.",
      "Carcinoma in situ does not invade deeper tissues or structures."
    ],
    "evidence_relations": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "Tumor Characteristic includes spread to blood vessels and liver for advanced stages"
    ]
  },
  {
    "id": "Medical-1892185a",
    "source": "Medical",
    "question": "What is the role of p16 protein in distinguishing subtypes of squamous cell carcinoma in the oropharynx?",
    "answer": "p16 protein overexpression identifies HPV-mediated squamous cell carcinoma in the oropharynx.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "p16 protein overexpression identifies HPV-mediated squamous cell carcinoma.",
      "p16 protein is used to distinguish subtypes of squamous cell carcinoma in the oropharynx."
    ],
    "evidence_relations": [
      "p16 protein overexpression is a surrogate biomarker for HPV-mediated throat cancer",
      "Squamous cell carcinoma is the most common type of throat cancer"
    ]
  },
  {
    "id": "Medical-edc3c6eb",
    "source": "Medical",
    "question": "Why is lung cancer screening particularly important for individuals exposed to air pollution and diesel fumes?",
    "answer": "Because both air pollution and diesel fumes are established risk factors for lung cancer, necessitating early detection strategies.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Air pollution is an established risk factor for lung cancer.",
      "Diesel fumes are an established risk factor for lung cancer.",
      "Both air pollution and diesel fumes necessitate early detection strategies for lung cancer."
    ],
    "evidence_relations": [
      "Exposure to diesel fumes and air pollution are risk factors for lung cancer",
      "Lung cancer screening is recommended for people at high risk"
    ]
  },
  {
    "id": "Medical-d1a87cb4",
    "source": "Medical",
    "question": "What combination of clinical findings and diagnostic results would indicate metastatic breast cancer (Stage IV)?",
    "answer": "Symptoms like bone pain or neurological symptoms plus imaging or biopsy showing distant spread indicate metastatic breast cancer (Stage IV).",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Symptoms like bone pain or neurological symptoms indicate metastatic breast cancer (Stage IV).",
      "Imaging or biopsy showing distant spread indicates metastatic breast cancer (Stage IV)."
    ],
    "evidence_relations": [
      "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs",
      "MBC symptoms include bone pain, shortness of breath, liver dysfunction, neurological symptoms",
      "MBC diagnostic methods include imaging tests and biopsy"
    ]
  },
  {
    "id": "Medical-2ebcf55d",
    "source": "Medical",
    "question": "What is the clinical significance of detecting a 17p deletion or TP53 mutation in CLL patients?",
    "answer": "Detection of 17p deletion or TP53 mutation indicates poorer prognosis and guides treatment selection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Detection of 17p deletion indicates poorer prognosis in CLL patients.",
      "Detection of TP53 mutation indicates poorer prognosis in CLL patients.",
      "Detection of 17p deletion guides treatment selection in CLL patients.",
      "Detection of TP53 mutation guides treatment selection in CLL patients."
    ],
    "evidence_relations": [
      "Biomarker testing includes FISH for 17p deletion, DNA sequencing for TP53 and IGHV mutations, and karyotype analysis",
      "Beta-2 microglobulin is a biomarker associated with CLL disease activity and prognosis",
      "In the ontology, 17p deletion and TP53 mutation are listed as biomarkers for CLL"
    ]
  },
  {
    "id": "Medical-14016ce3",
    "source": "Medical",
    "question": "What is the rationale for recommending surgery as the most common treatment for BCC lesions on sun-exposed areas?",
    "answer": "Because BCC most commonly develops on sun-exposed areas and surgery is the most effective treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Basal cell carcinoma most commonly develops on sun-exposed areas.",
      "Surgery is the most effective treatment for basal cell carcinoma lesions."
    ],
    "evidence_relations": [
      "BCC most commonly develops in sun-exposed areas such as the face, head, and neck",
      "Surgery is the most common treatment for BCC"
    ]
  },
  {
    "id": "Medical-ec84ae56",
    "source": "Medical",
    "question": "Why would a patient with FLT3-ITD mutated AML receive a targeted therapy in addition to chemotherapy?",
    "answer": "FLT3 inhibitors are used as targeted therapy for FLT3-mutated AML, which is treated alongside standard chemotherapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "FLT3 inhibitors are used as targeted therapy for FLT3-mutated AML.",
      "FLT3-ITD mutated AML may receive targeted therapy in addition to chemotherapy.",
      "FLT3-mutated AML is treated alongside standard chemotherapy."
    ],
    "evidence_relations": [
      "Targeted therapies are used for AML with specific genetic alterations, such as FLT3 inhibitors for FLT3-mutated AML",
      "Chemotherapy is the standard of care for AML",
      "Common genetic alterations in AML include FLT3-ITD"
    ]
  },
  {
    "id": "Medical-a7826934",
    "source": "Medical",
    "question": "Explain the relationship between the Philadelphia chromosome, BCR::ABL1 fusion gene, and the origin of CML.",
    "answer": "The Philadelphia chromosome results from a translocation that creates the BCR::ABL1 fusion gene, which causes CML.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "The Philadelphia chromosome results from a translocation.",
      "The translocation creates the BCR::ABL1 fusion gene.",
      "The BCR::ABL1 fusion gene causes CML."
    ],
    "evidence_relations": [
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
      "CML is caused by the BCR::ABL1 fusion gene"
    ]
  },
  {
    "id": "Medical-56131016",
    "source": "Medical",
    "question": "How do family history and older age together influence the risk and screening approach for CLL?",
    "answer": "Both increase CLL risk, so older individuals with a family history may warrant closer monitoring for early detection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Family history increases the risk of CLL.",
      "Older age increases the risk of CLL.",
      "Older individuals with a family history of CLL may warrant closer monitoring.",
      "Closer monitoring is recommended for early detection of CLL."
    ],
    "evidence_relations": [
      "Risk factors for CLL include older age and family history of CLL",
      "Family history increases the risk of developing CLL"
    ]
  },
  {
    "id": "Medical-4fe06961",
    "source": "Medical",
    "question": "What is the sequence of genetic and chromosomal events leading to CML?",
    "answer": "A translocation between chromosome 9 and 22 creates the Philadelphia chromosome, which produces the BCR::ABL1 fusion gene that causes CML.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A translocation between chromosome 9 and 22 creates the Philadelphia chromosome.",
      "The Philadelphia chromosome produces the BCR::ABL1 fusion gene.",
      "The BCR::ABL1 fusion gene causes CML."
    ],
    "evidence_relations": [
      "The BCR::ABL1 gene is created by a translocation between chromosome 9 and chromosome 22",
      "The Philadelphia chromosome (Ph) is the abnormal chromosome 22 resulting from this translocation",
      "CML is caused by the BCR::ABL1 fusion gene"
    ]
  },
  {
    "id": "Medical-cfc21569",
    "source": "Medical",
    "question": "Why is liver cancer screening with ultrasound and AFP test recommended every 6 months for some individuals?",
    "answer": "Because individuals with cirrhosis or chronic hepatitis B are at increased risk for liver cancer, and regular screening with ultrasound and AFP can detect cancer early.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Liver cancer screening with ultrasound is recommended every 6 months for some individuals.",
      "Liver cancer screening with AFP test is recommended every 6 months for some individuals.",
      "Individuals with cirrhosis are at increased risk for liver cancer.",
      "Individuals with chronic hepatitis B are at increased risk for liver cancer.",
      "Regular screening can detect liver cancer early."
    ],
    "evidence_relations": [
      "Screening for liver cancer is recommended for individuals with cirrhosis or chronic hepatitis B",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months"
    ]
  },
  {
    "id": "Medical-8488f954",
    "source": "Medical",
    "question": "How does performance status influence the treatment plan for a patient with metastatic breast cancer?",
    "answer": "Performance status is considered in treatment planning for metastatic breast cancer to tailor therapy to the patient's functional capacity.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Performance status is considered in treatment planning for metastatic breast cancer.",
      "Performance status helps tailor therapy to the patient's functional capacity."
    ],
    "evidence_relations": [
      "Performance status is considered in treatment planning",
      "Metastatic breast cancer (MBC) is breast cancer that has spread to distant organs",
      "Clinical management includes performance status assessment"
    ]
  },
  {
    "id": "Medical-072545c5",
    "source": "Medical",
    "question": "What is the role of molecular tests in the management of thyroid nodules and how do they impact surgical decisions?",
    "answer": "Molecular tests help determine malignancy and the need for surgery in patients with suspicious thyroid nodules.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Molecular tests help determine malignancy in thyroid nodules.",
      "Molecular tests help determine the need for surgery in patients with suspicious thyroid nodules."
    ],
    "evidence_relations": [
      "Molecular tests can help determine malignancy and need for surgery",
      "Fine-needle aspiration biopsy is used to sample suspicious thyroid nodules"
    ]
  },
  {
    "id": "Medical-7ea7ec68",
    "source": "Medical",
    "question": "Why would a patient with a history of exposure to asbestos and a persistent cough be prioritized for lung cancer screening?",
    "answer": "Because asbestos exposure is a risk factor and persistent cough is a symptom, both increasing the need for early detection via screening.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Asbestos exposure is a risk factor for lung cancer.",
      "A persistent cough is a symptom of lung cancer.",
      "Both asbestos exposure and persistent cough increase the need for early detection via screening."
    ],
    "evidence_relations": [
      "Exposure to asbestos is a risk factor for lung cancer",
      "Symptoms of lung cancer may include cough",
      "Lung cancer screening is recommended for people at high risk"
    ]
  },
  {
    "id": "Medical-cfab4b2d",
    "source": "Medical",
    "question": "Why is immunotherapy with checkpoint inhibitors recommended for some colon cancer patients but not others?",
    "answer": "Immunotherapy with checkpoint inhibitors is recommended for dMMR/MSI-H colon cancers but not for pMMR/MSS cancers, which are treated with chemotherapy.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Immunotherapy with checkpoint inhibitors is recommended for dMMR/MSI-H colon cancers.",
      "Immunotherapy with checkpoint inhibitors is not recommended for pMMR/MSS colon cancers.",
      "pMMR/MSS colon cancers are treated with chemotherapy."
    ],
    "evidence_relations": [
      "dMMR/MSI-H is a biomarker guiding immunotherapy",
      "Immunotherapy with checkpoint inhibitors is preferred for dMMR/MSI-H cancers",
      "pMMR/MSS cancers are treated with chemotherapy"
    ]
  },
  {
    "id": "Medical-bb678310",
    "source": "Medical",
    "question": "What is the hierarchical relationship between non-Hodgkin lymphoma, primary cutaneous lymphoma, and cutaneous B-cell lymphoma?",
    "answer": "Cutaneous B-cell lymphoma is a subtype of primary cutaneous lymphoma, which is a form of non-Hodgkin lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Cutaneous B-cell lymphoma is a subtype of primary cutaneous lymphoma.",
      "Primary cutaneous lymphoma is a form of non-Hodgkin lymphoma."
    ],
    "evidence_relations": [
      "Primary cutaneous lymphoma (PCL) is a type of non-Hodgkin lymphoma found in the skin",
      "Cutaneous B-cell lymphoma (CBCL) starts in B cells",
      "CBCL is a subtype of primary cutaneous lymphoma according to the ontology"
    ]
  },
  {
    "id": "Medical-91742d51",
    "source": "Medical",
    "question": "Why is glioblastoma associated with the worst prognosis among glioma subtypes?",
    "answer": "Glioblastoma is the most aggressive subtype and is always high-grade, leading to a poor prognosis.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Glioblastoma is associated with the worst prognosis among glioma subtypes.",
      "Glioblastoma is the most aggressive subtype of glioma.",
      "Glioblastoma is always high-grade."
    ],
    "evidence_relations": [
      "Glioblastoma is the most aggressive subtype of glioma",
      "Grade 4 gliomas are most commonly glioblastomas",
      "High-grade gliomas have poorer prognosis"
    ]
  },
  {
    "id": "Medical-166bcaa7",
    "source": "Medical",
    "question": "Why is Siewert type classification particularly important in the staging and treatment planning of tumors at the esophagogastric junction?",
    "answer": "Siewert types determine staging and guide treatment planning for esophagogastric junction tumors.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Siewert types determine staging for esophagogastric junction tumors.",
      "Siewert types guide treatment planning for esophagogastric junction tumors."
    ],
    "evidence_relations": [
      "Siewert types are used to stage tumors at the esophagogastric junction",
      "Treatment planning is based on cancer type, location, and stage",
      "Siewert types (for EGJ tumors) are included in treatment planning"
    ]
  },
  {
    "id": "Medical-ffffe4b8",
    "source": "Medical",
    "question": "How is platinum-resistant ovarian cancer managed differently from platinum-sensitive recurrence?",
    "answer": "Platinum-resistant disease is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies, while platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab and secondary cytoreductive surgery.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy.",
      "Platinum-resistant ovarian cancer is treated with bevacizumab.",
      "Platinum-resistant ovarian cancer is treated with targeted therapies.",
      "Platinum-sensitive recurrence is treated with platinum-based chemotherapy.",
      "Platinum-sensitive recurrence may be treated with bevacizumab.",
      "Platinum-sensitive recurrence may involve secondary cytoreductive surgery."
    ],
    "evidence_relations": [
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FRα-positive tumors",
      "Platinum-sensitive recurrence is treated with platinum-based chemotherapy, possibly with bevacizumab, and may include secondary cytoreductive surgery",
      "The ontology specifies different treatment regimens for platinum-sensitive and platinum-resistant recurrence"
    ]
  },
  {
    "id": "Medical-fd151825",
    "source": "Medical",
    "question": "Which patients with anal cancer should be encouraged to enroll in clinical trials, and what phases might these trials include?",
    "answer": "All patients with anal cancer should be encouraged to consider clinical trial enrollment, which may include phases I-IV.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "All patients with anal cancer should be encouraged to consider clinical trial enrollment.",
      "Clinical trials may include phases I-IV."
    ],
    "evidence_relations": [
      "Clinical trials are recommended for all patients if available",
      "Clinical Trial: Eligibility: All patients encouraged to consider enrollment",
      "Clinical Trial: Phases: Phase I, Phase II, Phase III, Phase IV"
    ]
  },
  {
    "id": "Medical-5b17d14f",
    "source": "Medical",
    "question": "Why are hyperplastic and inflammatory polyps less concerning than adenomas in colon cancer prevention?",
    "answer": "Hyperplastic and inflammatory polyps rarely become cancer, while adenomas can develop into invasive colon cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hyperplastic polyps rarely become cancer.",
      "Inflammatory polyps rarely become cancer.",
      "Adenomas can develop into invasive colon cancer."
    ],
    "evidence_relations": [
      "Hyperplastic and inflammatory polyps rarely become cancer",
      "Adenomas can become invasive colon cancer over many years"
    ]
  },
  {
    "id": "Medical-ac117ebf",
    "source": "Medical",
    "question": "Why is a biopsy essential in both the diagnosis and management planning for breast cancer?",
    "answer": "Biopsy is essential for definitive diagnosis and biomarker testing, which guides treatment planning in breast cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A biopsy is essential for definitive diagnosis in breast cancer.",
      "A biopsy is essential for biomarker testing in breast cancer.",
      "Biomarker testing guides treatment planning in breast cancer."
    ],
    "evidence_relations": [
      "Biopsy is required for definitive diagnosis and biomarker testing",
      "Diagnosis involves imaging (mammogram, ultrasound, MRI, CT, PET), biopsy, and blood tests"
    ]
  },
  {
    "id": "Medical-0955a900",
    "source": "Medical",
    "question": "How does the presence of both hepatitis B and alcohol use affect liver cancer risk, and what does the ontology indicate about their combined effect?",
    "answer": "Both hepatitis B and alcohol use independently increase the risk of liver cancer, and their presence together further elevates the risk.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hepatitis B independently increases the risk of liver cancer.",
      "Alcohol use independently increases the risk of liver cancer.",
      "The presence of both hepatitis B and alcohol use further elevates the risk of liver cancer."
    ],
    "evidence_relations": [
      "Chronic hepatitis B infection increases the risk of liver cancer",
      "Alcohol use is a risk factor for cirrhosis and liver cancer",
      "Risk Factor: Primary liver cancer is associated with hepatitis B virus (HBV) and alcohol use"
    ]
  },
  {
    "id": "Medical-1eda4787",
    "source": "Medical",
    "question": "Which patients with breast cancer should receive fertility preservation counseling before treatment, and why?",
    "answer": "All patients of reproductive potential should receive fertility preservation counseling before starting breast cancer treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "All patients of reproductive potential should receive fertility preservation counseling before starting breast cancer treatment."
    ],
    "evidence_relations": [
      "Fertility preservation should be discussed before starting treatment",
      "Clinical management includes fertility preservation counseling"
    ]
  },
  {
    "id": "Medical-a6155d9a",
    "source": "Medical",
    "question": "Which systemic therapies may be considered for bone sarcoma patients with MSI-H, dMMR, or TMB-H, and what is the biomarker testing relevance?",
    "answer": "Pembrolizumab, nivolumab, or ipilimumab may be used for bone sarcoma patients with MSI-H, dMMR, or TMB-H identified by biomarker testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pembrolizumab may be used for bone sarcoma patients with MSI-H, dMMR, or TMB-H.",
      "Nivolumab may be used for bone sarcoma patients with MSI-H, dMMR, or TMB-H.",
      "Ipilimumab may be used for bone sarcoma patients with MSI-H, dMMR, or TMB-H.",
      "Biomarker testing is used to identify patients with MSI-H, dMMR, or TMB-H."
    ],
    "evidence_relations": [
      "MSI-H/dMMR status may be treated with pembrolizumab",
      "Tumor mutational burden-high (TMB-H) may be treated with pembrolizumab, nivolumab, or ipilimumab",
      "Biomarker testing includes identification of gene mutations (e.g., IDH1), protein expression, and tumor mutational burden"
    ]
  },
  {
    "id": "Medical-1a56336a",
    "source": "Medical",
    "question": "What distinguishes B-cell lymphoblastic lymphoma (B-LL, B-LBL) from B-cell ALL in terms of disease site?",
    "answer": "B-cell lymphoblastic lymphoma is characterized by B-cell lymphoblasts growing in lymph nodes, whereas B-cell ALL primarily involves bone marrow and blood.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "B-cell lymphoblastic lymphoma is characterized by B-cell lymphoblasts growing in lymph nodes.",
      "B-cell ALL primarily involves bone marrow.",
      "B-cell ALL primarily involves blood."
    ],
    "evidence_relations": [
      "B-cell lymphoblasts growing in lymph nodes is called B-cell lymphoblastic lymphoma (B-LL or B-LBL)",
      "Acute lymphoblastic leukemia (ALL) can be found in bone marrow, blood, testicles, or central nervous system (CNS)",
      "B-cell ALL (B-ALL) starts in B-cell lymphocytes"
    ]
  },
  {
    "id": "Medical-c5b8734d",
    "source": "Medical",
    "question": "What distinguishes carcinoma in situ from invasive bile duct cancer based on histological layers?",
    "answer": "Carcinoma in situ is confined to the epithelium, while invasive cancer penetrates deeper layers such as lamina propria and beyond.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Carcinoma in situ is confined to the epithelium.",
      "Invasive bile duct cancer penetrates deeper layers such as lamina propria and beyond."
    ],
    "evidence_relations": [
      "Tis (carcinoma in situ) is an intraductal tumor confined to the epithelium",
      "The bile duct wall consists of epithelium, lamina propria, muscularis, perimuscular fibrous tissue, and serosa"
    ]
  },
  {
    "id": "Medical-24f2e8ea",
    "source": "Medical",
    "question": "How does the presence of HER2 positivity alter the systemic therapy options for invasive breast cancer?",
    "answer": "HER2 positivity adds HER2-targeted therapy to the systemic treatment options for invasive breast cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "HER2 positivity adds HER2-targeted therapy to the systemic treatment options for invasive breast cancer."
    ],
    "evidence_relations": [
      "HER2-targeted therapy is used for HER2-positive breast cancer",
      "Treatment options for invasive ductal carcinoma include HER2-targeted therapy"
    ]
  },
  {
    "id": "Medical-4777cfbb",
    "source": "Medical",
    "question": "Why would a child with an enlarged thymus and breathing problems be evaluated for T-cell ALL rather than B-cell ALL?",
    "answer": "Because T-cell ALL can cause an enlarged thymus leading to breathing problems, whereas these symptoms are not associated with B-cell ALL.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "A child with an enlarged thymus and breathing problems may be evaluated for T-cell ALL.",
      "T-cell ALL can cause an enlarged thymus.",
      "T-cell ALL can lead to breathing problems.",
      "Breathing problems are not associated with B-cell ALL."
    ],
    "evidence_relations": [
      "T-ALL starts in T-cell lymphocytes and can cause an enlarged thymus",
      "T-ALL can cause breathing problems due to an enlarged thymus",
      "B-ALL starts in B-cell lymphocytes and is more common than T-ALL"
    ]
  },
  {
    "id": "Medical-594504cc",
    "source": "Medical",
    "question": "What genetic and biomarker testing is necessary for ALL patients and how does it impact therapy selection?",
    "answer": "ALL patients require genetic and biomarker testing to identify alterations like BCR::ABL1, which guide targeted therapy selection.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "ALL patients require genetic testing.",
      "ALL patients require biomarker testing.",
      "Genetic and biomarker testing identifies alterations like BCR::ABL1.",
      "BCR::ABL1 alterations guide targeted therapy selection."
    ],
    "evidence_relations": [
      "Diagnosis of ALL involves genetic and biomarker testing",
      "Targeted therapy may be used based on genetic alterations",
      "BCR::ABL1-positive B-ALL is treated with therapies targeting the BCR::ABL protein"
    ]
  },
  {
    "id": "Medical-c57bf64d",
    "source": "Medical",
    "question": "How does family history affect AML risk assessment, and what additional steps should be taken in such cases?",
    "answer": "Family history increases AML risk due to hereditary predisposition, so genetic counseling and testing may be indicated.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Family history increases AML risk.",
      "Family history increases AML risk due to hereditary predisposition.",
      "Genetic counseling may be indicated for patients with a family history of AML.",
      "Genetic testing may be indicated for patients with a family history of AML."
    ],
    "evidence_relations": [
      "Family history of leukemia and hereditary predisposition syndromes are risk factors for AML",
      "Risk Factor includes family history of leukemia and leukemia predisposition syndrome"
    ]
  },
  {
    "id": "Medical-803f66d8",
    "source": "Medical",
    "question": "Why is elevated alpha-fetoprotein (AFP) particularly significant in the context of primary liver cancer screening and diagnosis?",
    "answer": "Because elevated AFP may indicate primary liver cancer and is used as a biomarker in screening and diagnostic protocols.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Elevated alpha-fetoprotein (AFP) may indicate primary liver cancer.",
      "Elevated AFP is used as a biomarker in screening protocols.",
      "Elevated AFP is used as a biomarker in diagnostic protocols."
    ],
    "evidence_relations": [
      "Elevated AFP may indicate primary liver cancer",
      "Liver cancer screening includes ultrasound and alpha-fetoprotein (AFP) test every 6 months",
      "Biomarker: Alpha-fetoprotein (AFP) is used for primary liver cancer"
    ]
  },
  {
    "id": "Medical-5e710a7f",
    "source": "Medical",
    "question": "Which adrenal tumor is most commonly associated with children under 5, and what is a key difference in its spread compared to benign tumors?",
    "answer": "Neuroblastoma is most common in children under 5 and may metastasize to bones, unlike benign tumors which do not metastasize.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Neuroblastoma is the most common adrenal tumor in children under 5.",
      "Neuroblastoma may metastasize to bones.",
      "Benign tumors do not metastasize."
    ],
    "evidence_relations": [
      "Neuroblastoma is a rare malignant adrenal tumor affecting mainly children under 5",
      "Neuroblastoma may metastasize to bones",
      "Benign adrenal tumors do not metastasize"
    ]
  },
  {
    "id": "Medical-65f00413",
    "source": "Medical",
    "question": "How does the treatment strategy differ between localized low-risk and metastatic prostate cancer?",
    "answer": "Localized low-risk prostate cancer may be managed with active surveillance, while metastatic disease requires androgen deprivation therapy and other systemic treatments.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Localized low-risk prostate cancer may be managed with active surveillance.",
      "Metastatic prostate cancer requires androgen deprivation therapy.",
      "Metastatic prostate cancer requires other systemic treatments."
    ],
    "evidence_relations": [
      "Active surveillance is a management option for low-risk, early-stage prostate cancer",
      "Androgen deprivation therapy (ADT) is a mainstay of advanced prostate cancer treatment",
      "Metastatic prostate cancer treatment includes ADT, chemotherapy, immunotherapy, and more"
    ]
  },
  {
    "id": "Medical-b2a64d4a",
    "source": "Medical",
    "question": "Which cell type is diagnostic for the most common subtype of Hodgkin lymphoma, and how is this subtype classified in the ontology?",
    "answer": "Reed-Sternberg cells are diagnostic for classic Hodgkin lymphoma, which is the most common subtype of Hodgkin lymphoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Reed-Sternberg cells are diagnostic for classic Hodgkin lymphoma.",
      "Classic Hodgkin lymphoma is the most common subtype of Hodgkin lymphoma."
    ],
    "evidence_relations": [
      "Classic Hodgkin lymphoma (CHL) is the most common subtype of Hodgkin lymphoma",
      "CHL is characterized by Reed-Sternberg cells"
    ]
  },
  {
    "id": "Medical-f3048835",
    "source": "Medical",
    "question": "What are the main differences in treatment between early and locally advanced NSCLC?",
    "answer": "Early NSCLC is mainly treated with surgery and sometimes radiation, while locally advanced NSCLC may also require chemoradiation.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Early NSCLC is mainly treated with surgery.",
      "Early NSCLC may sometimes be treated with radiation.",
      "Locally advanced NSCLC may require chemoradiation."
    ],
    "evidence_relations": [
      "Surgery is a primary treatment for early or locally advanced NSCLC when possible",
      "Radiation therapy is used for some early NSCLC cases",
      "Chemoradiation is used for some locally advanced NSCLC cases"
    ]
  },
  {
    "id": "Medical-0be2176d",
    "source": "Medical",
    "question": "Why might a patient with FRα-positive platinum-resistant ovarian cancer be treated with mirvetuximab soravtansine-gynx?",
    "answer": "Mirvetuximab soravtansine-gynx is a targeted therapy specifically indicated for FRα-positive platinum-resistant ovarian cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Mirvetuximab soravtansine-gynx is a targeted therapy.",
      "Mirvetuximab soravtansine-gynx is indicated for FRα-positive platinum-resistant ovarian cancer."
    ],
    "evidence_relations": [
      "Platinum-resistant ovarian cancer is treated with non-platinum chemotherapy, bevacizumab, or targeted therapies such as mirvetuximab soravtansine-gynx for FRα-positive tumors",
      "Folate receptor alpha (FRα) is listed as a genetic alteration/biomarker in the ontology"
    ]
  },
  {
    "id": "Medical-54a3a465",
    "source": "Medical",
    "question": "Which maintenance therapies are recommended for a patient with advanced ovarian cancer who is BRCA-mutated after initial treatment?",
    "answer": "PARP inhibitors such as olaparib, niraparib, or rucaparib are recommended as maintenance therapy for advanced or BRCA-mutated ovarian cancer after initial treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "PARP inhibitors are recommended as maintenance therapy for advanced ovarian cancer.",
      "Olaparib is a recommended PARP inhibitor for advanced or BRCA-mutated ovarian cancer.",
      "Niraparib is a recommended PARP inhibitor for advanced or BRCA-mutated ovarian cancer.",
      "Rucaparib is a recommended PARP inhibitor for advanced or BRCA-mutated ovarian cancer.",
      "Maintenance therapy is recommended after initial treatment for advanced or BRCA-mutated ovarian cancer."
    ],
    "evidence_relations": [
      "Maintenance therapy with PARP inhibitors (olaparib, niraparib, rucaparib) is recommended for advanced or BRCA-mutated/HRD-positive cancers after initial treatment",
      "BRCA1 and BRCA2 mutations are major hereditary risk factors for ovarian cancer",
      "Olaparib (Lynparza), Niraparib (Zejula), and Rucaparib (Rubraca) are listed as maintenance therapy options in the ontology"
    ]
  },
  {
    "id": "Medical-136a5739",
    "source": "Medical",
    "question": "Which two polyp types are unlikely to progress to rectal cancer, and how does this contrast with adenomas?",
    "answer": "Hyperplastic and inflammatory polyps rarely turn into cancer, while adenomas can become invasive rectal cancer over many years.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hyperplastic polyps rarely turn into rectal cancer.",
      "Inflammatory polyps rarely turn into rectal cancer.",
      "Adenomas can become invasive rectal cancer over many years."
    ],
    "evidence_relations": [
      "Hyperplastic and inflammatory polyps rarely turn into cancer",
      "Adenomas can become invasive rectal cancer over many years"
    ]
  },
  {
    "id": "Medical-6bd5b75d",
    "source": "Medical",
    "question": "What is the rationale for performing a sentinel lymph node biopsy in invasive breast cancer and not in DCIS?",
    "answer": "Sentinel lymph node biopsy is performed in invasive breast cancer to assess lymph node involvement, which is not required in noninvasive DCIS.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Sentinel lymph node biopsy is performed in invasive breast cancer.",
      "Sentinel lymph node biopsy assesses lymph node involvement.",
      "Sentinel lymph node biopsy is not required in noninvasive DCIS."
    ],
    "evidence_relations": [
      "Sentinel lymph node biopsy is used to assess lymph node involvement",
      "Invasive ductal carcinoma diagnostic methods include sentinel lymph node biopsy",
      "DCIS is noninvasive and does not require sentinel lymph node biopsy"
    ]
  },
  {
    "id": "Medical-8b99b755",
    "source": "Medical",
    "question": "How does the management of high-risk local CSCC differ from low-risk local CSCC in terms of treatment and follow-up?",
    "answer": "High-risk local CSCC is treated with Mohs surgery or standard excision and may require radiation or systemic therapy, with more frequent follow-up exams than low-risk cases.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "High-risk local CSCC is treated with Mohs surgery.",
      "High-risk local CSCC is treated with standard excision.",
      "High-risk local CSCC may require radiation therapy.",
      "High-risk local CSCC may require systemic therapy.",
      "High-risk local CSCC requires more frequent follow-up exams than low-risk cases."
    ],
    "evidence_relations": [
      "High-risk or very high-risk local CSCC is treated with Mohs surgery/PDEMA or standard excision, with consideration of radiation and/or systemic therapy if surgery is not possible",
      "Low-risk local CSCC is primarily treated with surgery (C&E, standard excision, Mohs surgery/PDEMA)",
      "High-risk: Follow-up Strategy: Skin and lymph node exams every 3-6 months for 2 years, then every 6 months for 3 years, then every 6-12 months",
      "Low-risk: Follow-up Strategy: Skin and lymph node exams every 3-12 months for 2 years, then every 6-12 months for 3 years, then annually"
    ]
  },
  {
    "id": "Medical-27c72004",
    "source": "Medical",
    "question": "How do tobacco and alcohol use impact both the risk and outcomes of mouth cancer treatment?",
    "answer": "Tobacco and alcohol use increase the risk of mouth cancer and negatively affect treatment outcomes by increasing toxicity.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Tobacco use increases the risk of mouth cancer.",
      "Alcohol use increases the risk of mouth cancer.",
      "Tobacco use negatively affects treatment outcomes for mouth cancer.",
      "Alcohol use negatively affects treatment outcomes for mouth cancer.",
      "Tobacco and alcohol use increase toxicity in mouth cancer treatment."
    ],
    "evidence_relations": [
      "Tobacco and alcohol use are risk factors for mouth cancer",
      "Smoking or vaping negatively affects treatment outcomes and increases toxicity"
    ]
  },
  {
    "id": "Medical-6f0e62e5",
    "source": "Medical",
    "question": "Why is follow-up with periodic MRI imaging recommended after treatment for glioma?",
    "answer": "Follow-up MRI is recommended to monitor for recurrence after glioma treatment.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Follow-up MRI is recommended after treatment for glioma.",
      "Follow-up MRI is used to monitor for recurrence after glioma treatment."
    ],
    "evidence_relations": [
      "Follow-up with periodic imaging (MRI) is recommended to monitor for recurrence",
      "Treatment options for glioma include surgery, radiation therapy, chemotherapy, and clinical trials"
    ]
  },
  {
    "id": "Medical-641dcaf5",
    "source": "Medical",
    "question": "What distinguishes primary bone cancer from secondary bone malignancy in terms of origin and common cancer types?",
    "answer": "Primary bone cancer originates in bone or cartilage and includes sarcomas, while secondary bone malignancies are metastases from other organs such as breast, lung, or kidney.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Primary bone cancer originates in bone or cartilage.",
      "Primary bone cancer includes sarcomas.",
      "Secondary bone malignancies are metastases from other organs.",
      "Common organs for secondary bone malignancies include breast, lung, or kidney."
    ],
    "evidence_relations": [
      "Primary bone cancer originates in bone or cartilage",
      "Most primary bone cancers are sarcomas",
      "Secondary bone malignancies are cancers that have metastasized to bone from other organs",
      "Secondary bone malignancy: Origin: [\"Breast cancer\", \"Lung cancer\", \"Kidney cancer\"]"
    ]
  },
  {
    "id": "Medical-47b62614",
    "source": "Medical",
    "question": "What is the appropriate targeted therapy for a patient with chondrosarcoma harboring an IDH1 mutation, and how is this mutation identified?",
    "answer": "Ivosidenib is the targeted therapy for chondrosarcoma with IDH1 mutation, which is identified through biomarker testing.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Ivosidenib is the targeted therapy for chondrosarcoma with IDH1 mutation.",
      "IDH1 mutation is identified through biomarker testing."
    ],
    "evidence_relations": [
      "IDH1 mutation in chondrosarcoma can be targeted with ivosidenib",
      "Biomarker testing includes identification of gene mutations (e.g., IDH1)",
      "Chondrosarcoma: Treatment: [\"Ivosidenib (for IDH1 mutation)\"]"
    ]
  },
  {
    "id": "Medical-4f7fc60b",
    "source": "Medical",
    "question": "How is Stage IV pancreatic cancer defined, and what is its alternative name?",
    "answer": "Stage IV pancreatic cancer is defined by distant metastasis to organs like liver, lungs, or abdominal lining, and is also known as metastatic pancreatic cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Stage IV pancreatic cancer is defined by distant metastasis.",
      "Distant metastasis in Stage IV pancreatic cancer can occur to the liver.",
      "Distant metastasis in Stage IV pancreatic cancer can occur to the lungs.",
      "Distant metastasis in Stage IV pancreatic cancer can occur to the abdominal lining.",
      "Stage IV pancreatic cancer is also known as metastatic pancreatic cancer."
    ],
    "evidence_relations": [
      "Stage IV pancreatic cancer has spread to distant organs such as liver, lungs, or abdominal lining",
      "Stage IV pancreatic cancer is metastatic cancer",
      "Stage IV: Distant metastasis (liver, lungs, abdominal lining), Also known as: Metastatic pancreatic cancer (ontology, rewritten: Stage IV pancreatic ductal adenocarcinoma is also called metastatic pancreatic cancer and involves distant metastasis)"
    ]
  },
  {
    "id": "Medical-fc13ecfe",
    "source": "Medical",
    "question": "What is the rationale for recommending chemotherapy after colectomy in stage 3 colon cancer but not always in stage 2?",
    "answer": "Chemotherapy is recommended after colectomy for all stage 3 colon cancers due to lymph node involvement, while only some stage 2 cases receive it as they lack lymph node spread.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chemotherapy is recommended after colectomy for all stage 3 colon cancers.",
      "Stage 3 colon cancers have lymph node involvement.",
      "Only some stage 2 colon cancer cases receive chemotherapy.",
      "Some stage 2 colon cancer cases lack lymph node spread."
    ],
    "evidence_relations": [
      "Stage 3 colon cancer involves spread to nearby lymph nodes or tumor deposits",
      "Chemotherapy is recommended after colectomy for all stage 3 and some stage 2 colon cancers"
    ]
  },
  {
    "id": "Medical-0103d518",
    "source": "Medical",
    "question": "How are hereditary breast-ovarian cancer syndrome and HBOC related to pancreatic ductal adenocarcinoma risk?",
    "answer": "Both hereditary breast-ovarian cancer syndrome and HBOC are genetic syndromes that increase the risk of pancreatic ductal adenocarcinoma.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Hereditary breast-ovarian cancer syndrome is a genetic syndrome.",
      "HBOC is a genetic syndrome.",
      "Both hereditary breast-ovarian cancer syndrome and HBOC increase the risk of pancreatic ductal adenocarcinoma."
    ],
    "evidence_relations": [
      "Hereditary syndromes such as HBOC and hereditary breast-ovarian cancer syndrome increase risk of pancreatic cancer",
      "Genetic Syndrome: Hereditary breast-ovarian cancer syndrome, HBOC (ontology, rewritten: Both hereditary breast-ovarian cancer syndrome and HBOC are risk factors for pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-d3dfaf75",
    "source": "Medical",
    "question": "If a patient presents with rapid heartbeat, headache, and sweating, which adrenal tumor is most likely and what is its origin?",
    "answer": "Pheochromocytoma is most likely, and it originates from the adrenal medulla.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Pheochromocytoma is the most likely adrenal tumor in this case.",
      "Pheochromocytoma originates from the adrenal medulla."
    ],
    "evidence_relations": [
      "Pheochromocytoma arises from the adrenal medulla and is often associated with high blood pressure, headache, rapid heartbeat, and sweating",
      "Pheochromocytoma origin is adrenal medulla"
    ]
  },
  {
    "id": "Medical-056e1e60",
    "source": "Medical",
    "question": "If a patient with pancreatic ductal adenocarcinoma has chronic pancreatitis and a family history of melanoma, what are their risk factors and what additional testing should be considered?",
    "answer": "Chronic pancreatitis and family history of melanoma are risk factors, and genetic testing should be considered to assess for hereditary syndromes.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Chronic pancreatitis is a risk factor for a patient with pancreatic ductal adenocarcinoma.",
      "Family history of melanoma is a risk factor for a patient with pancreatic ductal adenocarcinoma.",
      "Genetic testing should be considered to assess for hereditary syndromes in this patient."
    ],
    "evidence_relations": [
      "Risk factors for pancreatic cancer include chronic pancreatitis and family history of melanoma",
      "Genetic tests can detect inherited mutations linked to hereditary pancreatic cancer",
      "Risk Factor: Chronic pancreatitis, Family history of melanoma (ontology, rewritten: Chronic pancreatitis and family history of melanoma are risk factors for pancreatic ductal adenocarcinoma)"
    ]
  },
  {
    "id": "Medical-df78005a",
    "source": "Medical",
    "question": "How can you distinguish between classic Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma based on cell morphology?",
    "answer": "Classic Hodgkin lymphoma has Reed-Sternberg cells, while nodular lymphocyte-predominant Hodgkin lymphoma has popcorn-shaped cells.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Classic Hodgkin lymphoma has Reed-Sternberg cells.",
      "Nodular lymphocyte-predominant Hodgkin lymphoma has popcorn-shaped cells."
    ],
    "evidence_relations": [
      "CHL is characterized by Reed-Sternberg cells",
      "NLPHL is characterized by popcorn-shaped cells"
    ]
  },
  {
    "id": "Medical-0b5acb42",
    "source": "Medical",
    "question": "What is the relationship between alpha-1-antitrypsin deficiency, cirrhosis, and liver cancer risk?",
    "answer": "Alpha-1-antitrypsin deficiency increases the risk of cirrhosis, which in turn increases the risk of liver cancer.",
    "question_type": "Complex Reasoning",
    "evidence": [
      "Alpha-1-antitrypsin deficiency increases the risk of cirrhosis.",
      "Cirrhosis increases the risk of liver cancer."
    ],
    "evidence_relations": [
      "Alpha-1-antitrypsin deficiency is a risk factor for cirrhosis and liver cancer",
      "Cirrhosis is a major risk factor for developing liver cancer"
    ]
  }
]